Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ACTL6B "ACTL6, BAF53B" ENSG00000077080 "Actin like 6B" O94805 7 100643097-100656461 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 43.6" "Group enriched" "Detected in some" 75 "SCLC-21H: 21.0;SH-SY5Y: 21.4" "Group enriched" "Detected in some" 11 "glioma: 3.9;pancreatic cancer: 1.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045126 Uncertain Approved Nucleoli Nucleoli "HPA045126: AB_10961265" "unprognostic (3.31e-2)" "unprognostic (6.89e-2)" "unprognostic (4.59e-3)" "unprognostic (4.15e-2)" "unprognostic (1.27e-3)" "unprognostic (4.81e-3)" "unprognostic (6.00e-2)" "unprognostic (8.26e-3)" "unprognostic (1.29e-1)" "unprognostic (4.72e-3)" "unprognostic (1.28e-1)" "unprognostic (3.01e-4)" "unprognostic (1.64e-1)" "unprognostic (6.84e-2)" "unprognostic (2.01e-2)" 1.1 3.8 9.4 1.1 17.4 1.1 1.0 25.9 43.6 1.0 1.2 0.8 0.0 1.3 1.0 1.0 1.0 1.0 1.0 1.0 9.7 9.9 1.1 1.0 1.1 1.0 5.3 12.2 1.0 2.2 1.0 7.0 1.0 9.4 1.0 1.1 0.3 1.0 1.0 1.0 1.1 1.2 1.1 1.6 1.0 2.0 1.7 1.9 0.0 1.1 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 17.4 25.9 26.8 9.7 9.9 5.3 12.2 9.4 1.9 ACTR10 "ACTR11, Arp10, Arp11, HARP11" ENSG00000131966 "Actin related protein 10 homolog" Q9NZ32 14 58200080-58235636 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071251 Approved Nucleoli Nucleoli "HPA071251: " "prognostic unfavourable (3.24e-4)" "unprognostic (4.61e-2)" "unprognostic (6.22e-3)" "unprognostic (2.03e-2)" "unprognostic (4.42e-1)" "unprognostic (1.36e-2)" "prognostic unfavourable (2.71e-5)" "unprognostic (3.20e-1)" "unprognostic (9.30e-2)" "unprognostic (1.53e-1)" "unprognostic (4.86e-1)" "unprognostic (2.36e-1)" "prognostic favourable (8.48e-8)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (2.43e-2)" "unprognostic (8.48e-2)" 31.5 22.8 23.8 12.5 27.2 15.8 23.4 16.2 32.3 16.4 23.3 13.6 16.1 10.1 18.2 18.3 18.3 17.6 14.8 27.3 21.8 28.4 20.5 15.4 17.7 16.7 32.5 26.7 19.4 18.5 19.2 18.9 21.3 33.7 22.2 15.2 14.6 35.8 17.6 21.4 26.4 12.8 21.0 18.5 17.5 14.1 13.8 9.7 14.6 18.2 13.2 14.4 13.7 16.3 7.4 5.9 15.8 9.8 7.2 12.0 5.1 3.3 1.9 3.8 1.6 13.2 6.4 1.9 2.6 3.0 4.4 5.3 2.9 3.9 5.0 3.9 5.6 3.4 5.0 3.9 6.0 2.8 12.7 2.0 3.7 5.4 11.2 3.5 3.0 8.2 5.8 3.7 7.4 5.7 1.6 4.1 8.3 9.2 4.6 13.0 1.9 17.7 3.2 6.8 3.0 7.7 4.3 2.2 2.4 5.1 4.0 12.5 7.1 5.9 4.8 4.5 9.2 4.1 2.2 2.4 1.5 5.3 4.9 2.7 2.6 15.8 7.3 10.3 8.4 8.9 12.0 7.4 9.6 8.2 5.3 5.6 10.0 10.2 9.9 7.2 9.8 5.9 6.7 5.1 23.8 27.2 16.2 32.3 21.8 28.4 32.5 26.7 33.7 9.7 ADTRP "AIG1L, C6orf105, dJ413H6.1" ENSG00000111863 "Androgen dependent TFPI regulating protein" Q96IZ2 6 11712054-11807046 "Predicted membrane proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0" "Cell line enhanced" "Detected in some" "hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "pons and medulla: 12.4" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.5;T-reg: 9.8" "Lineage enriched" "Detected in many" 7 "T-cells: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048113 Uncertain Uncertain Nucleoli Nucleoli "HPA048113: " "unprognostic (6.82e-3)" "unprognostic (1.41e-1)" "unprognostic (1.58e-1)" "unprognostic (8.14e-3)" "unprognostic (3.04e-3)" "unprognostic (1.41e-2)" "unprognostic (4.00e-2)" "unprognostic (1.77e-1)" "unprognostic (1.85e-2)" "unprognostic (2.72e-1)" "unprognostic (5.41e-3)" "unprognostic (2.90e-1)" "prognostic unfavourable (1.13e-5)" "unprognostic (2.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.95e-2)" "unprognostic (1.26e-1)" 0.8 0.4 0.6 10.6 0.8 0.0 0.9 0.3 2.1 0.4 21.8 1.5 48.3 22.4 0.4 4.0 0.9 0.5 0.3 0.5 1.2 0.4 3.8 1.0 3.9 2.0 0.4 1.1 0.4 0.6 0.8 0.3 0.3 12.4 1.7 16.2 38.0 0.7 48.0 0.4 12.7 61.2 0.5 0.4 1.0 11.4 14.1 0.1 0.8 0.7 0.6 3.2 2.7 0.5 0.2 0.2 1.4 0.3 0.1 10.5 1.5 1.6 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.3 0.4 0.3 1.5 0.8 0.0 0.7 0.3 0.7 0.0 4.7 0.6 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 8.7 3.5 10.3 35.2 8.5 0.0 1.2 0.0 0.0 0.2 0.1 2.4 0.0 0.1 13.3 0.7 0.1 0.0 0.1 0.6 0.0 0.3 0.0 0.3 19.0 12.7 0.9 0.3 1.0 0.5 14.9 0.0 2.6 0.5 0.1 1.4 0.1 0.0 0.0 0.3 2.3 0.2 2.8 0.2 0.1 0.1 10.5 0.8 0.2 0.1 0.2 0.2 9.8 1.5 0.6 0.8 0.3 2.1 1.2 0.4 0.4 1.1 12.4 0.1 ANKRD30A NY-BR-1 ENSG00000148513 "Ankyrin repeat domain 30A" Q9BXX3 10 37125788-37384111 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 38 "breast: 31.7;testis: 17.8" "Group enriched" "Detected in some" 33 "A549: 3.8;U-266/70: 15.2" "Cancer enriched" "Detected in single" 37 "breast cancer: 11.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA071849 Uncertain Nucleoli Nucleoli "HPA071849: " "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (1.01e-7)" "unprognostic (1.41e-1)" "unprognostic (5.93e-1)" 0.6 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKRD30B NY-BR-1.1 ENSG00000180777 "Ankyrin repeat domain 30B" Q9BXX2 18 14728272-14852738 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 17 "testis: 42.2" "Cell line enriched" "Detected in some" 7 "U-2197: 31.3" "Cancer enhanced" "Detected in single" "breast cancer: 2.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA060455, HPA071849" Uncertain Uncertain Nucleoli Nucleoli "HPA060455: , HPA071849: " "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (9.74e-2)" "unprognostic (2.84e-1)" "unprognostic (1.55e-9)" "unprognostic (1.38e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" 0.3 0.2 1.2 0.1 2.5 0.1 2.3 0.0 1.8 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.9 0.9 0.1 0.1 0.1 0.1 0.4 1.2 0.1 0.6 0.1 0.0 0.1 1.0 0.1 0.2 2.5 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 42.2 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.7 2.5 0.1 31.3 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.5 0.0 1.8 0.9 0.9 0.4 1.2 1.0 0.0 AP002495.1 ENSG00000254469 "Putative short transient receptor potential channel 2-like protein " Q6ZNB5 11 71865509-71928654 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced Nucleoli Nucleoli "HPA051121: , HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 5.8 6.9 8.2 7.7 7.3 9.1 7.3 7.4 8.7 7.5 6.3 11.6 21.7 6.1 9.2 13.2 6.2 7.2 5.0 4.8 6.4 4.9 7.6 5.1 5.4 8.9 6.8 5.4 12.1 7.2 7.4 12.7 4.8 6.6 7.2 8.5 10.4 7.9 15.7 5.9 8.8 7.5 6.4 6.5 7.9 6.9 9.7 11.9 11.6 8.7 3.6 12.2 7.1 6.8 6.0 7.5 3.4 4.5 1.8 8.5 3.2 2.8 6.4 5.1 4.8 1.9 2.0 3.2 3.3 2.5 3.5 3.3 7.5 7.2 6.2 3.0 2.1 9.2 5.4 3.4 3.9 9.0 4.7 9.9 7.1 4.4 1.4 4.8 3.4 2.6 1.6 5.7 4.6 5.2 6.7 9.2 3.5 5.8 4.8 3.5 5.5 4.7 4.0 18.6 4.3 3.7 3.6 7.6 7.8 4.8 4.5 10.1 6.5 2.3 4.8 2.7 4.8 5.2 2.0 5.7 9.0 7.7 4.6 5.1 4.4 3.4 3.0 2.5 4.6 4.5 2.9 4.2 8.5 6.3 3.5 6.0 8.2 6.8 2.6 1.8 2.7 7.5 7.1 3.2 8.2 7.3 7.4 8.7 6.4 4.9 6.8 5.4 6.6 11.9 B3GNT5 "B3GN-T5, beta3Gn-T5" ENSG00000176597 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5" Q9BYG0 3 183253244-183298504 "Enzymes, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 80.2" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.8;hTCEpi: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "neutrophil: 9.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 9.0" "Region enriched" "Detected in single" 12 "cerebellum: 16.5" "Low region specificity" "Detected in many" HPA017292 Uncertain Approved Nucleoli Nucleoli "HPA017292: AB_1845237" "unprognostic (2.17e-1)" "unprognostic (5.73e-2)" "unprognostic (1.07e-2)" "unprognostic (4.83e-3)" "unprognostic (1.89e-1)" "unprognostic (3.08e-2)" "prognostic unfavourable (5.09e-4)" "unprognostic (7.10e-3)" "unprognostic (7.78e-2)" "unprognostic (8.48e-2)" "prognostic unfavourable (7.23e-6)" "unprognostic (4.20e-1)" "prognostic unfavourable (1.30e-7)" "unprognostic (1.18e-2)" "unprognostic (2.71e-1)" "unprognostic (3.53e-2)" "unprognostic (8.10e-3)" 8.6 1.4 2.2 6.1 2.3 31.6 4.3 1.2 2.5 6.4 29.8 5.4 2.1 17.5 3.2 5.4 23.5 5.4 10.1 3.3 3.0 2.9 3.5 3.0 11.2 5.1 4.0 0.7 4.2 3.5 1.8 5.1 19.8 4.5 3.9 9.2 3.2 8.7 2.5 6.6 8.0 80.2 2.9 6.3 2.3 5.1 2.9 2.3 1.0 4.6 18.9 8.9 5.0 10.6 0.1 1.1 9.0 1.5 0.0 0.3 0.4 16.4 1.6 8.9 5.4 7.4 22.0 8.0 0.2 0.4 1.7 1.4 3.3 8.7 0.0 1.0 0.0 7.6 9.1 25.8 1.4 0.0 5.6 0.8 0.7 0.0 9.5 8.3 4.1 10.3 31.4 1.4 23.5 16.0 9.4 0.0 14.1 0.0 0.0 2.7 3.7 14.3 2.6 4.5 0.0 5.4 4.6 0.4 8.5 4.6 0.0 1.9 0.0 10.1 23.6 0.4 3.5 0.5 4.0 0.0 0.0 0.0 3.3 19.6 8.8 0.0 1.5 1.5 0.0 0.3 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.3 0.4 2.2 2.3 1.2 2.5 3.0 2.9 4.0 0.7 4.5 2.3 B3GNTL1 B3GNT8 ENSG00000175711 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1" Q67FW5 17 82942155-83051810 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.6;HL-60: 18.3;THP-1: 17.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023585, HPA024547" Supported Approved Nucleoli Nucleoli "HPA023585: AB_2061075, HPA024547: AB_1845240" "unprognostic (1.51e-2)" "unprognostic (9.84e-2)" "unprognostic (4.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.38e-1)" "unprognostic (8.11e-2)" "unprognostic (2.61e-7)" "unprognostic (9.95e-2)" "unprognostic (2.62e-1)" "unprognostic (1.62e-1)" "unprognostic (8.74e-2)" "unprognostic (2.80e-2)" "unprognostic (4.17e-9)" "unprognostic (2.02e-1)" "unprognostic (1.47e-1)" "unprognostic (1.88e-1)" "unprognostic (3.39e-3)" 3.7 4.3 6.5 7.2 13.9 17.7 4.0 6.4 10.7 4.7 3.6 4.2 1.7 4.7 6.3 6.1 3.7 8.3 3.9 6.2 6.9 4.7 2.9 3.4 4.4 5.6 3.8 7.1 6.6 7.6 1.7 6.1 3.9 7.1 4.6 2.8 3.7 5.6 4.5 5.0 4.4 3.3 5.1 4.4 6.6 4.9 4.0 3.7 6.9 4.4 4.8 3.3 4.3 3.8 3.7 8.8 16.9 5.7 2.4 11.2 3.3 8.1 5.4 0.1 2.6 1.5 4.9 3.4 3.0 2.6 3.4 2.7 3.2 17.6 4.0 5.8 3.6 1.5 1.3 0.0 3.0 6.1 3.6 8.4 8.0 10.9 5.5 18.3 0.3 1.7 1.5 2.1 3.4 4.1 3.6 3.8 2.7 1.8 5.1 7.0 1.3 4.0 6.7 0.6 0.3 1.9 1.7 1.7 0.6 2.5 1.9 2.5 0.0 17.6 6.8 6.7 4.5 0.9 5.2 0.8 1.9 3.0 7.4 2.4 0.9 2.6 5.7 0.9 2.7 5.0 4.1 2.8 4.3 3.0 8.8 3.7 3.8 4.6 16.9 2.4 2.5 3.5 11.2 3.3 6.5 13.9 6.4 10.7 6.9 4.7 3.8 7.1 7.1 3.7 BAHCC1 "BAHD2, KIAA1447" ENSG00000266074 "BAH domain and coiled-coil containing 1" 17 81395475-81466332 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 22.2" "Cell line enhanced" "Detected in many" "MOLT-4: 13.3;NB-4: 45.8;REH: 14.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.4;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023386, HPA076910" Uncertain Approved Nucleoli Nucleoli "HPA023386: AB_1859537, HPA076910: " "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "unprognostic (1.52e-1)" "unprognostic (1.85e-2)" "unprognostic (1.08e-1)" "unprognostic (1.16e-2)" "unprognostic (5.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.05e-2)" "prognostic favourable (7.38e-4)" "unprognostic (1.43e-1)" "unprognostic (1.46e-1)" "unprognostic (2.85e-1)" "unprognostic (1.18e-1)" "unprognostic (2.18e-1)" "unprognostic (3.78e-2)" 5.9 4.8 5.0 3.0 8.3 8.1 3.6 22.2 7.4 5.1 3.1 10.6 1.1 6.0 4.5 2.3 2.5 3.8 5.6 2.2 4.8 2.8 1.1 4.4 1.1 8.5 5.7 6.0 4.3 5.3 3.2 1.6 4.9 4.4 1.5 9.5 6.1 3.8 6.2 4.4 5.5 4.0 3.2 4.9 3.6 4.4 10.4 9.6 2.5 1.6 0.5 3.7 4.4 0.0 1.1 1.4 0.1 0.0 0.0 0.0 1.7 2.9 2.2 7.1 0.8 1.2 1.0 1.3 1.1 0.7 0.4 0.5 0.7 0.0 1.9 1.4 1.7 1.0 0.8 0.1 0.0 3.3 2.3 0.7 0.9 0.7 10.7 2.3 2.0 0.3 0.6 0.6 0.7 1.6 0.0 0.3 1.0 13.3 45.8 0.1 2.0 14.0 1.5 0.0 0.9 0.1 10.0 1.6 1.6 0.0 5.7 0.3 8.6 0.9 3.9 0.5 2.1 0.6 0.0 0.0 0.0 0.0 5.0 0.7 0.1 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 BATF2 MGC20410 ENSG00000168062 "Basic leucine zipper ATF-like transcription factor 2" Q8N1L9 11 64987943-64997045 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 12.2;BJ hTERT+ SV40 Large T+ RasG12V: 18.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 6.6;neutrophil: 9.6" "Group enriched" "Detected in many" 6 "granulocytes: 9.6;monocytes: 6.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA062496 Approved Approved Nucleoli Nucleoli "HPA062496: " "unprognostic (5.29e-2)" "unprognostic (3.36e-2)" "unprognostic (1.44e-1)" "unprognostic (4.59e-2)" "unprognostic (2.31e-2)" "unprognostic (6.11e-2)" "unprognostic (5.08e-2)" "unprognostic (6.92e-3)" "unprognostic (1.03e-1)" "prognostic favourable (9.39e-5)" "prognostic unfavourable (2.12e-4)" "unprognostic (1.28e-1)" "unprognostic (9.09e-3)" "unprognostic (2.34e-3)" "unprognostic (3.17e-2)" "unprognostic (3.82e-2)" "unprognostic (1.12e-2)" 2.8 5.3 2.4 8.3 3.3 0.4 3.2 1.0 3.4 2.0 8.9 1.9 7.2 8.8 2.1 2.8 2.3 2.9 9.3 2.2 1.9 1.7 10.0 5.4 7.8 2.7 2.2 2.4 3.2 17.3 0.7 3.1 3.0 5.9 7.9 6.7 4.2 14.0 5.1 4.8 0.5 14.0 2.7 2.1 18.7 5.1 0.9 1.7 0.9 16.5 1.0 3.4 3.9 1.2 1.3 0.3 9.6 6.6 0.1 0.1 0.9 1.2 0.9 0.2 0.0 0.1 0.5 0.0 0.5 5.7 12.2 18.7 1.7 5.0 0.0 2.4 0.7 0.1 0.0 1.3 0.9 0.1 0.3 1.7 0.0 4.1 4.5 0.0 1.0 0.3 0.4 1.6 2.0 2.9 3.6 0.1 0.2 0.4 0.0 0.1 0.4 0.6 0.0 1.2 0.4 1.5 0.1 0.1 0.0 0.5 0.3 5.8 0.5 0.9 2.2 0.6 0.7 1.0 0.0 0.1 0.1 0.4 1.0 0.5 0.5 0.0 2.6 1.1 0.0 6.6 0.0 1.3 0.0 0.1 0.3 0.4 0.0 0.0 9.6 0.1 3.1 0.0 0.0 0.9 2.4 3.3 1.0 3.4 1.9 1.7 2.2 2.4 5.9 1.7 BCAS3 FLJ20128 ENSG00000141376 "BCAS3, microtubule associated cell migration factor" Q9H6U6 17 60677453-61392838 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052409, HPA057289" Approved Approved Nucleoli Nucleoli "HPA052409: , HPA057289: " "unprognostic (2.84e-2)" "prognostic favourable (2.04e-4)" "unprognostic (1.20e-1)" "unprognostic (3.52e-1)" "unprognostic (5.52e-1)" "unprognostic (3.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "prognostic favourable (1.23e-5)" "unprognostic (2.55e-1)" "prognostic favourable (1.73e-5)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" 12.1 15.9 13.9 8.3 24.1 8.8 11.6 21.5 30.8 12.9 11.4 32.2 12.6 7.1 20.6 18.6 14.3 21.1 11.3 11.7 15.8 14.3 17.1 18.3 13.6 8.5 19.2 18.6 11.9 13.5 26.5 16.9 14.7 24.3 17.1 9.3 16.1 13.6 14.3 20.3 17.0 8.4 13.6 16.3 10.8 11.7 20.2 20.0 16.6 13.7 7.6 13.9 17.0 11.9 9.1 6.9 26.8 8.0 11.7 12.9 6.4 3.3 8.1 4.2 14.0 8.6 7.3 4.9 3.5 4.8 3.6 4.6 5.5 7.4 1.3 6.0 5.8 2.6 2.4 2.9 4.7 3.0 9.4 3.2 4.6 4.9 4.8 1.6 2.7 8.6 3.4 3.0 5.5 4.2 2.7 6.6 3.2 43.2 4.6 1.2 4.4 9.3 5.7 5.7 6.0 3.0 12.6 6.2 5.3 7.1 2.1 5.0 7.7 2.4 3.9 4.8 4.1 2.0 1.6 15.4 12.7 5.6 5.7 1.2 3.7 15.8 7.8 11.7 12.1 6.7 9.8 9.1 8.4 9.2 6.9 8.4 9.3 7.5 26.8 11.7 8.0 4.9 12.9 6.4 13.9 24.1 21.5 30.8 15.8 14.3 19.2 18.6 24.3 20.0 BLCAP BC10 ENSG00000166619 "Bladder cancer associated protein" P62952 20 37492472-37527931 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 102.5" "Cell line enhanced" "Detected in all" "RT4: 70.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047390 Approved Nucleoli Nucleoli "HPA047390: " "unprognostic (1.05e-2)" "unprognostic (7.91e-3)" "unprognostic (3.52e-2)" "prognostic unfavourable (1.40e-4)" "unprognostic (7.08e-2)" "unprognostic (1.27e-2)" "unprognostic (3.49e-1)" "unprognostic (3.51e-1)" "unprognostic (4.45e-1)" "unprognostic (1.91e-3)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.04e-3)" "unprognostic (1.96e-2)" "unprognostic (7.62e-2)" "unprognostic (1.37e-2)" "prognostic favourable (7.28e-5)" 18.9 16.7 31.6 12.9 89.5 10.7 16.4 23.2 40.1 14.3 15.6 13.3 11.4 17.6 9.8 19.9 18.5 50.5 17.9 23.5 26.5 44.4 21.3 23.8 12.2 12.5 22.5 28.3 15.1 7.9 15.4 34.4 26.1 27.6 18.9 18.8 13.4 17.7 21.1 102.5 30.3 18.9 13.4 13.4 14.2 12.4 12.2 10.6 8.5 14.0 27.3 17.8 20.2 12.7 48.0 20.5 26.6 22.2 17.0 28.4 18.7 26.4 7.8 9.2 9.5 17.8 13.7 13.0 12.7 12.4 11.3 9.3 27.2 21.6 13.8 12.8 17.7 51.4 6.8 52.7 11.8 2.8 6.1 4.5 17.4 25.2 11.4 8.9 6.0 17.4 56.8 10.9 20.7 15.8 4.3 10.4 22.8 14.9 7.4 7.1 7.3 22.0 7.0 34.4 9.2 13.0 70.9 8.4 10.2 15.2 44.3 10.3 14.6 8.6 15.0 29.5 7.5 10.3 5.4 5.7 7.0 6.6 12.2 8.2 5.2 26.6 22.2 25.9 18.7 21.5 20.4 37.5 21.4 19.8 20.5 48.0 28.4 22.0 23.2 17.0 19.3 8.8 20.6 18.7 31.6 89.5 23.2 40.1 26.5 44.4 22.5 28.3 27.6 10.6 BRF2 "BRFU, FLJ11052, TFIIIB50" ENSG00000104221 "BRF2, RNA polymerase III transcription initiation factor subunit" Q9HAW0 8 37843268-37849904 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019269, HPA023378" Supported Supported Nucleoli Nucleoli "CAB019269: , HPA023378: AB_1845446" "unprognostic (9.85e-3)" "unprognostic (2.74e-1)" "unprognostic (2.95e-2)" "unprognostic (2.00e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-3)" "unprognostic (3.91e-2)" "unprognostic (2.35e-2)" "unprognostic (9.68e-2)" "unprognostic (3.31e-1)" "unprognostic (2.11e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (2.52e-3)" "unprognostic (1.33e-1)" "unprognostic (1.93e-1)" "unprognostic (7.41e-2)" 12.6 10.3 8.4 8.3 9.9 19.0 12.1 9.8 17.9 12.8 11.0 8.7 9.7 7.5 14.7 10.4 9.2 12.9 8.6 17.0 9.9 8.6 8.7 8.8 9.0 11.6 10.2 10.7 20.2 16.2 8.4 11.1 12.9 9.5 14.8 8.5 11.4 10.6 13.3 32.4 11.9 8.1 12.4 7.4 11.0 9.5 13.1 9.9 21.7 10.7 10.7 9.0 11.5 19.0 12.8 8.3 10.2 8.8 16.6 19.1 10.2 9.6 7.5 7.4 9.8 10.3 7.6 8.7 11.6 9.1 15.5 10.7 9.7 7.0 11.8 17.0 7.1 10.1 9.5 7.2 7.7 7.5 9.6 14.7 6.3 7.8 10.7 5.8 8.8 10.1 9.5 15.5 6.6 5.0 17.9 10.7 5.0 5.7 18.3 8.4 12.7 9.6 11.4 8.6 6.1 5.6 6.5 6.3 8.3 5.5 8.0 13.0 17.0 12.8 6.7 8.3 11.1 17.9 11.9 13.3 17.8 14.0 11.4 8.9 14.6 10.2 8.8 9.5 12.7 7.8 12.7 12.7 13.3 12.9 6.9 12.8 19.1 15.3 3.6 16.6 7.2 8.3 11.5 10.2 8.4 9.9 9.8 17.9 9.9 8.6 10.2 10.7 9.5 9.9 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281883-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.0" "Cell line enhanced" "Detected in some" "A-431: 7.9;BEWO: 8.8;CACO-2: 8.2;CAPAN-2: 26.6;SK-BR-3: 9.3;T-47d: 10.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 5.4" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013788 Uncertain Uncertain Nucleoli Nucleoli "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favourable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.3 0.1 0.3 6.5 0.3 0.0 7.4 0.3 0.3 3.9 28.6 0.4 7.4 20.6 1.0 10.9 11.2 2.6 20.7 0.3 0.3 0.1 25.2 3.3 13.5 0.3 0.3 0.3 1.0 29.8 3.0 9.6 6.1 0.4 4.4 14.4 0.4 25.8 7.2 0.3 10.6 64.0 0.5 0.3 0.3 14.6 1.1 0.3 1.0 32.1 7.8 7.7 3.4 5.2 0.1 0.3 5.4 0.3 0.4 0.2 0.0 7.9 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 8.2 26.6 0.0 0.2 0.0 6.0 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 5.1 3.2 0.2 0.0 9.3 0.0 10.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.1 0.0 0.2 0.3 0.4 0.3 0.2 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.4 0.3 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96032684 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.6" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA044091, HPA072122" Enhanced Approved Nucleoli Nucleoli "HPA044091: , HPA072122: " "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.5 1.7 1.0 1.7 1.0 1.7 0.6 0.3 3.1 0.8 0.8 0.6 2.3 0.2 0.8 1.3 2.0 0.8 0.6 0.6 0.6 0.3 0.9 1.1 0.9 0.8 0.2 0.0 0.4 0.7 0.9 0.0 0.5 0.1 1.6 2.6 0.9 1.2 0.7 1.4 0.6 10.6 4.0 0.0 1.0 1.1 4.1 1.0 1.8 1.0 0.8 2.9 0.5 1.1 3.9 3.8 7.1 0.2 0.4 4.1 3.8 0.4 0.6 0.1 4.1 0.8 5.0 3.0 0.0 2.7 0.3 0.2 0.0 4.9 8.6 9.1 3.3 3.1 0.0 9.6 0.6 0.6 0.0 0.4 0.1 0.3 7.8 2.9 0.9 2.4 4.4 3.2 8.3 6.5 11.4 3.4 4.2 0.7 1.3 7.0 3.7 4.2 1.1 2.7 6.9 4.3 3.3 4.4 4.4 3.0 5.5 2.6 10.8 0.1 3.3 9.8 2.8 0.0 1.0 0.2 1.9 0.3 2.9 3.4 1.4 1.1 0.9 4.1 1.3 0.4 1.8 0.8 0.8 1.0 0.8 0.5 CCDC136 "DKFZP434G156, KIAA1793, NAG6" ENSG00000128596 "Coiled-coil domain containing 136" Q96JN2 7 128790757-128822132 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Fertilization, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 34.7;testis: 109.6" "Cell line enhanced" "Detected in many" "U-87 MG: 18.4;U-937: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010647, HPA071015" Enhanced Uncertain Nucleoli Nucleoli "HPA010647: AB_2259798, HPA071015: " "unprognostic (2.07e-2)" "unprognostic (2.32e-2)" "unprognostic (1.29e-4)" "unprognostic (4.65e-2)" "unprognostic (4.52e-1)" "unprognostic (2.16e-1)" "unprognostic (1.66e-2)" "unprognostic (2.53e-1)" "unprognostic (5.43e-4)" "unprognostic (2.58e-2)" "unprognostic (8.44e-3)" "unprognostic (4.35e-1)" "unprognostic (1.18e-4)" "unprognostic (5.27e-3)" "unprognostic (4.85e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" 2.1 4.0 11.2 2.6 11.7 1.8 2.4 34.7 28.7 2.9 6.5 8.3 2.6 2.4 3.9 2.9 2.5 2.8 2.8 4.9 12.5 20.0 1.5 1.5 1.9 3.0 15.3 16.6 2.8 1.8 1.8 3.8 2.2 11.2 9.9 3.5 13.9 2.0 11.0 3.5 1.6 2.6 17.3 9.7 1.9 2.4 109.6 7.4 0.7 1.7 0.0 2.4 6.4 2.0 0.1 0.6 1.3 0.3 2.7 1.6 0.3 0.7 0.8 7.2 4.8 3.9 3.3 1.2 2.7 3.6 2.8 2.6 1.0 0.6 3.6 0.3 3.7 1.5 4.5 0.5 2.6 10.1 4.6 6.2 1.7 0.0 1.3 0.7 13.5 3.7 0.5 3.0 0.2 1.6 2.2 3.8 1.0 1.3 4.5 1.9 9.9 2.9 11.3 1.2 1.7 0.2 1.2 4.2 12.5 1.6 1.9 2.8 0.1 1.7 1.4 4.5 2.6 2.1 2.1 2.2 0.9 3.7 18.4 27.1 1.1 0.0 0.3 1.3 1.4 0.0 1.6 0.0 1.5 1.1 0.6 0.1 0.0 1.0 0.1 2.7 0.1 0.1 0.0 0.3 11.2 11.7 34.7 28.7 12.5 20.0 15.3 16.6 11.2 7.4 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666364-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Supported Nucleoli Nucleoli "HPA052637: , HPA053914: " "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavourable (1.35e-7)" "prognostic unfavourable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 11.3 10.9 10.9 16.0 14.1 20.2 10.2 11.3 17.0 10.3 11.5 8.0 8.9 16.2 9.1 6.4 25.2 9.2 9.1 9.1 12.1 9.0 10.6 12.1 8.7 18.8 12.4 11.9 8.4 12.0 9.4 8.4 11.2 11.8 13.1 6.4 5.7 13.0 9.9 12.7 29.8 11.8 10.3 9.1 17.7 11.4 13.4 12.4 9.8 9.2 13.1 16.6 10.6 14.7 12.8 12.6 10.2 9.2 11.9 11.2 5.9 12.4 24.6 6.7 11.9 4.8 4.9 13.4 14.2 6.8 20.5 11.3 21.6 7.5 12.8 7.6 8.5 16.3 13.8 16.0 7.6 6.5 21.2 19.9 10.9 17.1 7.4 15.2 13.0 7.1 8.6 18.8 8.5 14.3 18.8 6.8 9.6 13.5 15.1 16.4 16.0 24.8 18.1 12.7 8.2 6.4 11.3 16.4 21.2 13.0 26.8 11.6 19.3 12.6 9.8 29.6 17.3 11.9 19.6 18.1 10.4 13.0 10.7 14.9 16.7 1.9 7.8 10.2 11.2 8.4 7.0 10.3 9.7 9.6 7.4 12.8 10.7 9.6 3.5 11.9 9.2 12.6 9.5 5.9 10.9 14.1 11.3 17.0 12.1 9.0 12.4 11.9 11.8 12.4 CCDC149 DKFZp761B107 ENSG00000181982 "Coiled-coil domain containing 149" Q6ZUS6 4 24806117-24980204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-87 MG: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 4.5" "Lineage enriched" "Detected in single" 6 "monocytes: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044158, HPA047913" Uncertain Approved Nucleoli Nucleoli "HPA044158: , HPA047913: " "unprognostic (1.68e-1)" "unprognostic (2.43e-1)" "unprognostic (1.09e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.06e-1)" "unprognostic (4.11e-4)" "unprognostic (9.71e-5)" "unprognostic (2.68e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-2)" "unprognostic (8.59e-3)" "unprognostic (2.25e-1)" "unprognostic (2.80e-3)" "unprognostic (8.87e-2)" "unprognostic (2.25e-1)" "unprognostic (5.03e-2)" "unprognostic (4.80e-2)" 11.7 8.3 20.1 8.2 14.7 2.8 16.7 14.8 20.6 13.2 10.8 6.9 11.1 5.3 12.9 9.2 7.9 13.9 9.9 10.9 15.9 11.5 7.5 10.3 10.0 4.4 11.5 12.7 15.9 31.7 12.8 11.2 11.6 11.3 14.3 8.6 7.5 29.8 10.1 8.6 6.9 6.4 14.5 9.9 5.8 13.8 5.4 9.4 0.9 11.9 4.6 4.3 9.6 18.3 0.0 0.8 0.8 4.5 0.2 0.0 1.2 4.1 1.6 3.3 0.5 5.2 9.7 1.0 6.0 9.2 4.8 5.6 0.1 4.6 0.0 2.9 11.4 0.7 1.0 0.7 3.2 0.0 0.0 0.0 0.3 0.3 4.4 0.0 0.0 6.6 4.3 2.7 0.0 3.9 0.0 0.8 2.9 4.4 0.0 0.1 3.8 4.6 0.0 0.0 0.2 8.7 3.0 4.6 0.0 2.6 3.8 12.3 6.5 9.3 9.3 7.0 0.8 5.2 5.2 0.1 0.0 0.0 21.6 0.9 4.8 0.0 4.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.2 1.5 0.7 0.0 1.2 20.1 14.7 14.8 20.0 15.9 11.5 11.5 12.7 11.3 9.4 CDKN2A "ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf" ENSG00000147889 "Cyclin dependent kinase inhibitor 2A" "P42771, Q8N726" 9 21967753-21995301 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway" DNA-binding "Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 22.6;pituitary gland: 39.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "T-reg: 22.6" "Group enriched" "Detected in many" 8 "B-cells: 7.2;T-cells: 22.6" "Low region specificity" "Detected in many" "CAB000093, CAB000445, CAB018232, HPA047838" Enhanced Supported Nucleoli Nucleoli "CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: " "unprognostic (3.41e-2)" "unprognostic (4.51e-2)" "unprognostic (3.00e-3)" "prognostic unfavourable (1.82e-7)" "unprognostic (5.22e-2)" "prognostic favourable (5.19e-4)" "prognostic unfavourable (2.17e-4)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-1)" "unprognostic (1.56e-2)" "prognostic unfavourable (5.76e-7)" "unprognostic (9.41e-2)" "unprognostic (1.22e-2)" "unprognostic (3.05e-2)" "unprognostic (3.55e-1)" 5.4 8.6 2.9 4.5 3.9 1.8 5.3 1.7 3.1 1.2 2.5 4.4 0.1 1.2 1.2 1.9 6.3 3.0 2.6 0.7 1.7 1.0 0.9 1.2 3.0 3.0 3.6 1.6 1.5 1.5 8.5 39.3 6.7 5.0 1.9 1.1 1.2 2.4 2.9 0.9 1.3 3.7 1.0 3.0 8.9 6.0 13.0 1.9 3.9 1.4 3.0 14.0 2.7 1.5 7.2 0.2 0.8 1.8 0.4 22.6 2.2 2.1 0.0 0.3 14.1 0.1 0.1 6.1 2.3 0.0 19.6 34.9 3.5 50.0 7.2 32.2 1.6 6.0 5.9 36.4 15.8 30.9 56.7 0.0 53.1 2.3 1.5 3.5 3.0 3.8 0.0 19.8 11.0 2.0 0.0 32.9 17.9 0.1 0.3 0.0 0.4 29.2 0.0 13.3 26.4 4.0 0.0 33.0 2.3 38.0 6.3 53.0 7.5 0.1 6.5 0.1 0.4 0.0 0.1 14.7 8.3 29.4 0.0 9.4 0.1 0.8 1.3 0.2 6.2 0.6 9.7 7.2 8.0 11.0 0.2 7.0 0.5 4.7 0.4 0.4 1.8 0.0 22.6 2.2 2.9 3.9 1.7 3.1 1.7 1.0 3.6 1.6 5.0 1.9 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "liver: 298.3" "Cell line enhanced" "Detected in many" "HeLa: 88.4;SK-BR-3: 26.7" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported Nucleoli 2100000 Nucleoli "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favourable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 0.4 0.1 0.5 0.3 1.6 0.0 0.8 0.3 0.7 0.4 0.2 0.7 0.3 31.5 0.3 0.7 0.5 0.2 0.4 0.3 0.5 0.4 0.6 298.3 0.2 0.3 1.5 0.8 0.7 0.2 0.0 0.4 1.1 1.4 0.3 0.0 0.6 0.2 0.2 0.3 0.3 17.2 0.4 2.3 0.3 0.2 1.3 0.5 0.0 0.4 0.4 0.1 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.3 2.3 6.2 4.2 4.1 7.2 6.6 2.2 2.7 2.6 4.1 0.6 0.0 1.0 0.1 2.4 1.1 0.2 3.7 6.6 0.0 1.9 3.9 88.4 5.5 1.3 2.0 0.0 3.7 2.8 5.2 5.3 0.2 3.9 0.3 4.3 1.1 0.1 0.2 2.4 0.6 0.2 5.7 0.5 5.6 0.0 0.1 0.4 15.5 26.7 3.0 0.0 0.6 2.9 6.8 2.1 2.0 4.8 0.0 0.3 0.0 4.5 4.3 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.6 0.3 0.7 0.5 0.4 1.5 0.8 1.4 0.5 DDX10 "Dbp4, HRH-J8" ENSG00000178105 "DEAD-box helicase 10" Q13206 11 108665025-108940930 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 57.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004691 Approved Approved Nucleoli Nucleoli "HPA004691: AB_1078629" "unprognostic (9.49e-2)" "unprognostic (9.32e-2)" "unprognostic (1.34e-1)" "unprognostic (2.58e-1)" "unprognostic (7.97e-2)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.52e-5)" "unprognostic (2.86e-2)" "unprognostic (1.23e-2)" "unprognostic (1.06e-1)" "prognostic unfavourable (5.75e-4)" "unprognostic (1.00e-1)" "prognostic favourable (2.14e-5)" "unprognostic (5.20e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-1)" "unprognostic (2.43e-3)" 14.0 11.9 17.3 15.0 20.3 10.4 15.5 20.5 18.3 14.3 12.2 8.1 11.7 8.8 18.4 12.8 12.6 16.8 8.8 12.1 13.5 11.5 19.6 12.5 10.6 13.1 12.2 16.3 18.6 18.0 16.7 22.2 12.9 13.1 12.4 13.3 7.9 10.6 14.7 13.6 14.8 9.1 16.8 13.3 15.0 11.3 25.1 12.6 13.8 13.4 8.8 14.2 14.3 18.8 11.6 8.4 1.4 6.7 9.4 11.3 4.3 7.2 7.1 6.8 9.5 6.7 5.5 7.1 7.8 4.2 9.5 9.4 20.3 10.7 24.7 14.8 6.0 8.2 19.4 9.5 13.7 9.4 8.7 16.8 4.2 7.6 12.0 17.1 8.0 4.9 7.5 10.8 13.5 8.6 23.5 2.7 9.3 4.7 14.3 14.4 8.8 10.9 12.2 11.1 23.1 5.8 6.3 12.6 6.7 11.0 9.7 4.1 11.7 6.0 9.1 10.0 10.2 9.5 10.6 4.2 7.3 57.2 3.4 20.6 10.1 1.4 5.0 1.0 8.6 6.7 11.3 10.4 7.5 10.1 8.4 11.6 8.1 7.8 0.7 9.4 6.4 8.2 6.3 4.3 17.3 20.3 20.5 18.3 13.5 11.5 12.2 16.3 13.1 12.6 DDX18 "Has1, MrDb" ENSG00000088205 "DEAD-box helicase 18" Q9NVP1 2 117814650-117832379 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 88.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035400, HPA041056" Approved Supported Nucleoli Nucleoli "HPA035400: AB_10672091, HPA041056: " "unprognostic (1.44e-1)" "unprognostic (2.22e-2)" "unprognostic (5.63e-2)" "prognostic unfavourable (2.64e-4)" "unprognostic (2.06e-1)" "unprognostic (1.77e-3)" "prognostic unfavourable (3.07e-4)" "unprognostic (8.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (1.42e-2)" "unprognostic (4.94e-2)" "unprognostic (8.51e-2)" "unprognostic (1.45e-1)" "unprognostic (1.53e-1)" "unprognostic (7.28e-2)" "unprognostic (5.65e-2)" 35.3 21.3 20.5 28.7 26.0 17.4 31.2 27.1 25.6 31.2 27.9 16.7 21.6 20.9 32.0 22.9 27.8 28.5 21.3 22.9 19.6 19.1 32.0 40.3 24.1 35.0 25.5 22.9 36.3 29.5 21.0 25.9 25.0 25.0 25.0 30.3 11.5 24.2 26.6 37.0 24.9 26.3 28.3 30.8 46.5 26.2 22.9 31.1 40.7 31.3 23.9 37.6 37.6 23.7 22.2 20.5 9.4 18.5 17.2 23.6 16.3 21.5 9.8 14.7 13.2 8.7 7.9 24.2 12.8 10.1 17.7 15.7 24.1 14.3 31.8 21.0 10.6 16.8 28.5 16.6 26.2 16.2 19.9 30.4 9.2 24.2 12.2 40.5 15.9 8.2 15.3 22.5 22.8 10.6 33.1 13.8 13.5 13.4 22.1 21.2 36.8 14.8 19.3 22.9 27.9 11.7 12.8 14.1 24.0 14.9 16.4 16.6 10.4 22.4 8.1 15.9 23.4 11.1 23.0 15.9 19.8 88.2 11.7 19.2 7.1 6.2 13.8 9.4 16.2 17.3 20.6 22.2 19.3 18.5 12.5 19.1 23.6 20.7 3.6 17.2 18.5 20.5 15.0 16.3 20.5 26.0 27.1 25.6 19.6 19.1 25.5 22.9 25.0 31.1 DDX27 "dJ686N3.1, DRS1" ENSG00000124228 "DEAD-box helicase 27" Q96GQ7 20 49219295-49244077 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047087 Uncertain Approved Nucleoli Nucleoli "HPA047087: AB_10964059" "unprognostic (4.47e-2)" "unprognostic (2.41e-2)" "unprognostic (3.13e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (2.82e-1)" "unprognostic (7.12e-2)" "prognostic unfavourable (6.70e-7)" "unprognostic (2.28e-1)" "unprognostic (9.53e-2)" "unprognostic (2.74e-1)" "unprognostic (7.18e-2)" "unprognostic (5.84e-3)" "prognostic unfavourable (1.73e-4)" "unprognostic (1.26e-1)" "unprognostic (4.32e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" 22.0 22.5 21.9 33.0 23.2 40.9 23.6 34.8 26.3 24.3 26.4 16.3 20.4 23.2 26.2 19.1 26.5 23.9 27.1 19.2 22.6 17.3 25.9 21.0 20.1 32.3 19.9 18.8 37.4 27.3 25.9 25.6 23.9 21.2 22.0 22.1 14.4 22.9 24.3 32.9 27.8 33.6 20.0 20.7 34.1 22.9 25.0 24.0 30.6 23.5 19.4 35.3 24.0 27.2 30.4 28.0 22.2 24.2 18.2 26.7 18.6 20.1 19.1 9.8 7.5 11.0 10.1 28.0 13.4 11.0 42.3 19.6 62.3 22.6 24.0 25.0 10.9 28.6 21.8 21.5 31.5 8.4 12.8 18.2 16.1 30.2 16.1 23.0 21.3 10.7 25.2 24.6 19.0 7.0 24.7 13.3 13.7 13.5 24.2 30.4 18.6 24.9 20.9 24.5 22.0 15.3 15.6 12.8 15.2 37.4 54.0 22.5 28.5 26.7 8.7 27.2 24.0 22.7 27.8 15.2 16.3 31.4 17.4 18.3 17.5 11.1 19.8 22.2 21.7 21.2 22.8 29.4 20.6 19.7 23.3 30.4 26.7 20.3 8.1 18.2 24.2 28.0 26.3 18.6 21.9 23.2 34.8 26.3 22.6 17.3 19.9 18.8 21.2 24.0 DDX47 "DKFZp564O176, FLJ30012, HQ0256, RRP3" ENSG00000213782 "DEAD-box helicase 47" Q9H0S4 12 12813316-12829981 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014855 Approved Supported Nucleoli Nucleoli "HPA014855: AB_1847567" "unprognostic (3.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-2)" "unprognostic (2.38e-1)" "unprognostic (4.91e-2)" "unprognostic (5.84e-4)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "unprognostic (3.49e-3)" "unprognostic (6.55e-9)" "unprognostic (1.68e-1)" "unprognostic (1.27e-1)" "unprognostic (3.24e-1)" "unprognostic (8.20e-6)" 29.3 24.1 19.9 21.6 25.6 31.0 29.1 27.4 26.9 26.7 26.2 28.2 21.4 16.0 33.7 21.0 28.9 27.5 17.9 22.6 20.0 19.4 29.6 38.1 23.2 26.1 28.2 19.9 33.7 31.0 25.8 23.8 27.6 25.1 29.2 24.2 25.5 27.1 27.7 40.6 28.1 20.4 34.1 21.4 25.6 28.0 26.8 29.8 29.7 39.4 27.9 33.7 35.7 26.7 22.0 25.0 3.5 19.1 16.6 26.0 14.0 39.6 17.2 16.9 13.7 16.6 16.4 28.8 17.1 19.6 36.5 34.2 25.9 25.6 20.4 6.7 23.1 25.9 24.2 19.7 41.1 28.8 17.3 18.7 12.8 14.7 14.1 21.2 12.0 15.8 18.7 21.6 17.9 28.0 18.0 4.6 19.9 14.2 17.2 14.7 74.0 10.5 19.1 32.8 12.3 22.2 28.6 7.4 18.8 20.7 13.3 17.0 5.4 16.1 12.5 14.7 35.8 9.4 25.6 6.5 11.8 37.0 15.7 11.1 16.9 3.3 14.4 3.5 21.8 19.1 26.0 22.0 19.4 20.1 25.0 21.2 25.8 24.2 1.7 16.6 18.2 14.7 18.7 14.0 19.9 25.6 27.4 26.9 20.0 19.4 28.2 19.9 25.1 29.8 DDX50 "GU2, GUB, MGC3199, RH-II/GuB" ENSG00000107625 "DExD-box helicase 50" Q9BQ39 10 68901278-68946847 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037388, HPA037389, HPA058196" Approved Enhanced Nucleoli Nucleoli "HPA037388: AB_10671752, HPA037389: , HPA058196: " "unprognostic (2.05e-1)" "unprognostic (3.36e-1)" "unprognostic (9.90e-2)" "unprognostic (9.75e-2)" "unprognostic (1.29e-1)" "unprognostic (1.23e-1)" "unprognostic (1.47e-3)" "unprognostic (2.62e-1)" "unprognostic (1.97e-1)" "unprognostic (8.78e-2)" "unprognostic (4.57e-2)" "unprognostic (1.44e-1)" "unprognostic (4.22e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-2)" "unprognostic (4.91e-2)" "unprognostic (1.02e-1)" 25.0 17.8 16.7 25.5 19.2 14.7 24.8 20.8 17.0 26.5 25.3 13.1 24.0 12.9 30.0 22.6 24.0 23.0 17.5 20.3 15.7 15.0 18.6 16.1 16.4 24.5 17.6 15.0 35.3 24.1 24.9 35.2 23.0 16.1 30.0 18.1 12.6 19.5 25.0 26.6 18.3 17.4 31.9 18.3 22.0 19.9 25.6 17.3 33.0 26.1 21.5 25.7 35.4 27.2 14.2 10.3 10.7 12.2 13.8 20.2 10.9 19.3 12.5 22.2 27.5 18.9 24.7 14.2 20.7 22.8 18.7 17.7 28.0 16.9 25.2 12.5 18.2 17.4 21.5 15.2 23.4 22.1 16.3 13.5 12.4 12.2 19.1 28.1 16.9 19.0 15.9 17.8 49.8 15.0 24.1 15.4 23.0 15.5 26.8 27.0 12.9 28.1 23.3 25.3 4.5 14.7 11.6 15.5 21.4 15.2 17.8 22.8 20.7 18.3 13.0 14.6 17.1 16.5 28.1 20.9 18.8 21.4 15.7 29.4 8.5 5.5 7.8 10.7 15.0 12.2 18.3 13.6 18.5 15.4 10.3 14.2 20.2 17.7 2.7 13.8 9.6 10.2 16.1 10.9 16.7 19.2 20.8 17.0 15.7 15.0 17.6 15.0 16.1 17.3 DDX56 NOH61 ENSG00000136271 "DEAD-box helicase 56" Q9NY93 7 44565417-44575051 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019749, CAB037320" Uncertain Supported Nucleoli Nucleoli "CAB037320: , HPA019749: AB_1847579" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-2)" "unprognostic (1.93e-1)" "unprognostic (6.08e-3)" "unprognostic (2.12e-3)" "prognostic unfavourable (1.38e-5)" "unprognostic (5.17e-2)" "unprognostic (2.76e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-2)" "unprognostic (6.01e-3)" "prognostic unfavourable (8.41e-7)" "unprognostic (2.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 12.8 12.0 10.3 12.4 11.9 12.4 9.2 13.6 18.9 11.9 10.0 12.2 8.6 11.9 12.8 10.3 13.1 12.6 12.5 9.3 10.6 9.9 17.7 29.2 8.9 13.2 10.4 9.3 15.0 22.5 13.1 11.9 12.3 12.2 14.1 9.0 11.0 16.9 11.5 16.9 16.3 11.4 8.4 8.8 12.1 10.6 14.6 10.9 14.5 13.8 16.7 15.1 9.2 10.3 12.8 16.0 6.9 16.5 15.7 12.3 12.7 7.6 20.4 1.5 4.4 2.0 2.0 6.8 7.2 3.7 8.2 7.3 13.2 7.5 13.5 9.4 2.7 13.1 3.3 7.2 1.5 5.0 20.7 8.8 12.9 10.0 3.5 9.3 4.9 2.9 5.2 7.3 4.6 4.2 18.2 3.8 5.3 10.0 4.6 8.6 11.1 19.2 3.8 7.2 5.3 4.7 8.1 5.2 8.4 9.6 14.9 5.5 10.8 9.6 8.8 6.8 9.8 4.6 18.2 12.4 18.9 19.3 7.5 11.4 9.5 6.9 11.8 4.3 9.9 15.3 12.3 11.5 10.7 11.1 16.0 12.8 12.3 10.3 0.4 15.7 16.5 7.7 10.1 12.7 10.3 11.9 13.6 18.9 10.6 9.9 10.4 9.3 12.2 10.9 DHX33 "DDX33, DKFZp762F2011, FLJ21972" ENSG00000005100 "DEAH-box helicase 33" Q9H6R0 17 5440912-5469060 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073875 Supported Supported Nucleoli Nucleoli "HPA073875: " "unprognostic (4.96e-2)" "unprognostic (1.35e-1)" "unprognostic (3.41e-2)" "unprognostic (2.51e-2)" "unprognostic (9.24e-2)" "unprognostic (1.90e-1)" "unprognostic (1.49e-2)" "unprognostic (6.15e-2)" "unprognostic (3.11e-2)" "unprognostic (3.80e-1)" "unprognostic (2.10e-1)" "prognostic unfavourable (6.10e-4)" "unprognostic (1.03e-1)" "unprognostic (4.66e-1)" "unprognostic (3.55e-1)" "unprognostic (4.69e-2)" "unprognostic (3.37e-2)" 10.0 10.4 11.6 11.0 14.6 7.0 12.9 15.8 22.0 9.0 8.7 14.1 8.6 8.6 12.4 7.9 11.2 11.2 9.2 7.7 9.7 7.0 8.2 13.4 8.0 10.1 11.0 13.2 11.1 12.1 16.5 7.3 11.5 10.3 10.0 10.7 11.3 10.4 10.8 13.9 12.5 8.7 11.1 8.0 11.1 9.6 10.1 11.7 8.4 9.5 9.4 10.3 9.6 9.5 3.7 3.4 2.6 3.5 3.0 2.5 0.7 10.3 15.3 9.8 17.5 4.1 8.4 12.2 10.2 6.4 15.8 12.8 9.6 4.5 25.3 7.2 8.4 12.3 19.9 16.0 20.2 8.1 19.1 10.0 12.5 16.2 8.2 13.4 9.1 7.0 9.8 16.8 23.1 11.7 13.3 12.6 8.6 7.3 13.5 7.3 21.7 7.8 18.2 14.4 13.7 7.2 8.0 8.6 12.4 10.7 9.2 15.8 7.2 7.0 10.8 10.9 11.5 8.6 21.6 4.7 5.0 13.0 7.8 16.0 15.6 0.6 3.5 1.8 2.2 1.4 2.1 2.5 2.5 1.4 1.4 3.7 2.5 2.4 2.6 3.0 1.3 3.4 1.8 0.7 11.6 14.6 15.8 22.0 9.7 7.0 11.0 13.2 10.3 11.7 DNTTIP2 "ERBP, HSU15552, TdIF2" ENSG00000067334 "Deoxynucleotidyltransferase terminal interacting protein 2" Q5QJE6 1 93866283-93879918 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044502, HPA053707" Supported Enhanced Nucleoli Nucleoli "HPA044502: AB_10960277, HPA053707: " "unprognostic (2.95e-3)" "unprognostic (3.84e-2)" "unprognostic (6.21e-3)" "unprognostic (1.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.92e-2)" "prognostic unfavourable (1.90e-6)" "unprognostic (7.94e-2)" "unprognostic (5.57e-3)" "unprognostic (2.69e-2)" "unprognostic (2.02e-3)" "unprognostic (1.59e-1)" "prognostic unfavourable (7.80e-5)" "unprognostic (2.59e-1)" "unprognostic (8.41e-2)" "unprognostic (2.25e-1)" "unprognostic (1.06e-2)" 14.0 8.5 10.7 7.3 11.4 27.6 10.9 12.0 12.5 12.4 9.4 5.8 7.9 6.1 9.4 14.1 15.1 9.7 9.7 11.4 9.4 10.3 14.5 15.1 12.1 10.7 10.4 10.5 15.9 8.3 9.9 12.1 15.5 17.7 13.0 8.1 4.6 9.0 7.3 24.6 11.7 11.7 11.0 13.2 16.2 9.0 12.0 10.9 15.9 16.2 12.6 10.7 17.3 15.5 11.1 7.2 15.8 11.6 11.9 11.6 8.0 12.4 6.0 6.7 7.1 6.5 5.8 10.3 8.4 6.0 10.1 8.7 6.6 5.6 16.7 11.2 8.8 7.0 10.8 10.0 14.4 10.1 6.1 13.7 9.8 9.6 6.7 15.3 4.9 6.4 11.0 10.8 9.1 7.2 16.1 5.8 13.6 5.4 10.7 10.0 13.0 9.7 6.2 14.3 6.4 10.3 9.7 8.1 7.3 8.8 13.2 9.1 5.6 11.1 6.8 8.2 8.6 9.3 14.0 6.1 8.1 13.7 4.8 12.1 5.4 10.9 7.9 15.8 9.6 11.6 11.6 11.1 8.9 8.7 7.2 10.5 8.2 10.4 12.1 11.9 10.7 5.0 8.8 8.0 10.7 11.4 12.0 12.5 9.4 10.3 10.4 10.5 17.7 10.9 EBNA1BP2 "EBP2, NOBP, P40" ENSG00000117395 "EBNA1 binding protein 2" Q99848 1 43164175-43270936 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026512, HPA028277" Approved Enhanced Nucleoli Nucleoli "HPA026512: AB_1847954, HPA028277: AB_10603664" "unprognostic (9.30e-2)" "unprognostic (2.02e-1)" "unprognostic (1.05e-3)" "unprognostic (2.03e-2)" "unprognostic (8.59e-2)" "unprognostic (1.19e-1)" "prognostic unfavourable (4.22e-4)" "unprognostic (7.64e-3)" "unprognostic (2.89e-2)" "unprognostic (1.24e-3)" "unprognostic (7.11e-2)" "unprognostic (1.64e-3)" "unprognostic (4.10e-3)" "unprognostic (3.04e-3)" "unprognostic (1.69e-1)" "unprognostic (3.22e-2)" "unprognostic (1.33e-2)" 18.9 24.8 30.2 22.8 41.1 19.3 27.6 17.7 35.7 18.1 23.6 19.0 15.6 15.4 22.4 40.6 27.8 30.4 15.6 24.9 26.3 25.2 34.0 66.0 18.5 21.9 25.1 29.8 21.8 30.7 24.5 30.0 26.0 29.2 20.3 26.0 16.6 22.3 22.3 28.4 22.8 16.9 24.3 21.6 18.4 19.7 24.8 27.4 18.2 28.8 31.3 25.8 21.5 19.8 26.9 29.6 10.2 22.8 24.1 25.1 17.8 61.1 35.7 13.4 38.7 10.8 12.2 27.7 42.6 21.4 68.2 42.9 39.9 38.3 40.6 33.9 31.0 43.5 28.9 39.5 74.6 19.2 28.5 27.7 32.1 35.0 19.6 48.0 21.3 9.7 40.0 50.1 40.5 37.3 41.8 13.7 33.1 33.6 36.4 28.7 58.1 33.1 26.8 30.4 45.9 25.0 26.7 26.6 28.6 24.6 46.1 42.8 18.9 26.3 28.7 26.4 49.8 42.2 69.3 20.4 40.2 50.3 21.9 49.8 53.0 7.5 20.1 10.2 24.0 22.8 25.1 26.9 24.5 24.9 29.6 26.7 22.8 22.8 1.8 24.1 21.6 28.3 24.6 17.8 30.2 41.1 17.7 35.7 26.3 25.2 25.1 29.8 29.2 27.4 EFHB "CFAP21, FLJ25200" ENSG00000163576 "EF-hand domain family member B" Q8N7U6 3 19879472-19947025 "Predicted intracellular proteins" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 23.3;testis: 19.2" "Cell line enriched" "Detected in single" 33 "RPTEC TERT1: 21.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078067 Approved Nucleoli Nucleoli "HPA078067: " "unprognostic (9.70e-2)" "unprognostic (2.71e-2)" "unprognostic (2.37e-1)" "unprognostic (2.33e-2)" "unprognostic (1.20e-2)" "unprognostic (9.56e-3)" "unprognostic (1.51e-5)" "unprognostic (4.43e-2)" "unprognostic (3.66e-1)" "unprognostic (1.51e-1)" "unprognostic (4.92e-2)" "unprognostic (5.47e-2)" "unprognostic (6.06e-2)" "unprognostic (2.13e-2)" "unprognostic (9.35e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" 1.1 1.5 3.9 0.7 6.0 0.7 1.8 0.7 4.3 2.0 0.7 6.5 0.0 0.6 2.0 7.8 1.0 23.3 1.3 0.8 6.3 4.7 1.8 0.7 3.9 0.7 4.4 2.2 5.5 0.5 0.5 1.6 1.0 9.5 1.0 1.0 2.3 0.6 1.3 0.7 1.1 0.6 1.6 3.1 1.2 0.6 19.2 6.0 0.0 1.2 0.0 0.8 0.7 0.6 1.3 0.6 1.1 0.8 0.4 2.2 0.4 0.0 0.5 0.2 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.0 21.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 2.2 0.1 0.1 0.8 0.3 0.4 0.0 1.3 0.5 0.3 1.1 0.4 0.3 0.6 0.0 0.4 3.9 6.0 0.7 3.8 6.3 4.7 4.4 2.2 9.5 6.0 EMX1 ENSG00000135638 "Empty spiracles homeobox 1" Q04741 2 72916260-72936071 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 14.8;kidney: 27.4" "Cell line enhanced" "Detected in some" "BEWO: 3.6;CACO-2: 5.6;HEK 293: 12.5;HMC-1: 2.5;RPTEC TERT1: 2.2" "Cancer enhanced" "Detected in some" "renal cancer: 3.7" "Region enhanced" "Detected in many" "cerebral cortex: 14.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 13 "amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6" "HPA006230, HPA006421" Approved Supported Nucleoli Nucleoli "HPA006230: , HPA006421: AB_1078739" "unprognostic (4.54e-2)" "unprognostic (5.59e-2)" "unprognostic (8.71e-2)" "unprognostic (2.22e-6)" "unprognostic (4.82e-2)" "unprognostic (1.70e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.04e-1)" "unprognostic (2.99e-1)" "unprognostic (3.07e-1)" "prognostic favourable (1.54e-6)" "unprognostic (4.08e-2)" "unprognostic (1.44e-1)" "unprognostic (1.08e-3)" "unprognostic (5.02e-2)" 0.2 0.3 5.2 0.2 3.1 0.1 0.1 0.1 14.8 0.1 0.5 0.0 0.8 1.4 0.1 6.0 0.2 0.1 0.1 0.2 5.0 0.4 27.4 0.2 0.1 0.2 0.4 1.5 0.2 0.4 4.8 0.2 0.1 0.0 0.2 0.2 0.0 0.6 0.2 0.2 0.2 1.1 0.1 0.1 0.1 0.3 2.1 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 3.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.5 0.0 0.0 1.6 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 3.1 0.1 14.8 5.0 0.4 0.4 1.5 0.0 0.0 ETV4 "E1A-F, E1AF, PEA3" ENSG00000175832 "ETS variant 4" P43268 17 43527844-43579620 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 38.4" "Cell line enhanced" "Detected in many" "AN3-CA: 45.0;Hep G2: 42.2;SK-MEL-30: 48.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005768 Approved Supported Nucleoli Nucleoli "HPA005768: AB_1848294" "unprognostic (2.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.14e-1)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (3.14e-3)" "prognostic unfavourable (2.48e-4)" "unprognostic (1.58e-2)" "unprognostic (5.34e-2)" "unprognostic (8.13e-2)" "unprognostic (7.05e-2)" "unprognostic (3.01e-1)" "unprognostic (7.79e-2)" "unprognostic (2.03e-1)" "unprognostic (7.08e-2)" "prognostic favourable (7.60e-4)" "unprognostic (1.69e-1)" 0.6 2.4 1.4 0.9 1.4 0.0 6.8 1.6 8.3 3.6 3.3 0.4 1.3 5.7 3.4 2.2 9.9 2.4 38.4 2.6 1.8 1.3 7.8 1.4 2.5 0.4 2.3 1.1 1.2 23.8 19.3 19.7 11.6 2.7 4.7 1.6 1.7 4.9 4.5 1.3 6.7 3.8 1.2 1.8 0.5 3.6 1.3 0.5 0.3 6.6 15.0 12.1 3.1 5.3 0.2 0.0 1.3 0.2 0.0 0.6 0.1 5.9 16.7 20.5 45.0 0.8 5.3 4.5 1.9 5.3 3.8 3.9 9.4 8.5 0.0 1.1 1.0 10.9 0.6 10.0 3.4 0.2 0.1 0.5 2.6 42.2 1.1 11.4 5.3 0.9 0.3 14.5 9.0 8.1 11.7 0.0 7.8 2.3 0.0 20.2 29.6 28.0 24.4 2.4 14.3 8.4 4.3 0.0 18.3 0.5 1.1 48.7 0.2 3.4 3.7 2.7 13.4 4.0 5.4 1.8 11.2 0.0 4.9 2.2 15.8 0.0 0.0 0.0 0.0 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.6 1.3 0.0 0.0 0.0 0.0 0.1 1.4 1.4 1.6 3.6 1.8 1.3 2.3 1.1 2.7 0.5 FAM131A "C3orf40, MGC21688" ENSG00000175182 "Family with sequence similarity 131 member A" Q6UXB0 3 184335926-184348421 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 54.7" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5" HPA042800 Uncertain Approved Nucleoli "Secreted - unknown location" Nucleoli "HPA042800: AB_10797023" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (2.41e-3)" "prognostic unfavourable (2.22e-4)" "unprognostic (2.88e-1)" "unprognostic (4.84e-2)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (7.54e-2)" "unprognostic (7.02e-2)" "unprognostic (6.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.41e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (1.28e-2)" 8.1 14.9 18.8 4.6 26.4 2.5 5.0 21.9 54.7 5.4 6.4 8.0 4.8 6.3 7.5 4.9 7.5 7.7 8.4 11.9 28.1 13.0 4.1 3.0 6.0 3.4 9.1 25.9 8.8 11.3 9.2 16.4 5.0 7.8 6.7 3.5 3.3 7.1 11.7 9.3 10.5 5.8 8.7 5.9 5.3 5.5 7.0 7.0 0.8 3.5 3.9 2.7 5.5 4.1 2.1 5.5 11.1 6.5 1.6 2.2 2.5 8.1 3.4 5.4 9.5 7.4 6.1 5.1 3.6 8.3 5.8 4.5 2.6 2.9 1.2 15.2 3.5 7.6 0.0 6.6 3.7 8.7 9.1 0.0 5.1 5.5 7.5 0.1 6.4 4.5 1.1 4.9 11.4 11.6 1.8 1.2 2.1 6.2 3.1 0.2 9.3 6.8 5.7 2.2 7.8 5.8 0.2 16.6 17.3 2.3 6.4 8.5 18.8 2.1 11.7 7.1 5.6 5.7 11.4 13.7 8.3 0.8 22.9 1.2 5.0 2.0 4.8 6.0 1.5 6.5 1.6 2.0 1.2 1.6 5.5 2.1 1.2 1.5 11.1 1.6 3.4 2.3 2.2 2.5 18.8 26.4 21.9 54.7 28.1 13.0 9.1 25.9 7.8 7.0 FTSJ3 SPB1 ENSG00000108592 "FtsJ RNA methyltransferase homolog 3" Q8IY81 17 63819433-63830012 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055544, HPA062628" Supported Enhanced Nucleoli Nucleoli "HPA055544: , HPA062628: " "unprognostic (1.33e-1)" "unprognostic (1.41e-1)" "unprognostic (6.60e-2)" "unprognostic (7.82e-2)" "unprognostic (6.45e-2)" "unprognostic (2.92e-1)" "prognostic unfavourable (1.44e-5)" "unprognostic (1.27e-1)" "unprognostic (2.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.85e-1)" "unprognostic (1.12e-1)" "unprognostic (4.99e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (5.10e-1)" "unprognostic (3.43e-1)" 20.1 19.9 14.2 15.8 18.2 12.5 16.4 13.6 15.2 17.5 17.4 22.4 25.0 12.9 22.7 19.4 17.6 17.3 16.8 19.2 14.8 9.2 24.4 24.9 13.9 17.5 18.9 9.5 22.3 14.6 30.6 13.3 15.4 16.2 19.3 17.1 17.4 16.5 18.1 25.1 21.2 16.2 21.5 17.7 19.8 16.5 13.0 17.8 31.1 22.4 19.7 26.0 18.0 16.8 9.8 13.3 6.5 12.8 12.3 15.1 9.0 20.3 32.2 12.5 17.7 20.1 17.3 19.4 20.4 15.0 23.5 18.7 26.8 13.7 27.3 8.4 12.0 14.2 23.3 19.5 30.3 4.7 23.2 24.5 22.9 24.9 14.7 30.9 17.9 12.2 15.4 36.4 17.6 19.5 24.3 11.2 15.6 34.4 27.2 10.1 33.6 32.9 24.3 34.3 19.1 15.4 18.6 11.6 45.3 24.1 20.6 13.9 19.5 10.4 17.5 17.5 24.6 19.5 37.8 27.1 38.1 27.2 15.7 20.6 16.9 4.5 10.8 6.5 11.4 12.8 15.1 9.8 12.2 14.9 13.3 9.8 9.8 12.0 2.4 12.3 9.2 10.1 14.2 9.0 14.2 18.2 13.6 15.2 14.8 9.2 18.9 9.5 16.2 17.8 GLCCI1 "FAM117C, GIG18, TSSN1" ENSG00000106415 "Glucocorticoid induced 1" Q86VQ1 7 7968794-8094272 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 55.7" "Cell line enhanced" "Detected in many" "Karpas-707: 17.4;U-266/70: 40.5;U-698: 18.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001674, HPA005987" Approved Approved Nucleoli Nucleoli "HPA001674: AB_1078971, HPA005987: AB_1078970" "unprognostic (6.12e-2)" "unprognostic (7.81e-2)" "unprognostic (1.90e-1)" "unprognostic (1.45e-1)" "unprognostic (6.17e-3)" "unprognostic (1.02e-2)" "unprognostic (4.40e-1)" "unprognostic (1.68e-3)" "unprognostic (3.57e-1)" "unprognostic (2.54e-1)" "unprognostic (2.17e-3)" "unprognostic (3.35e-1)" "unprognostic (9.30e-2)" "unprognostic (2.14e-1)" "unprognostic (1.56e-1)" "unprognostic (3.09e-1)" "unprognostic (9.20e-3)" 4.6 4.3 5.6 19.1 12.5 7.6 4.1 26.6 8.0 5.4 4.9 3.4 0.9 5.7 3.4 1.8 3.0 2.8 3.9 2.2 3.7 4.1 3.9 3.8 18.4 13.8 3.1 5.6 5.1 2.3 8.0 6.5 9.3 4.4 3.2 4.7 3.1 6.3 2.0 3.0 7.5 5.6 2.5 3.2 9.2 6.4 14.2 3.7 55.7 20.7 1.9 15.9 7.7 3.3 3.1 2.4 3.7 0.4 4.7 4.5 0.7 2.3 0.3 3.9 0.9 1.2 1.7 0.8 2.0 2.8 1.2 1.1 1.2 0.8 6.4 0.5 1.6 0.4 3.5 1.0 1.5 3.2 2.7 1.9 4.9 0.8 1.9 3.0 2.8 0.8 1.3 0.7 2.6 1.0 6.9 17.4 2.0 1.3 1.3 3.0 9.6 2.3 6.8 2.9 3.4 1.1 2.7 6.4 12.6 3.0 3.8 0.2 4.5 7.8 0.8 2.2 0.9 1.9 1.0 40.5 12.9 18.3 2.3 3.2 1.6 3.7 0.1 1.5 2.7 0.4 2.5 1.8 2.8 2.0 0.1 3.1 1.6 1.8 1.2 4.7 0.1 2.4 4.5 0.7 5.6 12.5 26.6 8.0 3.7 4.1 3.1 5.6 4.4 3.7 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595935 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced Nucleoli Nucleoli "HPA027163: AB_10601655, HPA060026: " "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavourable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favourable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavourable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 24.1 17.4 13.8 24.1 15.0 30.7 21.9 11.2 14.2 15.9 15.7 11.7 16.8 12.4 20.2 18.3 21.8 16.4 14.8 17.9 12.5 11.3 18.0 26.9 18.7 19.6 21.2 11.5 19.6 17.4 15.2 21.6 24.5 15.8 16.4 18.7 10.1 19.4 18.9 40.3 22.2 16.3 17.4 15.0 21.8 17.8 21.4 15.2 24.3 17.1 27.5 22.2 20.5 19.8 18.4 25.2 14.4 22.7 20.7 17.4 12.2 19.3 10.0 19.4 20.3 15.6 18.0 31.6 29.5 20.5 27.3 27.9 27.3 22.9 31.8 19.3 21.8 18.3 31.7 24.1 37.8 18.0 24.8 31.9 20.1 21.9 20.9 41.9 22.9 11.3 22.1 37.2 44.7 19.6 42.3 22.9 26.4 17.1 22.5 25.3 50.9 19.6 24.1 35.3 36.1 22.8 21.2 23.8 22.0 22.3 22.5 21.9 16.1 24.5 15.8 18.5 26.1 39.1 40.9 21.5 19.3 55.4 21.3 33.8 23.6 10.3 17.1 14.4 15.3 22.7 17.4 18.4 14.3 16.5 25.2 13.5 15.1 14.5 1.8 20.7 20.7 18.5 16.9 12.2 13.8 15.0 11.2 14.2 12.5 11.3 21.2 11.5 15.8 15.2 GTSF1L "C20orf65, dJ1028D15.4, FAM112A" ENSG00000124196 "Gametocyte specific factor 1 like" Q9H1H1 20 43726164-43726998 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "testis: 104.1" "Cell line enhanced" "Detected in some" "Daudi: 1.3;EFO-21: 1.2;REH: 3.9;U-698: 4.3" "Cancer enriched" "Detected in single" 5 "testis cancer: 0.5" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 7.5" "Lineage enriched" "Detected in many" 5 "T-cells: 7.5" "Low region specificity" "Detected in some" HPA054694 Enhanced Uncertain Nucleoli Nucleoli "HPA054694: " "unprognostic (2.61e-2)" "unprognostic (4.24e-6)" "unprognostic (9.96e-3)" "unprognostic (1.30e-4)" "unprognostic (3.50e-2)" "unprognostic (6.70e-2)" "unprognostic (2.15e-2)" "unprognostic (3.06e-2)" "unprognostic (2.45e-7)" "unprognostic (1.19e-1)" "unprognostic (9.54e-2)" "unprognostic (6.07e-3)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 104.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.1 0.0 0.9 4.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.7 1.0 0.0 1.4 0.6 0.8 0.0 0.0 0.0 0.0 7.5 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35695571 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved Nucleoli Nucleoli "HPA015630: AB_1850609, HPA076087: " "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 22.7 13.7 19.2 25.6 21.7 34.3 21.9 25.0 21.7 24.2 20.3 18.6 18.8 16.1 24.3 17.1 21.2 19.9 26.4 16.6 17.5 14.0 17.6 25.3 22.7 33.7 16.7 18.3 37.0 31.4 18.0 22.5 21.6 15.4 21.6 19.3 19.5 19.6 23.8 17.9 20.9 20.5 23.9 18.5 24.1 18.0 39.5 18.3 34.3 22.5 15.4 23.2 25.0 22.0 5.7 5.9 19.2 9.2 12.1 12.2 4.8 18.5 7.0 13.3 13.0 20.0 15.3 10.8 13.2 18.6 8.6 9.7 8.4 22.2 13.3 21.1 16.7 23.4 7.4 9.5 13.4 8.9 9.5 9.2 8.6 5.6 17.2 9.3 11.8 19.1 17.2 10.8 17.7 14.2 14.4 17.9 14.9 7.8 10.6 15.3 11.2 9.7 12.8 16.1 10.7 11.2 8.3 11.1 18.4 16.7 15.9 11.4 16.0 11.3 16.6 13.5 15.6 13.1 10.5 24.9 28.3 14.1 13.0 14.4 24.8 5.8 6.8 19.2 10.6 7.6 12.2 4.4 9.5 11.3 5.9 5.7 5.9 8.0 11.7 12.1 9.2 3.6 8.6 4.8 19.2 21.7 25.0 21.7 17.5 14.0 16.7 18.3 15.4 18.3 HMGXB3 "HMGX3, KIAA0194, SMF" ENSG00000113716 "HMG-box containing 3" Q12766 5 150000046-150053142 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "parathyroid gland: 151.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005967 Approved Nucleoli Nucleoli "HPA005967: AB_1080044" "unprognostic (3.66e-2)" "unprognostic (3.74e-1)" "unprognostic (1.47e-1)" "unprognostic (1.33e-3)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "prognostic unfavourable (3.37e-5)" "unprognostic (9.72e-2)" "unprognostic (3.36e-1)" "unprognostic (3.89e-3)" "unprognostic (3.74e-2)" "unprognostic (2.11e-1)" "unprognostic (3.24e-3)" "unprognostic (1.30e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-2)" 12.0 14.2 8.2 14.5 14.4 15.3 16.1 14.5 17.4 11.3 10.3 15.0 15.4 8.3 13.9 20.0 9.3 13.5 12.1 9.4 8.6 8.3 11.6 11.7 14.7 10.3 10.1 11.0 15.0 13.8 151.8 15.3 11.8 12.9 17.6 10.8 16.8 12.4 18.4 12.5 13.1 9.9 12.8 8.9 14.4 12.0 17.7 7.3 15.3 14.7 10.1 12.0 11.2 10.1 5.8 6.2 5.1 5.9 2.2 8.1 3.7 12.2 14.4 10.2 16.1 14.7 12.5 17.8 11.9 22.0 17.9 22.6 20.2 15.0 11.7 14.0 16.2 9.1 19.4 20.4 15.5 10.9 13.9 10.3 15.2 9.8 20.4 19.6 23.4 16.3 15.3 26.2 20.7 12.7 13.4 12.3 18.8 9.7 12.2 10.2 7.7 21.7 10.6 14.2 11.3 10.7 15.4 13.2 13.3 10.4 25.5 26.4 11.9 12.8 10.9 26.8 11.4 12.9 21.9 14.6 13.7 16.7 31.3 15.1 13.8 5.1 4.7 4.0 7.0 5.9 5.5 5.8 5.7 4.9 6.2 5.0 4.4 4.6 0.5 2.2 3.9 4.6 8.1 3.7 8.2 14.4 14.5 17.4 8.6 8.3 10.1 11.0 12.9 7.3 IMP4 "BXDC4, MGC19606" ENSG00000136718 "IMP4, U3 small nucleolar ribonucleoprotein" Q96G21 2 130342225-130347810 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066222, HPA066673" Enhanced Nucleoli Nucleoli "HPA066222: , HPA066673: " "unprognostic (8.26e-2)" "unprognostic (5.10e-2)" "unprognostic (3.00e-1)" "unprognostic (2.55e-1)" "unprognostic (3.70e-3)" "unprognostic (2.18e-3)" "prognostic unfavourable (4.72e-4)" "unprognostic (1.33e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (1.04e-1)" "unprognostic (1.11e-1)" "unprognostic (1.28e-2)" "unprognostic (5.08e-2)" "unprognostic (4.47e-2)" "unprognostic (1.09e-1)" "unprognostic (6.10e-2)" 19.0 15.7 13.1 19.5 15.7 17.9 14.2 6.6 25.1 9.4 12.2 11.7 9.2 15.6 11.1 7.4 20.1 9.2 12.7 30.5 11.8 10.1 13.5 29.1 10.6 22.2 14.9 12.7 9.0 36.3 2.6 7.4 10.5 15.4 9.5 3.4 7.1 26.0 12.5 52.3 10.8 15.5 12.5 8.5 11.2 16.4 9.1 13.7 8.5 12.0 10.9 11.5 17.1 9.7 34.8 31.6 7.0 26.8 26.6 25.4 26.7 19.3 17.7 0.8 14.8 2.9 3.5 13.8 11.8 5.6 8.4 8.8 38.0 12.3 51.8 18.5 5.6 11.7 1.6 12.4 0.3 11.8 13.3 15.8 5.0 32.0 15.7 14.9 11.4 5.8 7.6 15.1 6.8 8.4 17.7 16.0 2.2 35.9 11.1 6.3 13.4 23.4 15.5 6.2 26.4 3.7 13.7 9.1 10.2 9.0 27.5 9.8 10.5 10.7 9.4 15.9 15.1 16.8 24.4 16.2 20.0 42.9 12.2 9.5 22.4 2.4 25.5 7.0 25.4 26.8 22.6 34.8 22.4 21.9 29.3 30.7 22.4 22.2 2.9 26.6 25.1 31.6 21.5 26.7 13.1 15.7 6.6 25.1 11.8 10.1 14.9 12.7 15.4 13.7 INTS4 "INT4, MGC16733, MST093" ENSG00000149262 "Integrator complex subunit 4" Q96HW7 11 77878720-77994678 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042378 Uncertain Supported Nucleoli Nucleoli "HPA042378: AB_10797388" "unprognostic (2.72e-1)" "unprognostic (1.93e-1)" "unprognostic (4.07e-2)" "unprognostic (9.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.55e-1)" "prognostic unfavourable (9.44e-6)" "unprognostic (2.04e-2)" "unprognostic (1.17e-2)" "unprognostic (5.59e-2)" "unprognostic (1.60e-2)" "unprognostic (1.77e-1)" "unprognostic (4.20e-2)" "unprognostic (5.44e-2)" "unprognostic (4.20e-1)" "prognostic favourable (9.66e-4)" "unprognostic (9.39e-2)" 15.8 17.7 13.6 15.7 16.5 21.4 17.0 23.9 17.5 17.1 13.6 27.7 13.0 12.2 31.0 16.3 14.8 13.9 12.1 12.1 13.6 12.1 14.4 18.7 14.0 20.6 20.0 12.1 20.0 19.6 22.9 24.4 20.8 19.3 17.3 16.1 17.7 23.1 13.5 12.1 16.0 16.7 14.6 18.0 23.2 14.4 11.7 17.6 33.6 15.9 8.6 28.1 14.5 16.6 12.5 13.8 10.9 13.7 14.6 17.1 10.0 6.0 10.1 13.2 15.8 11.1 9.8 11.0 7.3 8.1 9.4 8.6 21.0 17.2 10.5 15.6 12.8 15.3 14.4 14.3 15.2 15.6 9.0 16.2 13.5 12.0 9.8 16.3 9.9 10.0 7.8 19.4 16.7 14.7 15.6 16.2 14.4 12.6 15.5 26.8 12.6 11.0 15.0 12.2 20.1 11.7 12.2 9.4 13.6 12.8 8.5 5.3 16.2 9.5 9.9 13.1 17.5 34.2 9.4 17.8 17.2 23.7 4.9 11.2 12.9 10.9 12.6 6.7 12.2 13.7 16.9 11.8 12.6 14.3 13.8 12.5 17.1 13.2 3.2 14.6 12.0 5.5 15.7 10.0 13.6 16.5 23.9 17.5 13.6 12.1 20.0 12.1 19.3 17.6 KCNJ14 "IRK4, Kir2.4" ENSG00000182324 "Potassium voltage-gated channel subfamily J member 14" Q9UNX9 19 48455509-48466980 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 22.9" "Cell line enhanced" "Detected in many" "NB-4: 12.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA071765 Approved Nucleoli Nucleoli "HPA071765: " "unprognostic (1.38e-1)" "unprognostic (1.23e-2)" "unprognostic (1.33e-5)" "unprognostic (5.77e-2)" "unprognostic (9.41e-2)" "unprognostic (5.26e-2)" "unprognostic (7.05e-4)" "unprognostic (7.83e-4)" "unprognostic (1.26e-1)" "unprognostic (6.48e-2)" "unprognostic (4.43e-3)" "unprognostic (4.92e-2)" "unprognostic (5.02e-6)" "unprognostic (1.47e-1)" "unprognostic (4.98e-2)" "unprognostic (6.82e-3)" "unprognostic (4.41e-2)" 1.0 0.4 1.1 0.9 6.1 4.9 1.8 2.3 2.2 0.9 0.9 0.9 0.9 0.6 0.9 1.8 1.5 1.1 1.0 0.9 1.4 1.3 0.9 0.9 0.9 1.2 1.2 0.9 1.3 1.4 1.0 1.0 1.4 1.4 1.5 0.7 22.9 0.9 0.9 3.3 4.9 0.9 0.9 0.9 0.9 0.6 2.8 0.9 0.9 1.6 0.9 0.9 0.9 1.1 1.5 0.8 3.5 0.8 0.6 1.0 0.2 1.6 3.8 0.8 2.5 1.7 1.6 2.5 0.6 0.3 0.8 1.2 3.8 2.2 1.8 0.8 0.6 5.3 1.2 0.6 2.0 1.3 2.0 1.1 2.1 1.0 0.9 1.5 3.1 1.5 2.8 1.9 2.2 0.5 1.8 1.9 0.5 2.3 0.6 12.2 1.4 2.1 2.5 1.5 0.4 0.6 4.5 1.4 1.7 1.7 2.5 1.3 1.7 1.3 1.0 2.7 3.5 2.6 3.0 2.0 3.0 1.3 0.7 3.9 2.8 3.5 0.8 0.6 0.6 0.6 0.5 1.2 0.7 1.0 0.4 1.5 0.8 1.0 2.9 0.6 0.3 0.8 0.6 0.2 1.1 6.1 2.3 2.0 1.4 1.3 1.2 0.9 1.4 0.9 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 46.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved Nucleoli Nucleoli "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favourable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favourable (1.69e-4)" 12.7 12.1 13.5 23.1 15.5 17.0 12.7 15.5 15.8 9.9 13.8 14.6 16.1 13.1 17.5 14.4 12.8 13.1 17.7 10.2 14.7 12.9 11.4 16.1 12.5 21.0 14.7 13.6 12.1 20.6 15.6 14.2 8.7 12.9 11.0 15.8 10.7 16.6 16.3 30.7 15.9 12.0 12.7 15.5 14.9 14.5 26.6 12.9 22.7 14.0 14.5 19.5 12.7 11.8 6.1 6.1 4.4 11.1 17.6 14.4 6.4 6.6 12.2 6.2 9.4 2.5 3.4 9.7 6.3 5.9 10.5 4.9 18.1 9.6 10.6 8.5 4.9 10.9 9.4 8.4 7.5 1.6 10.5 6.0 7.7 11.8 6.4 5.6 6.3 1.5 4.4 9.4 10.5 8.7 19.3 5.5 6.9 28.6 12.9 16.4 10.4 9.1 12.6 7.2 6.1 6.2 7.8 9.5 9.1 13.3 6.8 3.0 10.7 8.9 5.4 5.9 9.9 2.9 11.9 26.9 9.2 46.0 5.7 14.3 3.9 0.0 6.0 4.4 14.4 7.8 12.6 6.1 6.0 11.6 4.4 5.5 6.1 9.2 0.4 17.6 11.1 6.1 5.0 6.4 13.5 15.5 15.5 15.8 14.7 12.9 14.7 13.6 12.9 12.9 KREMEN2 "KRM2, MGC10791" ENSG00000131650 "Kringle containing transmembrane protein 2" Q8NCW0 16 2963944-2968383 "Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 13.1;skin 1: 12.5" "Cell line enhanced" "Detected in many" "HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 6 "B-cells: 3.2;monocytes: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA003223 Uncertain Approved Nucleoli "Intracellular and membrane" Nucleoli "HPA003223: AB_1079217" "unprognostic (8.36e-2)" "unprognostic (4.65e-1)" "unprognostic (6.24e-3)" "unprognostic (4.61e-2)" "unprognostic (1.69e-1)" "unprognostic (1.73e-1)" "unprognostic (4.02e-3)" "prognostic unfavourable (8.98e-4)" "unprognostic (3.34e-2)" "unprognostic (1.57e-2)" "unprognostic (8.03e-2)" "unprognostic (8.57e-2)" "unprognostic (7.79e-12)" "unprognostic (6.69e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-2)" "unprognostic (6.58e-3)" 0.2 0.1 1.6 2.0 0.7 1.7 0.2 0.2 3.0 1.8 0.4 0.2 4.5 0.3 0.3 0.8 3.8 0.6 0.3 0.2 1.9 0.3 0.2 0.2 0.2 0.8 0.7 0.2 0.2 0.4 0.0 0.2 0.2 0.3 1.6 0.0 1.9 1.6 0.2 0.6 12.5 0.6 0.2 1.7 0.9 0.5 2.1 0.2 13.1 0.2 1.8 6.8 0.2 0.6 3.2 0.3 0.0 1.4 0.0 0.0 0.0 1.2 0.8 0.3 7.1 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.9 1.1 5.2 1.4 0.0 5.9 0.9 0.5 0.0 0.8 0.8 0.3 1.7 1.7 0.0 0.4 19.9 0.2 0.0 0.0 0.1 0.0 2.1 2.1 0.0 10.0 1.2 2.3 2.0 1.5 3.1 8.2 18.7 0.0 0.2 2.1 1.2 1.4 3.2 3.2 10.1 1.9 0.1 0.6 8.7 0.7 0.4 3.7 0.8 3.1 0.3 0.9 0.5 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.6 0.7 0.2 2.3 1.9 0.3 0.7 0.2 0.3 0.2 KRI1 FLJ12949 ENSG00000129347 "KRI1 homolog" Q8N9T8 19 10553078-10566037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043110, HPA043574" Approved Enhanced Nucleoli Nucleoli "HPA043110: , HPA043574: " "unprognostic (6.38e-2)" "unprognostic (2.34e-3)" "prognostic unfavourable (9.37e-4)" "unprognostic (6.70e-2)" "unprognostic (2.35e-2)" "unprognostic (5.10e-3)" "prognostic unfavourable (1.21e-4)" "unprognostic (3.46e-2)" "unprognostic (1.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.30e-2)" "unprognostic (4.43e-2)" "prognostic unfavourable (4.89e-10)" "unprognostic (2.99e-2)" "unprognostic (3.06e-2)" "unprognostic (2.70e-1)" "unprognostic (1.02e-1)" 14.7 12.5 10.4 23.6 20.6 19.1 14.3 27.8 19.6 14.5 13.4 16.6 12.4 12.7 15.9 17.6 17.2 14.3 15.0 12.1 13.1 10.3 11.9 13.3 12.4 25.2 16.7 9.8 17.2 19.5 21.0 18.3 10.9 14.9 15.6 9.8 20.3 14.7 18.2 23.0 25.3 16.8 15.0 17.2 23.0 12.7 14.6 18.6 46.8 15.6 10.9 21.3 15.8 15.9 8.5 14.1 2.5 4.9 8.5 11.2 3.9 12.0 6.2 8.0 11.5 4.3 4.8 5.5 11.2 5.3 7.1 6.6 8.9 4.4 17.9 13.3 4.5 9.5 9.7 8.8 8.0 19.4 22.1 56.7 12.0 5.8 7.9 22.2 20.6 5.8 7.2 10.2 10.5 4.5 15.8 18.2 6.1 10.8 22.8 33.0 12.7 14.9 9.6 10.4 8.8 6.0 10.7 13.1 6.1 13.2 7.8 8.2 9.7 16.3 5.4 9.2 7.8 24.8 23.3 13.0 15.0 12.9 7.7 18.0 13.7 1.3 4.5 2.5 11.2 4.9 10.3 7.1 7.5 9.0 5.8 8.5 8.4 9.0 0.8 8.5 2.5 14.1 5.4 3.9 10.4 20.6 27.8 19.6 13.1 10.3 16.7 9.8 14.9 18.6 LHFPL6 "LHFP, MGC22429" ENSG00000183722 "LHFPL tetraspan subfamily member 6" Q9Y693 13 39342892-39603528 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 65.0;HSkMC: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 9.4;plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058975 Approved Approved Nucleoli Nucleoli "HPA058975: " "unprognostic (6.98e-2)" "unprognostic (2.71e-1)" "unprognostic (2.00e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (4.10e-2)" "unprognostic (5.84e-2)" "unprognostic (1.08e-1)" "unprognostic (2.76e-1)" "unprognostic (5.45e-2)" "unprognostic (8.68e-2)" "unprognostic (1.90e-2)" "prognostic unfavourable (1.20e-7)" "unprognostic (4.41e-3)" "unprognostic (5.25e-2)" "unprognostic (7.75e-2)" "prognostic unfavourable (2.30e-4)" 57.2 26.8 12.5 14.8 17.7 0.9 45.7 40.8 19.0 20.3 16.4 12.3 8.5 5.3 28.6 23.7 17.9 27.0 34.9 49.4 12.7 12.9 12.8 6.9 27.0 27.4 19.3 12.6 25.7 8.3 7.1 14.3 62.0 16.8 21.4 8.4 19.8 11.4 18.8 13.6 13.1 9.6 33.1 18.5 18.5 10.2 16.2 11.9 1.3 22.7 22.1 8.3 20.1 25.8 0.2 9.4 0.1 0.6 0.0 0.0 0.4 2.7 0.9 29.5 1.2 65.0 29.5 12.9 15.0 21.7 7.7 5.8 0.1 2.8 4.2 0.3 20.9 4.2 3.7 8.8 6.4 4.0 4.3 11.3 0.9 0.0 6.8 0.2 0.3 47.5 1.1 6.9 11.5 7.1 0.0 0.0 14.7 2.3 0.0 3.4 2.2 3.9 1.8 12.8 0.0 5.1 3.6 0.1 0.9 1.3 1.8 4.0 1.6 0.0 13.2 19.6 2.9 6.0 8.1 0.2 0.0 11.8 8.1 0.0 14.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 9.4 0.2 0.0 0.0 0.1 0.0 0.1 3.2 0.0 0.4 12.5 17.7 40.8 19.0 12.7 12.9 19.3 12.6 16.8 11.9 LLPH "C12orf31, hLLP, MGC14817" ENSG00000139233 "LLP homolog, long-term synaptic facilitation" Q9BRT6 12 66116555-66130768 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048920, HPA058786" Enhanced Nucleoli Nucleoli "HPA048920: , HPA058786: " "unprognostic (3.60e-3)" "unprognostic (4.94e-2)" "unprognostic (4.07e-2)" "unprognostic (3.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.31e-2)" "prognostic unfavourable (6.44e-7)" "unprognostic (7.15e-2)" "unprognostic (1.30e-2)" "unprognostic (8.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.07e-2)" "unprognostic (3.87e-2)" "unprognostic (9.65e-3)" "unprognostic (2.49e-2)" "unprognostic (3.37e-1)" "unprognostic (2.94e-2)" 20.4 38.1 16.4 20.4 16.9 40.9 17.9 10.9 20.0 16.4 20.2 11.2 19.7 16.4 17.2 17.1 21.3 14.4 13.4 19.9 15.7 13.9 27.8 31.3 14.5 21.4 20.6 16.7 18.2 16.2 11.1 18.0 24.3 17.3 18.1 18.6 9.9 15.9 14.5 47.3 13.9 27.9 21.0 26.7 29.7 18.6 20.0 17.6 23.8 22.9 23.5 21.6 23.6 22.4 23.6 24.6 34.9 34.7 20.0 29.4 21.1 26.9 21.8 13.5 16.6 15.7 15.5 16.7 31.7 20.5 23.5 19.9 18.9 11.4 31.4 26.1 21.0 23.2 21.0 19.2 31.9 27.4 18.0 33.1 15.8 16.8 19.0 57.5 23.3 15.7 19.8 20.0 21.5 20.2 28.6 22.5 27.5 29.0 25.7 38.8 28.9 23.2 21.9 24.8 22.5 23.1 32.7 13.5 16.8 20.5 21.8 33.4 28.0 31.4 21.8 18.5 26.5 22.5 28.7 17.5 27.1 46.4 24.2 27.1 28.0 22.2 25.6 26.4 23.7 29.0 27.0 23.6 27.6 25.5 24.6 21.7 23.9 25.2 34.9 20.0 34.7 21.2 29.4 21.1 16.4 16.9 10.9 20.0 15.7 13.9 20.6 16.7 17.3 17.6 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "fallopian tube: 94.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported Nucleoli Nucleoli "HPA037766: AB_10672609, HPA057533: " "prognostic favourable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 3.6 4.2 11.4 2.4 12.8 3.4 4.8 10.5 10.9 5.8 3.1 10.8 6.9 2.2 6.0 13.1 2.9 94.2 4.2 4.7 12.2 12.9 6.9 3.7 9.4 2.9 7.3 9.6 5.9 2.5 9.3 9.0 3.4 9.9 4.8 3.3 9.4 4.0 5.0 5.5 3.5 2.1 4.8 7.0 3.5 4.5 21.1 8.4 2.2 7.1 2.4 3.7 3.1 3.1 7.8 5.9 9.0 4.4 5.3 4.7 2.2 5.5 10.8 1.8 4.0 8.2 6.2 6.4 2.2 7.7 3.8 7.1 2.2 11.4 4.9 2.5 5.9 1.4 3.3 4.7 8.0 3.8 1.6 3.5 4.2 4.4 6.6 1.9 3.3 4.3 8.8 7.1 6.5 5.0 2.0 2.8 4.3 6.2 4.2 1.3 1.2 3.2 4.0 9.0 5.6 7.6 1.6 3.0 7.0 3.6 4.8 6.8 2.4 4.4 2.2 3.7 9.9 4.2 2.5 2.6 1.8 4.0 9.1 2.5 5.3 1.3 4.4 9.0 3.7 4.2 4.7 7.8 3.6 3.1 4.0 4.8 4.1 4.0 0.7 5.3 3.8 5.9 0.2 2.2 11.4 12.8 10.5 10.9 12.2 12.9 7.3 9.6 9.9 8.4 LRRC40 FLJ20331 ENSG00000066557 "Leucine rich repeat containing 40" Q9H9A6 1 70144805-70205620 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026564 Approved Approved Nucleoli Nucleoli "HPA026564: AB_2250054" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "prognostic favourable (4.54e-4)" "unprognostic (6.42e-2)" "unprognostic (6.65e-3)" "unprognostic (3.94e-2)" "unprognostic (7.69e-3)" "unprognostic (9.90e-2)" "unprognostic (3.40e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-2)" "unprognostic (2.50e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-3)" "unprognostic (1.95e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 14.3 10.4 15.7 10.0 18.5 16.4 13.2 22.0 27.4 13.4 10.7 10.4 8.0 17.0 12.6 10.2 11.5 9.0 10.1 13.5 16.5 16.6 20.4 27.2 9.6 14.2 13.7 15.7 11.3 8.8 7.9 13.8 13.9 19.8 10.6 11.8 7.5 9.0 8.8 13.6 9.0 18.0 13.3 15.6 13.2 9.0 13.4 11.0 23.0 9.9 10.0 14.2 11.1 9.6 10.4 8.4 7.4 8.2 9.8 10.9 6.5 11.1 4.7 18.5 14.5 6.8 7.5 11.2 10.8 7.9 16.4 20.3 6.8 6.3 15.0 9.5 8.4 8.2 43.5 9.6 22.4 12.0 8.7 11.3 8.6 10.9 8.6 14.8 2.7 6.3 5.6 10.9 11.0 9.4 14.0 7.3 13.8 2.8 17.8 11.6 24.4 9.8 14.3 19.2 9.7 14.9 6.8 9.5 9.6 13.0 13.1 12.0 6.2 8.4 11.7 11.6 9.3 17.5 12.2 6.2 5.9 24.3 9.4 15.6 11.8 6.8 6.6 7.4 8.5 8.2 10.9 10.4 9.0 7.9 8.4 9.2 10.6 8.8 0.9 9.8 7.6 6.5 10.8 6.5 15.7 18.5 22.0 27.4 16.5 16.6 13.7 15.7 19.8 11.0 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452105-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "epididymis: 207.1" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011324 Uncertain Approved Nucleoli Nucleoli "HPA011324: AB_1853499" "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavourable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favourable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 8.3 13.2 21.5 7.6 21.6 3.0 8.1 19.9 29.7 13.5 7.5 14.4 13.8 5.2 13.3 207.1 5.2 19.2 8.3 10.2 22.8 32.1 11.4 8.7 10.2 9.0 19.8 20.6 16.1 11.9 9.0 22.5 9.2 17.9 20.8 5.9 11.4 8.9 19.6 5.7 5.6 6.3 11.8 17.2 8.1 9.3 18.2 15.3 10.8 12.4 5.2 7.5 8.5 10.0 9.4 14.0 9.5 8.5 8.3 26.0 9.4 0.0 2.5 14.8 0.0 23.9 14.5 0.2 16.0 14.8 4.4 11.9 0.0 3.3 0.0 22.0 16.0 2.2 5.6 6.0 7.0 18.4 0.9 4.9 0.0 2.0 7.9 0.2 6.4 12.0 0.5 2.5 1.8 6.7 2.7 19.8 4.8 9.5 13.1 4.2 4.2 3.0 8.3 1.8 10.4 8.0 0.0 0.1 11.2 0.0 4.3 6.6 2.1 3.7 7.8 6.1 7.1 3.7 0.8 11.8 14.8 2.0 11.4 6.9 7.7 5.0 4.4 9.5 11.3 6.8 10.1 9.4 18.7 12.9 6.7 8.8 26.0 16.1 0.6 8.3 8.5 14.0 24.7 9.4 21.5 21.6 19.9 28.4 22.8 32.1 19.8 20.6 17.9 15.3 MCEE GLOD2 ENSG00000124370 "Methylmalonyl-CoA epimerase" Q96PE7 2 71109684-71130239 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035196 Approved Nucleoli "Intracellular and membrane" 16000 Nucleoli "HPA035196: AB_10601871" "unprognostic (7.65e-2)" "unprognostic (8.20e-2)" "unprognostic (3.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" "prognostic favourable (4.76e-4)" "prognostic favourable (5.78e-4)" "unprognostic (4.86e-3)" "unprognostic (6.48e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-3)" "unprognostic (8.59e-2)" "unprognostic (9.40e-3)" "unprognostic (4.90e-2)" "unprognostic (3.55e-1)" "unprognostic (6.51e-2)" "unprognostic (5.38e-2)" 10.5 20.4 8.5 10.1 9.2 4.3 18.9 10.5 9.8 14.1 13.8 9.4 24.6 11.1 8.8 19.7 16.9 8.6 12.6 19.8 6.6 6.2 18.8 39.7 9.1 9.5 13.1 6.6 12.4 29.0 9.8 24.5 9.9 9.1 13.7 13.5 11.1 28.9 20.5 18.2 15.2 14.9 10.9 11.5 10.1 13.1 5.7 11.4 9.3 11.0 18.7 10.9 13.0 13.3 15.9 17.6 20.0 18.4 11.2 24.9 11.1 6.3 3.1 5.6 4.0 19.2 26.2 16.4 9.8 12.5 5.0 7.6 7.6 7.9 9.9 3.0 9.7 6.7 6.8 5.1 5.2 9.1 5.9 6.7 8.7 22.0 10.8 7.5 5.6 17.4 7.4 3.4 6.7 5.7 8.8 17.2 4.8 8.1 5.6 8.8 5.2 7.6 6.6 6.4 18.3 7.7 5.1 6.5 4.7 3.7 21.7 9.7 17.2 7.2 7.3 5.9 4.5 5.9 3.9 16.5 6.8 10.5 9.5 12.3 5.3 13.0 18.3 20.0 12.8 18.4 17.3 15.9 15.7 12.3 14.9 13.2 14.6 12.3 4.5 11.2 17.6 17.6 24.9 11.1 8.5 9.2 10.5 9.8 6.6 6.2 13.1 6.6 9.1 11.4 MED12L "KIAA1635, TNRC11L, TRALP, TRALPUSH" ENSG00000144893 "Mediator complex subunit 12 like" Q86YW9 3 151085697-151437072 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.1" "Cell line enhanced" "Detected in some" "BEWO: 16.0;HEL: 17.3;MOLT-4: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036807 Enhanced Approved Nucleoli Nucleoli "HPA036807: AB_10670242" "unprognostic (1.01e-2)" "unprognostic (5.82e-2)" "unprognostic (5.12e-2)" "unprognostic (8.14e-4)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (1.23e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" "unprognostic (1.38e-3)" "unprognostic (1.59e-1)" "unprognostic (2.00e-1)" "unprognostic (4.36e-3)" "unprognostic (3.84e-1)" "unprognostic (1.88e-1)" "unprognostic (2.92e-2)" 2.8 5.2 6.4 1.2 11.1 5.5 0.5 4.9 23.1 1.6 0.6 4.4 0.0 2.2 0.9 3.0 0.9 0.6 1.8 1.7 5.5 5.1 0.4 0.4 0.7 4.4 5.8 2.6 1.0 1.7 0.5 5.4 2.0 3.9 1.2 0.3 1.9 1.7 0.7 0.5 0.4 1.6 0.6 6.1 2.1 0.8 6.1 5.7 0.6 1.0 0.0 1.5 1.3 0.8 1.0 5.1 3.1 2.8 0.1 0.4 0.8 0.7 0.3 2.5 0.2 0.1 0.0 16.0 0.0 0.2 0.6 0.7 0.9 0.3 0.0 0.2 0.1 0.1 3.3 0.2 0.7 0.0 1.6 17.3 0.1 0.1 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.0 0.0 2.7 0.0 2.6 8.0 0.0 2.9 0.5 0.1 0.9 0.4 0.2 2.5 4.2 0.6 0.4 0.2 0.0 0.9 0.1 0.0 0.0 1.9 0.0 1.3 5.1 0.0 6.1 0.2 1.5 0.9 3.1 0.3 0.0 0.1 2.8 0.4 0.1 0.1 0.2 1.6 1.0 0.0 0.0 0.3 0.1 0.8 5.1 0.0 0.8 6.4 11.1 4.9 6.9 5.5 5.1 5.8 2.6 3.9 5.7 MED16 "DRIP92, THRAP5, TRAP95" ENSG00000175221 "Mediator complex subunit 16" Q9Y2X0 19 867630-893218 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030685, HPA046495" Uncertain Approved Nucleoli Nucleoli "HPA030685: AB_10601872, HPA046495: " "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "prognostic favourable (5.46e-4)" "unprognostic (1.90e-1)" "unprognostic (5.25e-3)" "unprognostic (1.68e-1)" "unprognostic (1.61e-1)" "unprognostic (2.80e-1)" "unprognostic (3.15e-2)" "unprognostic (4.93e-3)" "unprognostic (3.28e-1)" "prognostic favourable (1.11e-5)" "unprognostic (4.83e-2)" "unprognostic (5.52e-1)" "unprognostic (1.57e-1)" "unprognostic (5.17e-2)" 17.8 19.8 17.0 24.2 21.1 16.1 15.9 16.8 34.5 21.8 20.4 21.4 12.5 20.5 20.7 14.9 21.0 20.3 21.9 14.0 16.0 15.4 19.4 29.5 16.2 19.4 13.4 16.3 28.6 46.1 18.9 18.8 21.9 14.7 20.6 8.5 19.4 24.4 15.6 31.1 24.6 24.4 14.9 11.2 22.3 27.0 20.1 14.0 27.0 21.6 16.1 21.6 20.5 18.9 30.3 20.8 24.7 17.0 19.2 40.3 25.4 14.2 12.4 12.4 8.3 5.3 5.6 13.6 9.6 9.6 14.8 11.4 16.0 13.6 14.8 11.9 8.9 11.2 4.7 12.0 2.5 18.2 14.9 14.7 9.2 14.7 10.3 13.8 13.4 9.8 6.0 9.1 6.0 10.9 17.2 34.1 8.7 21.3 22.3 16.4 19.3 16.1 23.4 8.9 18.7 9.9 22.8 15.4 15.0 13.5 9.2 10.9 10.6 11.1 10.9 15.4 15.4 23.2 11.1 25.8 9.2 13.4 19.6 13.2 11.0 24.7 15.7 19.0 27.6 17.0 25.0 30.3 30.3 31.5 20.8 23.1 25.8 23.8 22.2 19.2 16.9 13.6 40.3 25.4 17.0 21.1 16.8 34.5 16.0 15.4 13.4 16.3 14.7 14.0 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102715840-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved Nucleoli Nucleoli "HPA055293: , HPA061859: " "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavourable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 4.3 4.1 3.0 3.5 3.1 6.2 6.2 12.9 5.2 4.6 8.4 2.4 11.0 11.6 2.8 3.8 7.2 2.7 4.1 3.8 2.3 2.8 7.2 16.2 3.0 4.5 2.3 1.5 3.3 16.8 6.3 10.7 3.4 4.8 3.4 7.9 5.1 9.0 6.8 2.2 4.4 16.0 4.0 2.7 4.8 6.7 2.7 1.7 10.0 5.0 3.9 6.3 5.5 3.5 3.0 4.4 6.4 3.2 4.1 4.3 3.0 3.9 3.2 3.5 6.3 4.1 1.8 8.7 2.6 2.4 3.8 3.9 9.9 6.0 3.2 4.2 1.8 6.2 4.9 2.6 2.7 12.9 5.0 5.7 3.6 13.0 3.6 4.5 7.7 2.1 6.4 2.6 1.3 2.5 3.5 2.0 1.8 3.8 4.3 6.9 3.4 3.7 3.5 5.5 3.3 6.7 13.4 6.8 5.0 2.5 7.8 7.7 3.3 6.5 1.9 3.0 5.6 4.2 3.4 4.7 3.7 2.4 2.8 9.6 3.6 3.7 1.2 6.4 4.3 3.2 3.3 3.0 3.4 3.1 2.6 2.7 3.7 3.8 5.0 4.1 1.9 4.4 2.2 3.0 3.0 3.1 12.9 5.2 2.3 2.8 2.3 1.5 4.8 1.7 MPHOSPH10 "CT90, MPP10, MPP10P, PPP1R106" ENSG00000124383 "M-phase phosphoprotein 10" O00566 2 71130314-71150101 "Predicted intracellular proteins, Predicted membrane proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035059, HPA035060, HPA049907" Enhanced Enhanced Nucleoli Nucleoli "HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: " "unprognostic (3.20e-3)" "unprognostic (1.59e-1)" "unprognostic (8.51e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (1.62e-1)" "unprognostic (3.58e-2)" "unprognostic (1.01e-1)" "unprognostic (6.41e-3)" "unprognostic (6.13e-2)" "unprognostic (3.50e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (3.89e-7)" "unprognostic (1.24e-1)" "unprognostic (2.91e-1)" "unprognostic (2.47e-1)" "unprognostic (2.23e-2)" 20.5 17.6 21.8 20.2 28.0 21.2 23.7 26.7 25.7 23.5 17.6 12.6 22.0 16.5 22.3 26.7 30.6 19.4 17.1 20.4 21.6 20.3 22.2 27.5 15.5 21.9 30.4 22.7 25.4 20.7 20.0 36.7 18.5 26.3 24.0 18.4 8.1 21.8 28.8 48.4 24.4 16.8 25.0 25.0 22.0 17.6 13.7 29.8 22.3 20.4 26.3 24.4 22.2 22.2 13.5 12.8 8.7 17.3 12.4 17.4 8.4 14.8 11.2 14.5 17.3 13.6 12.8 19.8 16.6 13.2 13.7 10.2 20.1 11.0 20.9 10.4 11.6 13.9 18.2 11.7 18.4 14.4 14.6 25.1 8.9 45.8 11.8 32.4 20.2 11.0 15.1 11.3 15.1 11.6 36.2 16.7 13.6 15.9 26.0 32.9 24.1 12.8 21.7 22.7 24.7 11.1 16.2 17.7 13.7 11.1 25.7 16.0 13.0 14.5 12.0 16.3 17.5 15.5 21.0 14.2 16.0 34.3 14.0 27.1 16.3 8.7 9.9 7.2 12.4 13.6 16.0 13.5 15.7 14.8 11.7 12.3 17.4 15.3 1.4 12.4 17.3 12.8 13.2 8.4 21.8 28.0 26.7 25.7 21.6 20.3 30.4 22.7 26.3 29.8 MXRA8 DKFZp586E2023 ENSG00000162576 "Matrix remodeling associated 8" Q9BRK3 1 1352689-1361777 "Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 16.4;BJ: 49.0;BJ hTERT+: 23.0;fHDF/TERT166: 24.3;HSkMC: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "naive CD8 T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053958, HPA055780" Uncertain Approved Nucleoli 450000 Nucleoli "HPA053958: , HPA055780: " "unprognostic (1.39e-1)" "unprognostic (2.85e-1)" "unprognostic (7.31e-3)" "unprognostic (1.26e-2)" "unprognostic (1.94e-3)" "unprognostic (2.61e-1)" "unprognostic (6.75e-2)" "unprognostic (2.03e-1)" "unprognostic (4.22e-2)" "unprognostic (5.38e-2)" "unprognostic (2.97e-2)" "unprognostic (7.13e-2)" "prognostic unfavourable (3.43e-6)" "prognostic unfavourable (9.93e-4)" "unprognostic (1.55e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (9.87e-4)" 45.6 5.3 2.3 11.4 4.6 1.1 25.2 3.9 3.8 34.8 14.3 4.8 6.2 6.5 34.0 16.3 13.7 14.4 20.5 12.7 3.6 1.1 7.6 3.5 13.4 5.6 2.6 2.6 30.4 3.7 1.6 6.0 25.0 5.4 23.4 2.3 36.6 8.4 12.3 15.5 10.9 8.6 22.0 4.5 9.5 8.7 16.4 2.9 0.3 13.9 11.8 4.5 22.3 17.8 0.0 0.0 0.0 0.0 0.0 9.8 0.3 1.3 0.3 0.4 0.3 5.9 16.4 14.8 49.0 23.0 5.8 6.9 2.6 1.1 0.5 0.2 24.3 1.0 0.3 0.0 1.1 1.0 0.4 0.4 0.8 4.1 15.4 0.0 0.5 19.5 0.0 2.1 0.0 0.0 5.7 0.4 7.3 0.1 0.1 0.1 4.8 1.6 0.2 0.1 0.1 0.0 0.2 1.1 3.1 0.1 0.4 0.0 3.8 0.2 0.4 0.2 8.2 7.6 0.1 1.1 0.1 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.3 2.3 4.6 3.9 2.7 3.6 1.1 2.6 2.6 5.4 2.9 MYRFL "bcm1377, C12orf15, C12orf28, FLJ25056" ENSG00000166268 "Myelin regulatory factor-like" Q96LU7 12 69825304-69959097 "Predicted intracellular proteins, Predicted membrane proteins" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 15 "intestine: 56.1" "Cell line enhanced" "Detected in some" "NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049340 Approved Approved Nucleoli "Intracellular and membrane" Nucleoli "HPA049340: AB_2680719" "unprognostic (2.95e-2)" "unprognostic (6.25e-2)" "unprognostic (2.49e-2)" "unprognostic (1.42e-1)" "unprognostic (5.18e-2)" "unprognostic (2.34e-1)" "unprognostic (5.45e-2)" "unprognostic (6.50e-2)" "unprognostic (3.37e-1)" "unprognostic (2.65e-1)" "unprognostic (3.08e-1)" "unprognostic (8.99e-2)" "unprognostic (1.91e-2)" "unprognostic (3.89e-2)" "unprognostic (2.07e-2)" "unprognostic (1.17e-1)" "unprognostic (9.96e-2)" 0.3 0.3 0.5 0.0 0.6 0.0 0.5 3.6 0.6 0.1 20.7 0.0 0.4 21.4 0.1 0.9 0.1 0.1 0.7 0.2 0.4 0.2 2.0 0.3 0.2 0.2 0.5 0.2 0.0 0.8 0.0 1.0 0.3 0.7 0.6 0.1 0.3 1.3 0.4 0.0 1.6 56.1 0.1 1.0 0.1 0.1 2.4 0.5 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.8 0.0 0.1 0.0 1.1 1.0 0.0 0.3 0.1 0.0 3.4 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 1.4 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.6 3.6 0.6 0.4 0.2 0.5 0.2 0.7 0.5 NIFK "hNIFK, MKI67IP, Nopp34" ENSG00000155438 "Nucleolar protein interacting with the FHA domain of MKI67" Q9BYG3 2 121726945-121736923 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015382, HPA035735, HPA035736, CAB075728, CAB075729" Supported Enhanced Nucleoli Nucleoli "CAB015382: AB_2142390, CAB075728: , CAB075729: , HPA035735: , HPA035736: " "unprognostic (3.53e-2)" "unprognostic (1.67e-1)" "unprognostic (3.49e-1)" "prognostic unfavourable (5.57e-4)" "unprognostic (1.21e-1)" "unprognostic (4.15e-3)" "prognostic unfavourable (2.92e-6)" "unprognostic (7.74e-3)" "unprognostic (4.63e-2)" "unprognostic (3.21e-2)" "unprognostic (6.02e-3)" "unprognostic (9.50e-2)" "prognostic unfavourable (5.01e-11)" "unprognostic (1.72e-1)" "unprognostic (1.29e-1)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" 25.1 18.7 18.4 22.1 19.0 19.9 28.1 14.3 20.8 24.0 17.3 14.8 9.8 16.5 21.4 17.4 28.2 20.3 16.6 15.4 16.1 15.1 24.2 40.1 14.7 30.8 15.8 15.2 32.8 33.7 12.9 28.9 19.8 18.5 21.2 19.7 10.2 16.5 14.2 35.5 22.8 17.9 20.9 18.3 28.1 19.2 18.7 18.0 31.3 23.6 21.3 29.5 26.1 21.0 28.1 25.9 12.5 23.5 27.1 32.9 24.6 28.5 8.6 18.7 18.4 16.5 22.9 22.5 22.5 20.3 28.4 31.1 25.3 14.6 39.4 28.2 17.5 18.6 40.3 30.5 42.6 23.9 21.3 38.7 12.2 23.7 23.2 35.6 21.4 23.0 35.2 37.6 50.4 20.4 43.5 19.6 24.6 14.1 27.3 35.4 45.9 31.2 26.2 21.1 48.3 25.2 17.9 23.5 24.3 14.2 28.3 49.2 13.6 30.7 11.7 19.5 32.0 22.1 32.0 23.0 34.6 43.8 15.2 35.3 27.2 12.5 19.8 9.3 22.9 23.5 32.1 27.0 28.2 26.2 25.9 28.1 32.9 30.8 1.3 27.1 20.9 22.6 23.5 24.6 18.4 19.0 14.3 20.8 16.1 15.1 15.8 15.2 18.5 18.0 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944204-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced Nucleoli 420000 Nucleoli "HPA044258: AB_10961284, HPA062195: " "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 17.7 15.6 13.4 20.5 17.8 23.8 18.2 23.7 27.4 15.0 15.3 15.6 13.5 16.8 19.0 13.5 27.7 18.3 21.8 23.0 15.3 15.3 15.2 36.6 14.0 19.3 18.7 19.0 16.9 26.8 20.8 15.3 15.9 16.7 16.6 11.1 14.0 22.0 16.5 40.0 32.4 14.6 14.7 13.6 17.5 16.4 21.1 18.0 22.7 19.8 29.5 21.8 17.5 18.0 14.3 20.2 11.3 29.0 18.8 18.4 16.0 27.6 27.6 4.9 32.0 9.0 8.0 18.1 20.6 9.7 28.9 15.9 36.5 27.1 31.2 29.4 13.7 25.4 36.6 30.9 12.3 19.5 41.7 16.5 35.6 31.6 20.3 36.3 16.2 13.1 8.7 31.8 21.2 14.0 46.5 14.4 12.7 43.7 23.3 21.9 28.2 32.7 29.2 20.6 37.7 13.3 11.6 34.6 34.0 27.4 41.4 25.3 18.5 19.9 16.0 17.3 24.7 18.9 35.2 24.8 26.7 56.3 21.5 51.5 14.4 7.2 17.0 11.3 14.2 25.7 18.4 14.3 13.8 13.6 20.2 11.9 14.3 11.1 1.6 18.8 29.0 13.0 10.9 16.0 13.4 17.8 23.7 27.4 15.3 15.3 18.7 19.0 16.7 18.0 NOL10 "FLJ14075, PQBP5" ENSG00000115761 "Nucleolar protein 10" Q9BSC4 2 10570766-10689987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035286, HPA043075" Approved Supported Nucleoli Nucleoli "HPA035286: , HPA043075: AB_10794652" "unprognostic (6.53e-3)" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "prognostic unfavourable (2.92e-5)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "prognostic unfavourable (1.43e-7)" "unprognostic (1.25e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" "unprognostic (1.74e-2)" "prognostic unfavourable (7.51e-5)" "unprognostic (2.43e-2)" "unprognostic (2.92e-1)" "unprognostic (3.82e-1)" "unprognostic (3.87e-2)" 18.6 22.4 13.5 18.7 16.1 20.5 17.7 20.4 16.9 14.7 15.5 16.2 19.6 13.1 21.5 19.1 20.9 11.8 15.7 15.7 11.6 11.8 18.2 21.9 13.8 17.5 17.4 12.5 15.2 25.8 17.0 21.4 19.8 16.2 15.2 17.6 14.4 19.8 15.5 27.5 19.4 13.5 15.2 17.0 15.3 17.2 18.4 15.4 16.4 16.8 21.3 18.9 14.6 18.2 8.1 7.4 3.6 8.5 7.0 9.7 4.4 11.4 18.5 10.9 19.4 13.0 14.3 21.6 19.5 15.2 20.7 16.3 21.9 14.7 26.8 12.1 17.3 14.9 25.7 23.5 26.1 18.7 20.1 25.9 11.7 25.8 17.3 29.8 14.4 12.8 17.4 23.0 23.0 14.8 34.1 17.1 20.4 20.7 19.7 21.4 30.3 17.6 18.4 30.0 24.9 14.6 15.7 19.0 20.6 14.6 24.1 17.0 12.6 11.7 14.6 20.2 25.0 20.8 31.7 22.8 35.8 30.9 17.0 29.6 24.9 2.5 6.1 3.6 6.8 8.5 9.6 8.1 7.1 7.7 7.4 6.3 5.5 7.6 0.8 7.0 8.3 5.3 9.7 4.4 13.5 16.1 20.4 16.9 11.6 11.8 17.4 12.5 16.2 15.4 NOL11 DKFZP586L0724 ENSG00000130935 "Nucleolar protein 11" Q9H8H0 17 67717833-67744531 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022010 Supported Supported Nucleoli Nucleoli "HPA022010: AB_2267158" "unprognostic (6.81e-2)" "unprognostic (2.85e-2)" "prognostic favourable (1.00e-6)" "unprognostic (3.07e-3)" "unprognostic (5.04e-2)" "unprognostic (2.55e-2)" "prognostic unfavourable (2.59e-6)" "unprognostic (1.37e-2)" "unprognostic (1.25e-3)" "unprognostic (4.77e-3)" "unprognostic (8.74e-2)" "unprognostic (4.41e-3)" "unprognostic (6.55e-2)" "unprognostic (2.16e-2)" "unprognostic (2.19e-1)" "unprognostic (8.44e-2)" "unprognostic (3.11e-1)" 17.3 15.1 12.2 14.3 13.4 17.0 14.5 19.8 11.6 15.2 12.9 10.2 11.9 10.3 17.2 11.7 18.1 13.9 10.4 12.8 9.5 7.6 18.9 22.1 10.4 17.5 14.4 5.4 19.5 16.9 18.4 17.0 19.8 10.8 14.6 13.9 10.4 14.1 10.7 26.8 13.8 13.8 13.6 11.1 16.6 14.4 10.6 14.3 32.1 13.6 16.4 20.1 14.5 13.4 9.7 7.0 7.4 5.8 10.0 14.7 7.8 14.5 17.0 14.3 9.3 6.8 8.1 15.6 10.1 8.8 22.6 18.5 16.1 11.2 24.8 7.9 11.0 11.4 34.8 16.8 33.2 7.0 27.6 16.3 10.3 14.3 7.9 21.7 10.7 6.3 10.6 16.9 11.6 21.0 27.2 7.6 17.9 14.3 26.6 9.1 15.7 23.8 18.4 30.0 17.4 10.2 17.3 11.8 10.9 9.4 26.5 12.3 18.0 12.2 7.2 19.7 13.3 6.7 21.0 4.8 12.3 26.7 8.4 15.2 11.7 7.4 5.2 3.6 8.5 5.8 8.8 8.8 8.9 10.2 7.0 9.7 14.7 10.8 0.8 10.0 5.3 5.3 9.6 7.8 12.2 13.4 19.8 11.6 9.5 7.6 14.4 5.4 10.8 14.3 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported Nucleoli Nucleoli "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavourable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavourable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 15.8 11.5 11.6 14.6 20.0 8.5 13.6 15.9 15.9 15.1 13.2 7.3 12.1 6.4 16.4 11.1 14.1 13.0 9.4 9.4 13.7 8.2 10.6 8.9 9.5 13.6 17.9 8.4 17.5 11.1 25.3 23.6 11.8 13.4 14.0 11.0 5.2 11.0 13.2 15.0 12.9 10.7 14.6 19.5 15.7 10.6 7.7 17.8 18.7 15.2 11.2 15.1 16.3 16.2 13.6 12.2 13.6 14.7 12.6 17.5 6.6 7.9 13.0 6.0 12.1 13.7 11.7 8.3 9.2 7.2 9.8 9.5 4.6 8.4 25.3 8.1 9.7 16.7 21.5 12.8 10.9 15.8 9.7 18.0 13.0 10.4 9.2 29.9 13.7 12.2 9.5 11.0 15.5 12.1 27.2 7.8 11.3 12.9 20.8 10.5 10.2 12.4 12.6 17.8 10.3 5.1 5.4 11.3 5.5 12.6 11.0 7.7 4.5 9.4 11.8 9.1 5.9 12.9 9.6 7.9 17.7 13.7 8.5 17.2 11.8 13.6 8.3 11.3 12.5 11.1 17.5 13.6 11.9 12.0 12.2 12.6 14.6 12.5 3.2 12.6 14.7 10.3 13.2 6.6 11.6 20.0 15.9 15.9 13.7 8.2 17.9 8.4 13.4 17.8 NOM1 "C7orf3, PPP1R113, SGD1" ENSG00000146909 "Nucleolar protein with MIF4G domain 1" Q5C9Z4 7 156949723-156973182 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019866, HPA051624" Approved Enhanced Nucleoli Nucleoli "HPA019866: , HPA051624: " "unprognostic (1.24e-1)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (1.43e-1)" "unprognostic (3.30e-2)" "unprognostic (5.23e-2)" "unprognostic (1.15e-2)" "unprognostic (2.09e-1)" "unprognostic (4.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-1)" "unprognostic (6.30e-3)" "unprognostic (1.49e-1)" 12.3 10.9 10.8 16.9 14.2 15.3 11.1 13.0 15.9 9.7 11.4 9.9 11.1 8.9 12.8 9.0 12.9 11.4 8.1 8.3 11.2 6.4 8.4 12.2 9.9 13.4 11.9 11.7 13.9 14.5 11.1 8.4 10.3 11.4 9.6 10.0 9.3 10.5 12.5 21.0 15.5 10.5 12.0 10.0 12.1 10.6 13.9 11.9 9.9 9.9 9.8 12.4 11.4 17.0 5.0 2.8 2.5 2.8 2.6 3.4 0.9 9.0 7.8 5.8 8.5 5.8 6.1 7.9 9.0 4.5 7.4 6.0 8.4 7.7 15.9 9.1 7.3 7.4 10.3 11.0 9.1 7.2 9.0 13.3 6.5 7.7 4.7 23.1 8.1 4.4 5.4 6.6 8.6 6.2 20.0 8.6 6.6 11.8 14.6 19.3 13.9 8.4 10.5 8.7 12.2 4.7 10.8 7.1 8.6 8.2 6.6 6.2 3.2 12.5 10.0 8.0 2.6 14.8 11.6 11.1 7.9 14.6 10.2 16.7 7.5 2.5 2.8 1.5 2.1 1.9 1.2 3.8 2.7 2.9 2.8 5.0 3.4 1.8 1.3 2.6 2.1 2.8 1.0 0.9 10.8 14.2 13.0 15.9 11.2 6.4 11.9 11.7 11.4 11.9 NOP16 "HSPC111, HSPC185, LOC51491" ENSG00000048162 "NOP16 nucleolar protein" Q9Y3C1 5 176383938-176388975 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036506, HPA058147" Approved Enhanced Nucleoli Nucleoli "HPA036506: AB_10672223, HPA058147: AB_2683620" "unprognostic (4.55e-2)" "unprognostic (1.72e-1)" "unprognostic (2.21e-2)" "unprognostic (1.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.89e-1)" "prognostic unfavourable (5.14e-4)" "unprognostic (1.19e-2)" "unprognostic (2.27e-2)" "unprognostic (1.87e-2)" "unprognostic (1.67e-1)" "unprognostic (1.01e-2)" "prognostic unfavourable (5.75e-6)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" 17.1 12.8 11.0 15.3 12.7 13.2 13.5 6.1 10.4 8.5 13.3 4.9 8.4 12.0 9.5 8.1 23.2 9.6 9.9 18.2 8.0 8.2 18.2 34.3 8.7 15.0 11.0 8.8 10.9 16.2 5.8 7.2 9.5 14.8 9.1 11.8 3.2 8.8 7.7 50.2 15.6 9.5 8.7 6.8 14.7 11.2 12.2 9.5 9.4 11.3 29.3 17.1 11.1 12.2 26.8 30.3 2.7 26.6 24.1 22.6 13.7 17.5 26.9 6.7 28.5 9.9 10.4 26.0 14.6 8.6 21.2 18.4 36.8 17.8 29.3 20.0 10.8 16.6 31.3 48.4 14.8 37.3 25.6 15.1 19.8 31.2 19.9 30.9 17.9 10.7 21.8 19.4 24.1 15.5 29.6 15.1 15.3 51.2 23.7 42.8 23.6 34.2 19.8 9.4 31.2 19.8 15.0 20.1 17.0 8.6 34.8 19.4 15.5 22.7 14.0 16.2 16.6 15.1 36.4 19.4 22.9 32.6 12.7 42.4 13.9 2.1 16.8 2.7 17.4 26.6 22.6 25.1 19.6 18.7 24.9 26.8 21.5 22.5 1.7 24.1 13.0 30.3 13.6 13.7 11.0 12.7 6.1 10.4 8.0 8.2 11.0 8.8 14.8 9.5 NOP2 "NOL1, NOP120, NSUN1, p120" ENSG00000111641 "NOP2 nucleolar protein" P46087 12 6556863-6568691 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040119 Supported Supported Nucleoli Nucleoli "HPA040119: AB_10965321" "unprognostic (2.88e-1)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (7.15e-2)" "unprognostic (8.74e-2)" "unprognostic (6.47e-2)" "prognostic unfavourable (1.12e-5)" "unprognostic (6.38e-2)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (2.53e-1)" "prognostic unfavourable (2.35e-10)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-3)" 16.5 12.7 14.8 21.7 17.1 30.9 15.3 14.8 14.9 10.8 12.8 6.9 7.3 14.0 15.2 11.4 19.5 15.0 11.2 12.8 11.9 8.7 12.8 31.2 14.0 25.9 14.7 8.9 14.5 21.5 12.1 15.1 12.3 13.8 17.4 14.7 9.0 21.3 9.4 32.6 19.1 15.7 14.7 8.9 23.1 13.4 19.4 13.2 24.7 16.8 18.5 27.2 11.5 17.1 12.6 16.5 3.3 11.5 11.9 20.3 10.9 16.1 26.0 7.1 24.3 9.1 7.8 38.6 14.7 9.5 17.4 15.0 31.7 16.5 34.5 4.0 7.2 20.0 27.2 16.2 16.9 40.7 25.5 33.8 24.8 18.3 12.2 33.3 19.5 7.9 16.0 21.0 32.8 11.7 23.7 5.5 13.8 20.0 17.8 29.0 59.4 14.5 25.4 20.7 16.9 12.7 22.3 5.5 10.9 23.0 25.1 12.1 4.1 16.0 11.0 12.0 16.1 15.5 33.7 7.7 11.2 51.5 11.0 19.1 20.8 1.4 8.2 0.9 14.8 11.5 20.3 12.6 14.1 16.6 16.5 10.1 17.3 17.6 3.3 11.9 10.0 14.5 9.7 10.9 14.8 17.1 14.8 14.9 11.9 8.7 14.7 8.9 13.8 13.2 NOP53 "GLTSCR2, PICT-1, PICT1" ENSG00000105373 "NOP53 ribosome biogenesis factor" Q9NZM5 19 47745522-47757058 "Predicted intracellular proteins" "Host-virus interaction, Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 158.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018999, HPA049600" Approved Supported Nucleoli Nucleoli "HPA018999: AB_1849733, HPA049600: " "unprognostic (2.08e-3)" "unprognostic (1.84e-1)" "unprognostic (4.02e-3)" "prognostic favourable (2.35e-4)" "unprognostic (1.76e-2)" "unprognostic (1.16e-1)" "unprognostic (5.83e-2)" "unprognostic (2.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.56e-2)" "unprognostic (3.62e-3)" "unprognostic (1.89e-1)" "unprognostic (9.27e-2)" "unprognostic (2.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" 35.2 34.8 13.4 35.1 19.7 39.3 40.6 21.0 21.6 44.4 36.9 15.4 30.7 35.9 41.4 30.8 37.2 32.2 36.1 24.5 12.7 10.2 24.8 24.7 22.6 48.7 18.2 19.7 90.1 92.0 18.6 19.8 20.3 16.1 42.3 12.7 22.8 67.3 28.2 51.6 54.7 32.8 50.2 16.4 49.8 39.0 31.9 17.4 49.7 54.9 33.8 40.9 39.6 68.7 51.0 8.8 4.8 7.2 20.5 52.7 2.9 12.0 12.7 11.5 27.0 14.3 24.0 21.8 7.5 13.9 7.3 10.9 11.8 24.4 53.0 10.9 8.8 17.2 6.6 11.0 3.9 15.5 21.9 17.4 10.8 13.7 21.2 24.9 34.1 21.1 25.5 6.4 17.5 11.6 21.1 26.1 6.5 10.5 67.9 158.3 26.2 7.4 45.5 20.4 24.5 14.0 18.7 12.1 42.6 6.3 41.8 37.7 19.7 60.9 14.2 7.2 19.3 6.2 15.3 38.2 34.1 14.4 9.1 17.8 11.6 3.6 4.8 4.8 12.0 7.2 16.7 51.0 23.9 21.2 6.9 36.0 52.7 24.0 0.7 20.5 5.0 8.8 22.7 2.9 13.4 19.7 21.0 21.6 12.7 10.2 18.2 19.7 16.1 17.4 NSMAF "FAN, GRAMD5" ENSG00000035681 "Neutral sphingomyelinase activation associated factor" Q92636 8 58583504-58659844 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023067, HPA023148, HPA023151" Uncertain Approved Nucleoli Nucleoli "HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654" "unprognostic (1.09e-1)" "unprognostic (1.94e-1)" "unprognostic (1.75e-1)" "unprognostic (8.86e-3)" "unprognostic (2.69e-1)" "unprognostic (8.73e-2)" "unprognostic (2.96e-3)" "unprognostic (9.03e-2)" "unprognostic (2.29e-1)" "unprognostic (8.11e-2)" "unprognostic (1.52e-1)" "unprognostic (4.44e-1)" "prognostic unfavourable (4.61e-9)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (2.38e-1)" "unprognostic (1.69e-1)" 19.3 18.9 13.3 19.2 23.5 8.9 22.7 19.5 14.8 15.2 16.8 11.3 6.0 11.0 17.9 11.5 16.1 12.7 13.1 17.3 12.8 10.9 9.9 6.7 17.7 27.2 13.4 11.7 15.5 20.9 25.6 16.3 15.6 12.9 14.9 17.9 12.7 14.1 15.9 20.3 22.4 16.9 22.3 12.1 20.9 16.8 8.4 11.1 43.8 16.3 11.2 25.0 19.2 17.9 4.8 14.5 15.4 7.2 6.4 8.7 4.5 13.0 12.7 5.8 8.1 22.1 18.0 10.0 10.5 23.4 14.6 13.8 7.1 8.2 15.8 8.8 16.5 10.5 9.8 8.4 16.8 17.7 5.4 29.7 7.9 7.9 28.1 12.9 20.6 12.1 13.6 10.6 40.8 14.6 12.7 11.7 16.6 9.8 27.1 10.5 10.3 5.0 10.3 8.6 4.5 8.2 10.5 5.4 6.9 8.8 3.3 9.6 8.1 16.3 13.4 14.6 8.8 19.5 10.7 2.2 1.0 12.5 21.4 10.2 9.2 8.3 7.2 4.8 6.8 5.3 7.0 4.8 7.2 7.1 14.5 4.6 5.1 4.8 15.4 6.4 3.6 5.0 8.7 4.5 13.3 23.5 19.5 14.8 12.8 10.9 13.4 11.7 12.9 11.1 NVL NVL2 ENSG00000143748 "Nuclear VCP-like" O15381 1 224227334-224330387 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028207, HPA028219, HPA028224, HPA028654" Supported Enhanced Nucleoli Nucleoli "HPA028207: AB_10601382, HPA028219: , HPA028224: , HPA028654: " "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "prognostic unfavourable (5.77e-5)" "prognostic favourable (2.95e-4)" "unprognostic (4.43e-2)" "unprognostic (7.14e-2)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavourable (4.10e-11)" "unprognostic (1.67e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" 11.3 12.6 13.3 14.3 12.6 12.5 16.2 24.4 15.7 14.2 13.8 16.9 11.4 9.0 17.1 12.2 11.6 13.5 8.5 9.8 10.4 9.9 13.6 9.4 11.8 16.9 10.5 10.8 16.9 19.3 16.8 20.7 25.8 13.4 14.2 16.0 16.5 11.6 12.6 9.8 22.7 12.5 17.5 13.3 16.4 11.1 9.4 12.0 23.8 15.5 8.5 19.1 14.4 13.7 14.0 9.9 12.5 15.2 12.3 13.5 7.9 14.5 8.3 17.3 13.8 6.5 9.3 17.4 12.4 8.7 16.4 15.1 12.6 12.5 20.3 13.4 7.9 13.8 18.8 11.6 17.9 15.8 25.9 9.7 14.1 6.4 11.2 19.1 15.5 7.5 9.3 14.6 16.5 10.7 25.4 12.5 10.7 11.3 14.8 9.5 26.6 14.8 18.6 21.5 13.0 9.9 10.3 15.3 13.4 18.8 28.7 17.0 13.7 17.5 10.4 13.1 8.5 15.2 23.0 8.3 18.0 21.5 8.4 15.6 13.6 12.5 8.2 8.2 13.1 13.0 13.0 14.0 13.5 9.6 9.9 10.1 11.3 11.5 0.8 12.3 15.2 9.6 9.5 7.9 13.3 12.6 24.4 15.7 10.4 9.9 10.5 10.8 13.4 12.0 OSGIN2 "C8orf1, hT41" ENSG00000164823 "Oxidative stress induced growth inhibitor family member 2" Q9Y236 8 89901859-89927888 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 17.0" "Lineage enriched" "Detected in all" 6 "granulocytes: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028515, HPA050595" Approved Approved Nucleoli Nucleoli "HPA028515: AB_10602014, HPA050595: " "unprognostic (3.29e-2)" "unprognostic (1.15e-1)" "unprognostic (7.09e-2)" "unprognostic (4.32e-3)" "unprognostic (1.42e-3)" "unprognostic (3.26e-2)" "prognostic unfavourable (3.91e-6)" "prognostic unfavourable (2.93e-4)" "unprognostic (2.32e-1)" "unprognostic (2.22e-3)" "unprognostic (4.38e-3)" "unprognostic (1.81e-1)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.66e-1)" "unprognostic (1.09e-1)" "unprognostic (7.25e-2)" 15.2 7.5 12.5 7.8 13.9 40.4 16.8 9.6 17.5 7.6 13.3 26.4 6.0 6.8 26.1 6.1 11.7 8.1 14.2 11.2 14.2 13.4 14.7 16.2 15.7 9.1 13.7 13.0 15.9 7.8 53.5 25.2 6.5 18.2 9.1 8.6 8.3 8.6 7.3 13.2 7.6 8.7 17.1 25.3 9.0 7.5 20.5 14.7 7.1 12.9 8.0 8.9 11.1 8.5 3.0 1.5 17.0 1.4 2.0 2.5 1.3 11.9 11.7 3.0 6.0 6.6 4.8 3.9 8.6 16.5 7.9 7.7 5.5 11.5 8.2 17.6 4.4 4.4 5.6 6.8 12.4 11.8 4.5 12.5 4.6 3.0 11.2 6.3 7.8 5.6 8.9 9.2 7.6 9.7 7.2 14.7 5.6 9.3 10.8 4.2 1.5 6.3 4.8 4.4 7.0 12.0 9.3 2.8 6.9 6.4 56.3 10.4 11.5 9.4 6.5 8.7 8.0 7.1 7.9 13.6 11.6 9.0 14.4 7.7 6.1 17.0 1.4 5.8 1.7 0.9 2.4 3.0 2.5 1.5 1.5 1.8 2.1 2.3 10.3 2.0 1.1 1.1 2.5 1.3 12.5 13.9 9.6 17.5 14.2 13.4 13.7 13.0 18.2 14.7 OSMR OSMRB ENSG00000145623 "Oncostatin M receptor" Q99650 5 38845858-38945596 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Amyloidosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 38.9;HSkMC: 48.2;U-2197: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017278 Approved Approved Nucleoli "Intracellular and membrane" 21000000 Nucleoli "HPA017278: AB_1854818" "unprognostic (6.34e-3)" "prognostic unfavourable (4.87e-4)" "unprognostic (2.58e-1)" "unprognostic (2.11e-1)" "unprognostic (2.18e-3)" "unprognostic (1.13e-1)" "unprognostic (8.00e-3)" "unprognostic (5.70e-2)" "unprognostic (1.79e-3)" "unprognostic (1.72e-3)" "unprognostic (1.60e-3)" "unprognostic (1.12e-1)" "prognostic unfavourable (3.96e-6)" "unprognostic (1.88e-2)" "unprognostic (1.49e-2)" "unprognostic (4.43e-1)" "unprognostic (1.75e-2)" 41.1 18.0 7.3 18.7 9.4 0.3 31.0 3.1 9.4 14.1 13.7 2.8 4.6 4.4 14.4 12.9 14.7 14.5 22.4 22.4 5.4 3.5 19.7 23.6 25.7 31.7 9.0 1.3 33.6 10.1 6.6 10.5 40.1 13.3 20.8 8.6 9.2 17.2 11.1 13.0 12.5 8.0 32.5 15.6 23.5 11.5 10.8 6.9 3.6 17.5 10.4 11.3 40.4 43.6 0.6 0.6 1.6 0.4 0.7 0.6 0.1 7.5 9.8 1.6 4.2 18.1 38.9 5.7 12.4 19.7 12.2 16.4 0.0 20.6 0.0 5.9 13.1 10.5 2.1 15.2 19.7 0.0 1.2 0.5 7.7 7.4 20.6 0.0 0.1 48.2 9.1 27.3 23.5 1.8 0.0 0.0 7.7 2.0 0.0 0.0 0.2 3.2 0.0 0.5 0.0 24.5 2.2 0.0 0.0 27.9 0.0 0.0 8.6 0.0 2.9 29.8 11.3 38.5 6.5 0.0 0.0 0.0 23.9 0.0 6.4 1.6 0.4 0.4 0.5 0.3 0.2 0.3 0.3 0.1 0.1 0.6 0.4 0.6 1.0 0.7 0.1 0.6 0.2 0.1 7.3 9.4 3.1 9.4 5.4 3.5 9.0 1.3 13.3 6.9 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694695-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 48.8" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli Nucleoli "HPA030111: , HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavourable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 12.8 9.9 12.0 12.2 9.7 11.5 15.9 9.1 15.7 12.7 8.7 5.8 7.7 5.9 10.5 9.9 15.7 8.7 7.2 8.6 9.2 9.8 12.3 17.5 7.2 16.3 10.9 9.2 13.8 10.6 6.8 9.1 9.1 11.3 48.8 9.8 4.2 10.3 10.4 20.6 7.8 6.8 10.5 10.1 10.9 7.4 6.3 9.9 8.4 9.3 18.5 11.7 8.2 9.1 8.4 11.5 2.4 10.3 8.1 12.3 5.8 14.1 5.6 7.3 12.5 9.1 8.3 10.5 9.3 7.7 14.1 13.9 12.3 6.4 14.4 23.4 7.9 7.6 14.9 12.0 20.4 8.4 10.0 7.9 5.2 14.1 13.3 21.8 10.4 7.7 10.5 13.7 23.4 9.4 23.8 4.2 11.7 8.4 10.9 20.1 15.8 10.0 11.3 9.5 22.3 10.2 8.5 11.0 9.5 6.9 17.9 19.9 7.9 8.0 8.1 11.5 8.3 12.3 23.0 9.9 27.0 15.8 4.7 14.7 21.5 1.1 7.1 2.4 8.4 10.3 8.6 8.4 7.6 8.4 10.0 6.4 10.2 12.3 0.3 8.1 8.0 11.5 4.8 5.8 12.0 9.7 9.1 15.7 9.2 9.8 10.9 9.2 11.3 9.9 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284331 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038349 Approved Approved Nucleoli Nucleoli "HPA038349: AB_10669523" "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favourable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favourable (6.90e-4)" 16.0 30.1 28.0 15.0 25.1 6.3 14.6 19.4 24.5 15.9 21.8 18.6 16.9 21.0 15.4 14.7 16.1 15.4 15.7 32.5 24.0 27.5 29.0 31.1 17.2 25.8 27.9 20.5 19.3 19.3 25.3 16.0 18.9 21.0 17.5 17.5 12.4 19.6 18.4 24.5 13.6 30.9 24.4 29.7 20.9 17.3 14.1 24.1 31.6 29.4 13.5 18.4 20.4 21.2 6.1 3.0 8.0 9.9 7.3 7.4 4.0 15.9 7.0 5.9 2.5 8.6 13.5 4.1 9.0 18.7 8.2 11.6 1.0 9.4 21.1 4.2 11.3 3.1 6.3 6.2 14.6 24.3 4.6 9.8 4.7 10.7 11.4 7.6 15.8 6.1 11.5 6.1 8.6 6.9 5.2 11.9 12.7 2.9 17.3 1.9 0.8 3.9 8.6 10.9 5.7 15.1 2.5 2.8 4.0 4.4 4.7 7.5 3.8 3.5 17.6 9.8 6.9 6.0 10.7 20.8 12.8 19.1 13.7 5.6 3.0 8.0 2.2 3.8 4.2 5.6 7.4 6.1 6.2 4.2 3.0 5.8 6.3 6.1 3.1 7.3 9.9 0.8 3.4 4.0 28.0 25.1 19.4 24.5 24.0 27.5 27.9 20.5 21.0 24.1 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.0" "Cell line enhanced" "Detected in many" "U-87 MG: 37.1;WM-115: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2" "Group enriched" "Detected in many" 6 "granulocytes: 21.6;monocytes: 12.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli Nucleoli "HPA047719: , HPA066058: " "unprognostic (7.60e-2)" "prognostic unfavourable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavourable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 2.0 2.2 4.0 3.9 4.9 12.7 2.1 6.3 6.3 2.6 17.1 8.6 3.0 17.8 2.1 18.5 6.4 1.5 1.8 1.4 4.2 5.2 3.6 1.7 3.8 6.3 7.4 2.7 3.5 18.9 4.1 5.1 9.5 6.9 3.3 3.5 3.3 2.5 2.0 4.8 3.3 24.0 2.5 5.3 10.0 1.2 26.0 5.2 0.4 1.6 3.6 2.6 4.9 4.2 0.2 2.7 21.6 12.2 0.2 0.5 2.1 5.1 1.6 3.7 3.4 1.2 1.8 7.2 2.6 4.4 5.3 12.8 2.6 1.8 2.2 2.5 2.0 1.5 1.5 4.4 4.7 1.5 1.2 5.2 3.3 2.8 1.0 0.9 2.3 1.9 6.8 8.5 0.8 1.3 1.7 1.9 4.2 1.1 0.3 7.2 2.3 3.4 0.4 1.8 2.4 2.0 4.8 1.0 2.3 2.8 1.2 10.1 2.8 2.2 0.4 5.4 2.2 0.7 15.6 8.9 1.9 1.3 37.1 1.9 32.3 0.0 6.5 11.4 0.2 7.3 0.1 0.2 0.3 0.0 2.7 0.1 0.5 0.1 21.6 0.2 12.2 0.3 0.0 2.1 4.0 4.9 6.3 6.3 4.2 5.2 7.4 2.7 6.9 5.2 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell line enhanced" "Detected in many" "HDLM-2: 82.0;PC-3: 66.6;SK-MEL-30: 52.3;WM-115: 71.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavourable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavourable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.2 8.2 0.3 0.1 0.1 1.7 9.0 20.5 5.2 2.9 2.2 3.3 18.3 0.0 10.0 2.2 11.4 0.0 8.2 0.3 82.0 2.7 0.0 4.4 2.1 6.7 0.0 4.9 2.8 3.7 2.5 2.0 2.4 1.7 0.1 1.2 29.2 0.0 1.4 3.3 66.6 0.0 0.0 5.6 5.9 2.9 0.9 0.0 6.6 4.5 52.3 1.3 0.8 13.6 6.6 3.6 9.2 6.9 0.0 0.1 0.0 5.4 1.4 71.9 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027735-135034813 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8" "Cell line enhanced" "Detected in many" "CACO-2: 39.6;HeLa: 32.4;K-562: 31.6;T-47d: 47.1" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 0.3 0.3 0.0 4.7 0.0 0.3 0.2 0.0 0.2 14.8 2.8 0.0 0.0 5.6 0.5 1.2 119.4 0.3 1.9 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 32.9 1.3 1.0 8.8 1.1 10.8 33.0 0.2 8.6 0.5 3.2 18.6 0.0 0.2 7.4 0.4 0.0 0.0 0.4 58.8 60.8 18.2 28.9 0.3 0.3 1.4 0.4 0.4 1.1 0.2 16.9 10.4 0.0 14.0 0.5 0.2 4.3 3.4 4.9 1.6 0.6 39.6 10.0 19.0 5.4 0.2 5.7 2.3 8.1 0.1 0.2 14.8 4.7 32.4 10.9 5.1 1.7 0.0 0.4 5.9 0.0 1.9 0.0 31.6 0.0 0.5 5.2 0.1 3.8 0.0 9.3 5.6 0.3 0.3 0.2 5.3 6.5 0.0 14.8 8.0 0.0 47.1 1.1 0.6 1.8 4.7 1.0 5.2 0.0 0.0 12.5 2.4 0.1 0.0 1.4 0.3 0.1 0.9 0.3 0.5 0.3 0.6 1.1 0.2 0.3 0.3 1.0 0.7 0.4 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 PLEK P47 ENSG00000115956 Pleckstrin P08567 2 68365173-68397453 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0" "Cell line enhanced" "Detected in some" "HEL: 91.5;HMC-1: 35.0;NB-4: 30.8;THP-1: 35.8;U-266/84: 23.8;U-698: 24.4;U-937: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA031838, HPA057341" Enhanced Approved Nucleoli 970000000 Nucleoli "HPA031838: AB_10602146, HPA057341: " "unprognostic (2.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.52e-3)" "unprognostic (3.52e-1)" "unprognostic (3.08e-2)" "unprognostic (4.67e-2)" "unprognostic (3.40e-2)" "unprognostic (4.00e-2)" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (1.22e-1)" "prognostic unfavourable (1.95e-4)" "unprognostic (3.57e-1)" "unprognostic (4.42e-2)" "unprognostic (2.03e-1)" "unprognostic (1.56e-1)" 27.8 3.6 3.0 21.7 7.7 120.1 4.6 1.0 3.0 1.8 4.2 7.0 0.4 2.4 2.4 7.5 3.5 5.5 4.9 4.9 2.6 2.4 3.8 6.5 17.0 36.6 6.4 0.8 4.3 2.8 0.7 2.0 8.5 5.0 4.0 4.5 2.7 3.5 0.8 2.3 1.7 8.0 5.0 8.6 51.0 3.2 5.7 3.7 8.2 3.8 2.7 25.7 7.3 2.0 22.9 66.9 80.4 50.8 33.2 44.7 65.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.5 0.0 0.0 0.0 20.6 35.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 30.8 0.0 0.0 0.2 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 0.0 0.0 1.3 23.8 24.4 0.0 56.8 0.0 24.8 39.7 57.2 44.7 49.2 23.5 22.9 8.2 32.2 32.1 13.5 2.3 25.3 80.4 33.2 50.8 66.9 0.8 65.9 3.0 7.7 1.0 3.0 2.6 2.4 6.4 0.8 5.0 3.7 POP1 ENSG00000104356 "POP1 homolog, ribonuclease P/MRP subunit" Q99575 8 98117297-98159834 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066194 Supported Nucleoli Nucleoli "HPA066194: " "prognostic unfavourable (2.54e-4)" "unprognostic (9.42e-2)" "unprognostic (5.96e-3)" "unprognostic (3.31e-2)" "unprognostic (1.46e-1)" "unprognostic (7.46e-2)" "prognostic unfavourable (1.26e-6)" "prognostic unfavourable (9.88e-4)" "unprognostic (4.85e-1)" "unprognostic (1.47e-1)" "unprognostic (3.79e-1)" "unprognostic (1.39e-2)" "prognostic unfavourable (5.97e-4)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (1.34e-1)" "unprognostic (2.96e-1)" 6.1 5.5 7.8 9.0 9.7 3.7 5.8 14.3 10.2 4.3 5.4 5.2 2.7 4.3 6.0 4.2 9.1 6.6 3.9 5.0 5.7 4.7 10.5 6.4 5.2 9.1 4.1 7.6 8.4 5.8 7.6 11.1 3.5 7.4 5.0 13.8 6.2 5.1 4.2 5.7 8.2 5.1 5.2 4.0 8.8 5.7 11.8 6.2 8.8 5.0 5.6 11.3 4.3 5.0 10.5 7.7 10.9 7.4 4.1 9.8 2.5 12.6 7.6 8.3 7.7 2.9 2.1 5.5 10.9 9.2 11.4 8.5 7.8 8.2 8.9 15.7 7.9 8.5 24.2 10.8 12.3 6.4 10.2 17.8 6.1 5.3 1.3 9.4 11.2 1.7 2.0 12.6 5.0 8.8 9.7 8.1 10.6 10.1 13.6 4.8 6.3 10.6 11.3 4.9 6.4 8.3 6.8 20.0 4.7 5.0 8.5 3.8 11.6 3.5 12.0 10.0 7.2 12.6 21.5 8.1 7.6 19.2 7.8 10.2 8.7 10.9 6.7 4.6 9.8 7.4 7.8 6.2 7.1 6.5 6.2 10.5 9.3 8.6 0.9 4.1 3.4 7.7 5.9 2.5 7.8 9.7 14.3 10.2 5.7 4.7 4.1 7.6 7.4 6.2 PPIL1 CYPL1 ENSG00000137168 "Peptidylprolyl isomerase like 1" Q9Y3C6 6 36854827-36875024 "Enzymes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062916 Approved Nucleoli Nucleoli "HPA062916: " "unprognostic (3.51e-2)" "unprognostic (2.33e-1)" "unprognostic (2.64e-3)" "unprognostic (1.11e-2)" "unprognostic (1.87e-1)" "unprognostic (1.81e-2)" "prognostic unfavourable (1.28e-5)" "unprognostic (2.01e-1)" "unprognostic (3.37e-2)" "prognostic favourable (4.90e-4)" "unprognostic (6.58e-2)" "unprognostic (5.49e-2)" "unprognostic (8.99e-2)" "unprognostic (1.30e-1)" "unprognostic (2.30e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-2)" 9.0 17.2 15.9 11.1 23.1 7.3 12.3 16.6 18.7 11.1 10.2 13.0 5.7 8.7 13.7 11.7 13.1 17.5 7.5 29.7 13.2 19.8 17.6 34.3 7.5 13.4 15.0 15.5 13.2 36.7 10.6 19.4 16.0 15.3 11.2 13.2 11.0 12.0 12.5 11.7 5.6 8.2 17.4 15.8 10.3 8.5 14.0 11.0 10.2 23.5 13.4 17.4 12.2 8.1 7.7 6.6 1.1 4.4 5.0 15.0 6.9 14.1 11.2 29.6 19.7 4.0 8.4 16.0 14.4 9.6 21.7 18.1 19.6 9.4 21.7 18.3 10.1 11.5 35.0 24.0 24.9 18.1 29.2 25.8 7.3 25.9 13.2 22.0 10.8 6.3 11.4 16.7 31.3 19.4 48.3 10.6 15.7 13.4 26.1 10.1 19.6 15.2 21.1 25.9 19.5 12.9 10.0 31.5 16.6 9.6 10.3 18.9 15.0 18.7 11.8 16.8 15.5 12.8 24.0 11.6 30.3 39.7 5.3 40.8 31.9 1.1 3.2 0.8 11.2 4.4 15.0 7.7 9.3 10.7 6.6 6.2 10.5 12.3 0.9 5.0 2.1 5.6 6.8 6.9 15.9 23.1 16.6 18.7 13.2 19.8 15.0 15.5 15.3 11.0 PPP1R7 sds22 ENSG00000115685 "Protein phosphatase 1 regulatory subunit 7" Q15435 2 241149576-241183652 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034500, HPA034501" Supported Approved Nucleoli 650000 Nucleoli "HPA034500: AB_2674192, HPA034501: AB_10670965" "unprognostic (1.63e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-1)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (4.38e-1)" "unprognostic (8.07e-3)" "unprognostic (5.01e-2)" "unprognostic (2.49e-1)" "unprognostic (9.05e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-1)" "unprognostic (1.57e-1)" "unprognostic (4.51e-3)" "unprognostic (1.23e-1)" 21.5 21.9 39.2 19.4 82.1 22.2 19.7 25.0 40.5 19.0 24.8 16.4 18.8 22.2 18.9 24.8 31.5 32.2 20.5 36.9 31.3 23.3 24.9 28.8 20.4 27.2 23.7 35.2 16.4 22.8 21.9 18.4 17.3 23.5 37.9 25.3 17.6 22.9 22.2 46.4 24.2 22.7 21.3 20.8 17.6 21.8 57.3 29.4 21.2 25.5 26.1 29.6 24.4 25.0 31.4 37.5 48.5 41.0 32.8 53.3 37.4 31.0 18.8 21.4 27.0 42.5 42.7 29.6 34.4 31.5 23.8 33.7 10.2 39.8 16.0 10.3 29.4 30.6 35.0 32.5 36.6 41.6 34.6 28.0 30.7 40.4 27.4 38.7 29.6 32.9 25.8 28.1 20.8 35.2 28.2 23.8 55.4 41.4 34.4 29.9 29.4 18.0 24.0 55.8 32.4 44.1 31.5 29.2 23.2 18.4 43.4 31.4 25.8 42.1 34.6 21.6 20.5 40.5 27.6 25.4 15.3 43.4 60.5 41.3 28.4 40.4 39.8 48.5 32.1 40.0 33.7 31.4 38.4 37.7 37.5 28.8 29.8 34.5 31.4 32.8 41.0 22.4 53.3 37.4 39.2 82.1 25.0 40.5 31.3 23.3 23.7 35.2 23.5 29.4 PRR29 "C17orf72, DKFZp761M2312, FLJ11724" ENSG00000224383 "Proline rich 29" P0C7W0 17 63998351-64004304 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 17.9;fallopian tube: 48.7;testis: 23.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.7;REH: 6.8;RPMI-8226: 2.8;TIME: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA051264 Uncertain Nucleoli Nucleoli "HPA051264: " "unprognostic (2.05e-2)" "unprognostic (6.46e-2)" "unprognostic (2.87e-2)" "unprognostic (2.92e-3)" "unprognostic (4.71e-3)" "unprognostic (3.22e-2)" "unprognostic (3.84e-1)" "unprognostic (3.95e-2)" "unprognostic (1.04e-2)" "unprognostic (1.44e-1)" "unprognostic (2.63e-3)" "unprognostic (5.76e-2)" "unprognostic (1.30e-3)" "unprognostic (6.48e-2)" "unprognostic (1.80e-1)" "unprognostic (1.32e-1)" "unprognostic (9.98e-3)" 0.9 0.5 3.3 0.8 7.6 0.6 0.9 0.1 2.1 4.0 0.5 8.3 0.4 0.6 1.0 17.9 0.6 48.7 1.0 0.7 5.6 5.5 0.6 0.6 7.3 0.7 1.6 0.8 8.1 0.5 0.9 5.8 0.7 15.2 0.6 0.4 0.2 0.9 0.9 0.6 0.5 0.5 0.6 1.1 2.5 0.5 23.5 1.0 0.0 2.5 0.0 0.7 1.0 0.0 1.0 0.7 3.1 1.8 1.0 3.0 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.2 0.0 0.0 0.4 0.0 6.7 0.0 0.7 0.0 0.0 0.1 0.4 0.2 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 1.0 0.0 0.0 0.0 2.3 0.0 0.2 0.2 6.8 0.1 2.8 0.5 0.0 0.4 2.0 0.0 0.3 0.4 1.0 0.0 5.5 0.2 2.3 0.7 0.2 0.7 0.1 0.5 0.9 0.3 0.0 3.1 0.9 0.0 2.0 1.8 0.4 0.7 1.7 1.0 0.7 1.0 3.0 1.7 0.8 1.0 1.7 0.1 1.1 1.6 3.3 7.6 0.1 2.1 5.6 5.5 1.6 0.8 15.2 1.0 PUM3 "HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5" ENSG00000080608 "Pumilio RNA binding family member 3" Q15397 9 2720469-2844241 "Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 71.7;HEL: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002353 Approved Supported Nucleoli Nucleoli "HPA002353: AB_1852266" "unprognostic (1.39e-2)" "unprognostic (1.32e-2)" "unprognostic (7.54e-2)" "unprognostic (2.50e-1)" "unprognostic (2.06e-2)" "unprognostic (1.56e-1)" "prognostic unfavourable (4.89e-5)" "unprognostic (2.02e-1)" "unprognostic (6.92e-2)" "unprognostic (1.56e-2)" "unprognostic (1.30e-2)" "prognostic unfavourable (1.74e-4)" "unprognostic (2.44e-3)" "unprognostic (8.44e-2)" "unprognostic (1.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.43e-2)" 19.4 17.0 11.5 19.0 15.2 14.8 22.1 15.6 17.7 18.9 16.9 8.3 9.8 11.2 17.1 10.6 29.3 15.7 10.5 15.1 16.7 5.9 23.2 18.4 18.6 18.9 14.0 14.3 24.4 17.8 11.5 23.1 15.9 15.8 18.0 17.3 6.1 20.7 10.3 21.0 16.4 13.2 19.5 18.2 17.8 14.2 13.8 14.9 15.4 15.1 14.5 18.9 20.1 21.6 15.3 13.7 3.8 12.8 15.9 18.4 7.8 16.6 12.3 10.4 10.6 8.7 9.3 11.9 15.6 8.2 16.1 15.1 9.3 7.8 18.4 3.6 10.6 8.4 18.7 13.4 21.0 71.7 6.6 69.9 12.4 11.1 11.6 30.8 13.1 7.5 5.9 13.0 18.7 11.8 7.3 8.4 13.9 7.6 15.6 25.1 26.6 5.4 18.4 8.1 7.9 10.9 11.3 10.8 10.3 9.4 8.7 8.4 5.5 16.7 11.3 10.9 8.9 10.3 20.8 3.9 6.4 26.0 8.2 11.2 7.9 3.8 9.2 2.7 13.2 12.8 18.4 15.3 13.7 13.2 12.1 13.5 15.3 14.8 1.3 15.9 10.4 13.7 10.0 7.8 11.5 15.2 15.6 17.7 16.7 5.9 14.0 14.3 15.8 14.9 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966371 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli Nucleoli "HPA038860: AB_10697400, HPA058732: " "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavourable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 15.4 18.4 19.9 23.5 26.1 23.8 17.1 25.0 26.7 13.7 15.4 27.5 16.0 14.7 17.7 15.1 15.7 15.1 13.0 14.3 19.4 12.6 16.5 15.7 15.2 22.1 22.4 16.2 25.5 21.3 22.0 16.6 16.9 19.4 19.0 15.8 16.0 16.1 16.2 20.0 16.3 16.5 19.6 14.5 19.1 16.7 17.3 26.3 16.8 26.7 14.4 21.5 17.1 21.7 8.1 6.7 1.4 11.9 7.9 9.1 4.8 7.0 14.2 8.5 16.6 8.6 6.9 13.0 12.8 10.1 14.5 10.7 19.0 10.0 12.7 8.0 10.8 10.1 20.0 12.3 11.5 22.9 11.7 27.2 14.0 18.2 6.5 20.5 13.0 8.5 8.2 17.7 6.5 10.5 29.2 5.2 8.9 10.6 11.5 15.5 18.6 12.2 15.4 8.2 11.0 9.9 13.8 10.2 8.2 11.4 16.7 7.8 18.3 5.9 11.9 9.6 11.8 8.2 7.8 9.5 7.1 12.7 12.9 14.7 12.1 0.0 4.9 1.4 9.1 8.8 6.9 8.1 6.4 7.4 6.7 7.0 5.2 7.1 0.3 7.9 11.9 4.6 5.5 4.8 19.9 26.1 25.0 26.7 19.4 12.6 22.4 16.2 19.4 26.3 RBM28 FLJ10377 ENSG00000106344 "RNA binding motif protein 28" Q9NW13 7 128297685-128343908 "Disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019058, HPA026672, HPA031519" Enhanced Supported Nucleoli Nucleoli "HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: " "unprognostic (2.34e-1)" "unprognostic (1.87e-2)" "unprognostic (6.43e-2)" "prognostic unfavourable (2.94e-4)" "unprognostic (2.19e-1)" "unprognostic (2.13e-1)" "prognostic unfavourable (2.72e-11)" "unprognostic (6.83e-2)" "prognostic unfavourable (6.44e-4)" "unprognostic (7.20e-2)" "unprognostic (4.01e-2)" "unprognostic (3.97e-3)" "unprognostic (1.45e-3)" "unprognostic (7.15e-3)" "unprognostic (3.05e-1)" "unprognostic (2.18e-2)" "unprognostic (1.04e-1)" 22.1 17.7 16.3 18.4 25.1 14.2 17.5 26.5 25.3 12.8 13.7 19.7 9.6 13.2 17.1 9.9 15.1 12.5 10.9 24.4 18.1 8.6 12.0 18.8 13.2 17.9 26.5 16.2 19.7 15.7 16.5 18.4 14.5 17.3 13.1 12.7 12.3 13.0 13.0 33.5 17.3 11.2 14.2 25.4 13.8 14.1 18.4 24.4 11.7 16.1 12.2 15.6 13.8 18.9 14.5 14.3 9.8 11.5 12.3 13.7 5.5 18.4 20.4 12.3 35.2 8.8 5.6 16.9 17.0 7.0 15.4 16.8 16.9 16.2 24.5 9.3 7.7 12.5 18.1 14.4 20.1 12.2 17.3 24.6 14.3 15.5 7.8 30.9 22.1 6.4 9.4 20.5 12.4 14.2 45.9 14.4 12.0 14.9 22.1 17.7 23.5 16.0 17.6 14.8 23.5 7.5 12.5 13.8 16.8 21.9 36.7 11.6 9.4 9.5 13.6 22.5 11.7 19.8 20.6 14.8 12.6 42.5 14.7 26.2 24.1 3.5 11.5 4.4 13.7 8.9 9.4 12.8 11.6 12.2 11.5 14.5 10.5 12.0 9.8 12.3 7.8 14.3 7.1 5.5 16.3 25.1 26.5 25.3 18.1 8.6 26.5 16.2 17.3 24.4 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85342088-85354620 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 86.1" "Cell line enhanced" "Detected in many" "ASC diff: 64.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli Nucleoli "HPA007961: AB_1079802, HPA046513: " "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favourable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favourable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 65.7 24.8 7.7 9.8 9.1 0.9 35.6 5.6 9.3 7.4 46.5 12.4 12.7 49.0 6.8 12.3 16.7 5.0 17.7 7.3 7.4 5.7 20.6 51.9 7.2 5.1 10.2 7.7 5.5 11.5 13.1 3.5 5.7 8.9 10.1 22.6 10.0 12.5 7.6 24.3 14.3 86.1 7.0 12.7 4.0 18.2 9.2 10.1 3.5 27.2 13.9 9.3 9.9 9.0 3.8 5.6 5.3 10.0 6.5 9.2 4.1 15.9 9.3 5.4 12.5 64.5 12.1 7.0 11.7 14.5 7.1 10.0 6.4 11.2 5.6 9.7 9.3 13.4 7.2 20.4 7.0 6.9 5.0 2.7 7.6 15.7 15.5 5.3 6.2 15.8 28.0 9.1 12.2 11.8 2.9 13.5 13.2 3.4 3.8 2.8 1.7 11.4 2.5 10.7 7.3 12.6 9.4 2.6 4.4 9.8 18.8 31.8 8.8 0.9 9.2 8.0 4.4 7.5 6.1 7.3 6.8 2.2 9.9 6.4 5.5 0.0 5.1 2.4 7.0 5.5 9.2 3.8 5.6 8.8 5.6 2.5 3.8 4.0 5.3 6.5 10.0 4.0 5.8 4.1 7.7 9.1 5.6 9.3 7.4 5.7 10.2 7.7 8.9 10.1 RIOX1 "C14orf169, FLJ21802, JMJD9, MAPJD, NO66" ENSG00000170468 "Ribosomal oxygenase 1" Q9H6W3 14 73490964-73493392 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003730 Supported Nucleoli Nucleoli "HPA003730: " "unprognostic (4.70e-3)" "unprognostic (1.94e-2)" "unprognostic (2.45e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-3)" "unprognostic (1.73e-1)" "unprognostic (2.27e-2)" "unprognostic (1.48e-1)" "unprognostic (6.51e-2)" "unprognostic (5.36e-2)" "unprognostic (1.35e-3)" "unprognostic (4.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (1.67e-1)" "unprognostic (7.97e-3)" "unprognostic (8.62e-2)" 3.9 2.4 4.3 5.2 5.6 8.0 4.0 7.6 8.0 5.3 4.1 6.7 3.6 4.1 4.5 5.7 3.9 4.7 3.3 5.3 3.4 4.1 5.1 4.1 8.4 5.8 4.9 4.5 6.1 5.2 3.2 2.8 4.6 4.0 4.1 4.7 5.0 5.0 2.8 4.0 3.4 4.8 2.1 5.0 3.9 10.5 5.2 17.3 4.5 3.6 7.5 3.7 4.4 3.5 5.2 5.1 3.8 4.9 7.4 1.3 10.3 9.4 6.1 9.4 7.9 4.5 11.7 7.1 5.2 7.3 6.6 8.1 5.3 17.7 5.2 6.1 12.3 11.6 7.0 6.1 11.2 12.8 11.1 5.6 5.3 4.4 0.0 14.9 4.8 6.5 7.0 3.2 6.6 8.0 6.6 6.5 16.3 19.3 12.6 6.7 15.9 15.4 9.5 5.3 7.2 7.8 12.7 9.2 11.8 21.2 7.5 21.1 11.1 9.4 0.0 12.2 6.3 0.0 9.1 9.7 6.2 3.2 9.2 7.2 0.2 2.2 5.1 6.4 3.8 7.4 3.5 6.5 5.1 3.0 2.7 6.0 4.4 0.9 4.9 2.3 5.2 2.8 1.3 RNFT1 PTD016 ENSG00000189050 "Ring finger protein, transmembrane 1" Q5M7Z0 17 59952240-59964761 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 45.5" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013739 Approved Nucleoli Nucleoli "HPA013739: AB_1856382" "unprognostic (1.61e-1)" "unprognostic (2.83e-1)" "prognostic favourable (6.57e-4)" "unprognostic (3.04e-2)" "unprognostic (6.90e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "prognostic favourable (7.48e-4)" "unprognostic (5.42e-2)" "unprognostic (3.45e-1)" "unprognostic (8.26e-3)" "unprognostic (9.44e-3)" "unprognostic (1.19e-3)" "unprognostic (1.44e-2)" "unprognostic (2.05e-1)" "prognostic favourable (2.57e-4)" "unprognostic (2.60e-1)" 7.9 6.2 2.8 5.3 4.3 3.8 4.2 5.1 3.7 3.1 4.0 2.4 3.7 5.3 2.7 8.1 4.6 3.2 3.1 4.1 3.1 2.2 4.7 12.0 5.0 4.4 2.9 3.1 3.5 7.5 4.7 6.1 4.4 3.4 4.5 4.8 4.2 5.1 3.0 6.7 2.7 7.6 3.0 3.4 4.1 3.9 45.5 3.0 5.9 6.1 4.3 6.0 5.1 3.7 9.5 10.1 20.2 17.1 8.9 7.7 7.9 4.8 2.2 2.3 3.1 7.6 5.7 4.5 6.2 3.3 4.8 6.0 6.9 1.9 7.2 10.4 5.1 5.6 7.2 4.7 8.4 6.8 7.8 6.0 5.8 6.2 5.6 9.3 9.3 6.3 2.5 4.5 2.0 4.9 17.3 4.4 4.1 6.2 3.8 4.5 0.9 5.1 5.2 17.4 4.1 3.9 3.4 1.4 2.7 8.9 2.1 12.3 10.2 17.8 3.5 9.4 8.4 5.5 5.2 6.5 18.0 4.2 6.5 5.2 4.7 17.3 11.8 20.2 5.6 13.9 7.7 9.5 5.2 6.3 10.1 6.1 6.8 6.1 5.7 8.9 17.1 6.7 6.5 7.9 2.8 4.3 5.1 3.7 3.1 2.2 2.9 3.1 3.4 3.0 RPF1 BXDC5 ENSG00000117133 "Ribosome production factor 1 homolog" Q9H9Y2 1 84479259-84497790 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024642 Supported Supported Nucleoli Nucleoli "HPA024642: AB_1856428" "unprognostic (1.56e-3)" "unprognostic (2.65e-1)" "unprognostic (3.63e-2)" "unprognostic (7.95e-3)" "unprognostic (2.16e-3)" "unprognostic (1.73e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (2.86e-1)" "unprognostic (1.04e-1)" "unprognostic (4.81e-2)" "unprognostic (1.73e-2)" "unprognostic (2.45e-1)" "unprognostic (1.45e-1)" "unprognostic (3.90e-2)" "unprognostic (1.53e-2)" "unprognostic (1.42e-2)" "unprognostic (2.71e-1)" 20.9 20.4 21.3 25.1 36.2 42.7 26.3 14.8 24.7 21.3 24.8 12.8 18.8 18.8 25.5 27.4 26.0 20.8 18.2 39.8 17.9 16.5 33.1 33.8 21.3 27.2 16.7 15.1 23.9 21.3 16.8 25.7 19.8 16.0 23.7 24.0 14.1 20.8 26.2 56.8 22.1 22.7 20.8 16.6 33.9 22.8 31.0 20.3 31.8 29.3 27.9 30.2 30.0 23.1 36.9 23.1 29.2 26.0 31.8 33.9 26.1 19.0 13.4 17.0 14.2 13.3 17.7 19.2 19.6 17.4 25.7 22.9 10.1 8.2 14.7 22.2 15.5 14.5 25.5 20.2 28.4 21.1 26.8 36.9 15.1 17.5 18.5 35.5 12.1 14.1 30.1 26.8 19.1 20.5 35.6 18.9 22.4 9.9 33.3 23.9 42.4 30.0 21.5 27.3 11.8 24.4 22.4 21.4 20.0 11.4 24.5 46.8 13.8 24.3 14.0 19.4 19.3 30.5 40.5 13.1 15.4 32.4 9.1 32.0 17.3 29.2 21.3 19.6 26.6 24.6 29.3 36.9 30.4 26.9 22.5 31.0 33.8 33.9 8.9 31.8 26.0 23.1 31.3 26.1 21.3 36.2 14.8 24.7 17.9 16.5 16.7 15.1 16.0 20.3 RPP38 ENSG00000152464 "Ribonuclease P/MRP subunit p38" P78345 10 15097180-15139818 "Enzymes, Predicted intracellular proteins, Ribosomal proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045128, HPA050398" Approved Supported Nucleoli Nucleoli "HPA045128: , HPA050398: " "unprognostic (1.75e-1)" "unprognostic (3.91e-2)" "unprognostic (3.76e-2)" "unprognostic (1.51e-1)" "unprognostic (9.93e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (1.46e-4)" "unprognostic (1.41e-2)" "unprognostic (4.86e-1)" "unprognostic (1.57e-3)" "unprognostic (3.42e-1)" "unprognostic (7.21e-2)" "prognostic unfavourable (6.25e-4)" "unprognostic (6.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.11e-2)" "prognostic favourable (2.89e-6)" 13.1 12.2 12.4 10.7 13.6 9.7 18.3 22.4 12.4 13.6 16.7 12.0 15.8 14.4 15.7 16.1 15.2 18.2 10.3 10.0 11.6 10.2 17.4 21.6 12.5 16.3 15.0 10.0 14.4 16.8 11.3 16.0 17.4 12.7 18.4 15.7 11.7 17.1 14.9 20.9 14.8 17.9 14.3 11.5 16.7 13.5 38.6 12.7 18.8 19.8 13.9 18.5 13.4 13.6 31.0 25.7 23.4 24.5 18.6 31.4 20.2 20.9 15.9 8.7 11.2 11.8 12.2 15.4 10.2 7.7 16.0 16.5 16.0 22.1 17.6 11.0 9.5 19.7 17.5 17.7 14.8 13.4 15.9 18.1 9.7 14.0 25.4 10.2 15.3 14.5 24.5 13.1 11.6 12.8 20.9 12.6 12.2 17.3 18.2 11.2 10.1 7.8 15.0 8.8 21.9 20.5 8.3 8.3 10.5 14.1 24.5 28.2 21.9 16.5 11.0 7.4 12.9 15.6 13.4 17.5 18.7 24.0 14.5 12.5 7.0 8.5 24.5 23.4 25.6 23.7 25.1 28.8 26.2 31.4 25.3 31.0 30.6 27.8 8.3 18.6 18.6 25.7 22.0 20.2 12.4 13.6 22.4 12.4 11.6 10.2 15.0 10.0 12.7 12.7 RRN3 "DKFZp566E104, TIF-IA" ENSG00000085721 "RRN3 homolog, RNA polymerase I transcription factor" Q9NYV6 16 15060022-15094317 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049837 Supported Supported Nucleoli Nucleoli "HPA049837: " "unprognostic (1.83e-1)" "unprognostic (6.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.05e-2)" "unprognostic (2.37e-1)" "unprognostic (5.74e-3)" "unprognostic (3.67e-2)" "unprognostic (4.50e-2)" "unprognostic (7.81e-2)" "unprognostic (1.12e-1)" "unprognostic (5.25e-3)" "unprognostic (1.17e-2)" "unprognostic (7.71e-2)" "unprognostic (2.76e-2)" "unprognostic (2.30e-1)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" 7.8 6.0 4.3 4.0 5.7 10.0 7.2 9.2 6.3 4.9 5.1 5.0 6.3 5.4 4.5 5.9 4.7 5.5 3.9 5.0 5.5 10.1 4.3 5.9 3.7 8.4 5.8 8.9 5.8 4.9 6.6 6.5 4.6 4.8 15.2 5.3 5.0 5.1 3.9 6.2 5.3 4.9 6.2 6.3 6.6 4.9 10.7 8.2 12.3 7.0 10.0 14.2 9.5 7.6 10.2 8.0 6.8 9.5 8.2 5.8 9.7 6.5 9.5 9.1 9.4 11.2 13.5 15.5 8.6 7.5 14.9 9.9 13.8 10.8 10.1 29.6 13.6 18.0 13.8 11.0 34.6 8.5 13.7 13.4 15.2 6.7 8.2 11.7 13.1 12.0 10.6 14.1 9.0 8.5 23.3 11.1 14.9 7.9 10.0 16.9 11.9 10.4 12.3 10.7 15.9 9.9 6.8 11.3 5.3 7.9 9.8 9.4 13.4 19.0 6.7 13.3 14.5 12.3 6.4 5.9 11.2 6.6 13.3 10.7 9.8 11.0 8.2 7.7 14.2 11.0 1.0 10.0 7.0 5.2 9.4 9.5 RRP1 "D21S2056E, NNP-1, Nop52, RRP1A" ENSG00000160214 "Ribosomal RNA processing 1" P56182 21 43789513-43805293 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016818, HPA018166" Approved Enhanced Nucleoli Nucleoli "HPA016818: AB_1854561, HPA018166: AB_1854562" "unprognostic (5.38e-2)" "unprognostic (3.48e-1)" "unprognostic (3.43e-1)" "unprognostic (2.53e-2)" "unprognostic (9.44e-2)" "unprognostic (1.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.26e-1)" "unprognostic (7.63e-3)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.25e-2)" "prognostic unfavourable (6.29e-5)" "unprognostic (1.13e-1)" "unprognostic (9.21e-3)" "unprognostic (2.64e-1)" "unprognostic (1.88e-1)" 12.0 10.6 12.1 12.8 15.6 9.7 9.4 11.4 20.0 8.6 8.9 18.0 6.0 10.6 10.0 9.1 19.8 10.9 9.3 8.5 14.3 11.3 8.3 16.6 7.3 15.1 16.3 14.4 14.8 16.6 9.4 7.6 10.3 14.9 9.4 6.7 9.9 14.7 9.8 15.6 20.1 9.7 7.4 11.5 11.1 11.9 13.8 15.6 10.5 9.6 11.4 14.7 8.9 9.8 10.9 8.8 1.5 4.3 10.4 12.3 6.0 16.2 8.8 6.0 10.1 3.3 3.7 11.7 8.3 4.9 11.6 8.2 22.9 9.7 15.7 6.9 4.5 8.3 11.2 8.1 5.3 7.8 21.9 22.4 8.1 14.0 6.8 14.1 8.1 5.0 7.6 11.6 9.2 6.1 29.2 11.8 5.4 19.2 12.2 19.4 20.2 13.1 22.7 4.8 28.9 5.9 9.0 14.3 8.6 8.7 9.3 10.9 9.8 9.7 7.0 7.8 8.8 8.2 14.4 14.8 12.7 16.3 11.8 23.7 10.1 0.1 4.3 1.5 9.7 4.0 12.3 9.6 10.1 9.9 8.8 10.9 11.2 7.4 0.9 10.4 1.9 7.5 5.8 6.0 12.1 15.6 11.4 20.0 14.3 11.3 16.3 14.4 14.9 15.6 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator homolog" Q15050 8 66429028-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Enhanced Nucleoli Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 12.0 11.2 8.7 14.1 12.4 7.0 9.9 8.5 9.8 8.5 9.6 7.1 7.2 10.3 13.4 6.6 12.2 11.2 9.8 9.6 8.5 7.5 9.5 18.0 6.7 14.6 11.5 7.9 19.0 41.4 8.3 5.8 7.6 11.1 9.0 7.1 6.4 9.8 9.7 31.7 10.2 7.7 14.0 7.8 9.5 12.0 4.9 9.9 8.6 7.5 19.2 11.5 13.7 13.1 6.8 15.2 0.6 11.8 11.2 17.8 6.8 22.7 28.8 5.9 12.4 6.4 5.2 9.6 14.4 6.4 11.2 8.3 12.8 15.2 31.0 5.0 7.6 21.4 14.5 16.4 12.4 17.0 24.4 24.6 8.7 22.8 9.5 14.6 13.1 6.8 13.3 12.3 16.4 7.2 21.5 13.2 8.1 26.4 29.0 26.6 38.5 33.9 6.2 7.6 12.9 15.6 18.8 8.1 17.9 7.0 11.7 16.0 20.1 13.0 12.4 20.8 18.6 17.4 33.1 23.7 21.2 23.9 9.7 23.1 14.0 0.0 8.9 0.6 10.0 11.8 17.8 6.8 12.7 11.7 15.2 6.7 11.9 13.6 0.3 11.2 7.2 7.1 9.1 6.8 8.7 12.4 8.5 9.8 8.5 7.5 11.5 7.9 11.1 9.9 RSL1D1 "CSIG, DKFZP564M182, L12, PBK1, UTP30" ENSG00000171490 "Ribosomal L1 domain containing 1" O76021 16 11833850-11851585 "Predicted intracellular proteins, Ribosomal proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043483 Supported Enhanced Nucleoli Nucleoli "HPA043483: " "unprognostic (4.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.23e-2)" "unprognostic (8.88e-2)" "unprognostic (7.77e-2)" "prognostic unfavourable (2.95e-4)" "prognostic unfavourable (1.38e-4)" "unprognostic (6.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.28e-1)" "unprognostic (2.24e-3)" "unprognostic (1.24e-1)" "prognostic unfavourable (3.24e-4)" "unprognostic (4.72e-2)" "unprognostic (1.36e-1)" "unprognostic (2.02e-2)" "unprognostic (2.68e-2)" 31.5 16.8 11.6 15.8 15.0 18.6 36.1 16.3 16.2 26.6 21.5 11.5 12.6 14.9 20.6 14.0 28.6 21.8 14.2 17.3 11.2 11.4 17.9 24.0 15.9 29.4 14.2 11.7 58.1 32.7 14.9 20.7 22.0 15.0 30.2 18.1 14.7 18.1 17.0 66.9 21.2 23.2 25.6 15.7 25.2 17.8 19.9 12.6 25.2 27.8 19.8 28.7 37.8 20.8 32.2 31.0 3.0 30.2 28.5 49.0 53.4 21.0 20.1 16.9 21.1 22.2 40.1 20.1 19.7 22.1 25.6 26.2 19.4 20.0 53.1 32.7 16.3 15.0 45.2 29.9 41.7 20.7 24.3 26.1 19.8 44.2 41.5 37.0 17.5 29.2 42.5 26.4 61.5 24.8 45.8 24.7 31.3 23.4 28.9 21.5 43.2 20.9 30.2 31.1 56.2 22.9 18.6 23.7 19.4 37.1 28.3 26.3 24.4 28.8 15.1 17.1 19.1 16.1 28.3 19.9 28.5 61.9 18.5 39.0 22.7 3.0 30.2 2.9 18.2 28.6 33.2 32.2 33.6 23.4 31.0 27.0 49.0 35.0 1.6 28.5 26.1 19.1 23.4 53.4 11.6 15.0 16.3 16.2 11.2 11.4 14.2 11.7 15.0 12.6 RSPH14 RTDR1 ENSG00000100218 "Radial spoke head 14 homolog" Q9UHP6 22 23059415-23145021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 15.3;testis: 24.8" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 7.0;SCLC-21H: 4.6;U-266/70: 8.1" "Cancer enhanced" "Detected in some" "renal cancer: 2.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 10.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA018420, HPA050425" Approved Uncertain Nucleoli Nucleoli "HPA018420: AB_1856496, HPA050425: " "unprognostic (8.81e-2)" "unprognostic (1.57e-2)" "unprognostic (1.15e-3)" "unprognostic (3.80e-3)" "unprognostic (1.97e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.41e-1)" "unprognostic (1.22e-2)" "unprognostic (8.31e-2)" "unprognostic (7.28e-2)" "prognostic favourable (4.04e-4)" "unprognostic (5.18e-2)" "unprognostic (4.40e-2)" "unprognostic (3.16e-1)" "unprognostic (7.73e-2)" 0.8 3.0 4.8 0.5 6.8 0.4 0.5 1.2 8.8 1.4 0.7 2.6 0.9 0.4 1.3 4.9 0.6 15.3 1.8 0.3 4.7 4.7 9.3 0.3 1.8 0.5 2.9 3.3 5.5 0.6 0.9 3.1 0.4 6.4 1.1 0.5 1.0 1.0 2.4 0.9 1.6 0.4 0.6 1.6 0.4 0.8 24.8 1.6 0.0 2.7 0.0 0.5 0.6 0.3 0.1 0.0 10.8 2.0 0.2 0.3 0.6 0.4 4.0 3.6 3.4 0.0 1.6 0.2 0.0 0.8 0.7 0.6 0.7 1.2 0.8 1.3 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.4 0.2 1.5 0.2 0.2 1.8 0.0 0.4 0.6 0.0 0.0 0.1 1.7 0.0 0.5 0.8 0.6 0.0 0.1 0.2 0.1 3.7 7.0 0.0 4.6 2.2 0.1 0.1 0.2 0.7 0.8 0.0 3.1 0.8 0.2 0.0 8.1 3.1 2.3 2.6 0.4 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 10.8 0.2 2.0 0.0 0.1 0.6 4.8 6.8 1.2 8.8 4.7 4.7 2.9 3.3 6.4 1.6 SELENBP1 "hSBP, hSP56, LPSB" ENSG00000143416 "Selenium binding protein 1" Q13228 1 151364302-151372733 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein transport, Transport" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 112.3" "Cell line enhanced" "Detected in many" "ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "myeloid DC: 4.8" "Lineage enriched" "Detected in many" 4 "dendritic cells: 4.8" "Low region specificity" "Detected in all" "HPA005741, CAB008366, HPA011731" Enhanced Supported Nucleoli 57000000 Nucleoli "CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663" "unprognostic (1.51e-1)" "unprognostic (7.01e-2)" "unprognostic (8.52e-3)" "unprognostic (6.25e-3)" "unprognostic (6.28e-2)" "prognostic favourable (6.63e-4)" "unprognostic (1.08e-2)" "unprognostic (1.21e-2)" "unprognostic (3.78e-3)" "unprognostic (2.86e-1)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (2.67e-2)" "unprognostic (6.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.86e-2)" "unprognostic (6.86e-3)" 27.9 5.1 17.2 28.9 16.4 17.6 18.4 6.5 11.9 15.1 105.1 10.4 15.8 17.2 13.5 23.1 11.0 32.4 28.8 11.7 18.5 5.1 20.8 56.3 64.9 5.6 10.9 14.9 13.2 7.2 1.4 4.1 5.6 11.3 19.1 112.3 27.9 14.5 15.4 15.9 6.4 29.1 22.9 6.5 13.0 29.1 4.1 13.0 0.0 52.9 18.3 6.0 15.8 8.1 0.0 4.8 0.0 1.1 0.0 0.0 5.5 0.0 4.2 7.9 0.4 38.1 15.2 2.0 1.5 0.7 0.8 1.6 4.3 1.3 0.0 7.3 2.6 0.0 0.0 0.1 0.6 0.0 3.6 28.3 14.2 6.8 8.0 0.0 0.0 19.6 0.2 1.3 0.0 4.8 2.8 0.0 2.0 3.1 0.0 0.0 6.3 8.0 0.0 0.4 0.1 1.7 0.0 0.1 0.1 0.0 68.0 0.0 11.7 0.4 0.4 0.0 0.2 4.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 17.2 16.4 6.5 11.9 18.5 5.1 10.9 14.9 11.3 13.0 SERTAD3 RBT1 ENSG00000167565 "SERTA domain containing 3" Q9UJW9 19 40440844-40444705 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068262 Approved Nucleoli Nucleoli "HPA068262: " "unprognostic (1.56e-2)" "unprognostic (3.57e-2)" "unprognostic (1.10e-1)" "unprognostic (6.55e-3)" "unprognostic (6.50e-2)" "unprognostic (6.74e-2)" "unprognostic (2.24e-2)" "unprognostic (3.51e-3)" "unprognostic (7.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.28e-3)" "unprognostic (2.80e-2)" "unprognostic (8.74e-3)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.18e-1)" "unprognostic (4.66e-3)" 28.3 13.0 5.7 16.8 7.1 10.8 18.6 3.7 6.9 29.3 31.5 13.0 22.0 12.3 24.6 22.2 29.6 18.8 24.9 21.1 5.8 5.7 21.4 19.6 23.6 12.3 8.8 4.5 33.1 8.0 8.8 14.1 49.1 6.6 24.8 14.2 13.6 15.7 25.1 32.1 13.5 25.2 18.9 7.9 21.4 18.6 16.6 6.8 7.8 25.6 24.2 17.3 31.8 18.3 14.4 24.8 28.7 20.6 7.8 7.7 12.2 15.4 30.0 10.5 13.7 11.8 18.2 14.5 12.6 17.1 18.0 15.6 10.8 12.1 7.5 5.7 16.2 5.6 10.6 12.3 10.2 8.4 4.7 5.0 9.8 9.2 13.9 1.2 15.9 16.0 16.9 11.2 8.2 14.6 14.9 5.1 14.2 23.1 3.0 6.1 5.5 7.4 4.6 6.5 6.1 14.3 12.2 1.5 6.5 10.7 18.7 9.5 16.4 12.5 12.2 15.5 12.4 11.9 9.9 8.7 4.5 6.4 12.3 5.4 6.8 12.2 20.6 22.0 7.1 20.4 7.1 14.4 7.7 7.6 23.0 12.7 5.7 6.8 28.7 7.8 17.1 24.8 6.0 12.2 5.7 7.1 3.7 6.9 5.8 5.7 8.8 4.5 6.6 6.8 SETD7 "KIAA1717, KMT7, SET7, SET7/9, Set9" ENSG00000145391 "SET domain containing lysine methyltransferase 7" Q8WTS6 4 139495941-139606699 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058111 Enhanced Enhanced Nucleoli Nucleoli "HPA058111: " "prognostic unfavourable (8.28e-4)" "unprognostic (7.07e-2)" "unprognostic (4.04e-1)" "unprognostic (2.07e-1)" "unprognostic (2.92e-1)" "unprognostic (4.82e-2)" "unprognostic (1.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.71e-2)" "unprognostic (9.10e-2)" "unprognostic (6.44e-2)" "unprognostic (7.75e-2)" "unprognostic (1.37e-1)" "unprognostic (6.16e-3)" "unprognostic (1.17e-1)" "unprognostic (6.92e-2)" "unprognostic (6.56e-3)" 26.1 13.2 12.0 9.6 12.3 5.7 26.3 10.2 16.2 27.9 17.7 17.9 11.0 4.8 23.8 12.0 18.3 13.8 16.9 25.2 13.0 10.0 7.2 30.7 12.1 6.9 18.0 10.1 13.3 13.8 26.8 9.3 12.0 15.4 22.8 10.2 12.4 13.7 13.9 56.4 14.2 9.9 33.3 19.0 11.8 17.7 10.6 16.5 2.9 10.3 15.2 9.9 24.2 30.1 2.3 6.8 1.8 5.6 0.5 5.6 1.6 8.9 11.5 4.4 2.6 26.1 22.5 9.7 21.2 22.0 10.8 9.2 6.8 12.2 20.8 8.4 35.6 4.5 14.6 16.7 17.7 10.2 10.3 2.9 15.0 0.2 12.9 9.9 4.4 19.5 19.6 17.2 18.4 13.7 1.7 32.3 13.8 14.9 6.5 1.5 2.1 7.6 6.1 15.3 11.9 10.5 8.2 17.2 5.7 14.1 20.9 5.0 8.3 9.1 22.2 19.2 13.6 22.9 17.5 28.0 26.8 13.2 22.1 10.0 9.2 1.0 5.6 0.5 0.6 3.2 4.1 1.8 1.8 1.8 6.8 2.3 0.8 0.5 1.8 0.5 4.8 3.5 5.6 1.6 12.0 12.3 10.2 16.2 13.0 10.0 18.0 10.1 15.4 16.5 SETMAR metnase ENSG00000170364 "SET domain and mariner transposase fusion gene" Q53H47 3 4303304-4317567 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA057999 Supported Nucleoli Nucleoli "HPA057999: " "unprognostic (1.59e-1)" "unprognostic (1.22e-2)" "unprognostic (5.24e-3)" "unprognostic (4.89e-2)" "unprognostic (7.73e-2)" "unprognostic (4.73e-2)" "prognostic unfavourable (2.85e-4)" "unprognostic (1.58e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-1)" "unprognostic (1.19e-3)" "unprognostic (1.19e-1)" "prognostic favourable (6.61e-6)" "unprognostic (5.42e-1)" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (1.26e-3)" 14.1 6.2 7.3 7.2 9.2 3.7 14.2 6.9 8.5 12.5 6.5 6.2 5.2 4.3 19.4 7.6 7.2 12.5 8.2 6.3 6.6 4.3 10.1 5.3 5.1 6.5 9.1 8.7 19.4 9.8 5.7 7.4 5.6 6.5 13.9 6.9 5.7 11.9 10.0 7.7 7.3 5.7 16.8 7.2 5.0 6.0 7.3 10.8 13.1 11.5 8.3 4.4 11.3 13.3 3.8 1.6 1.9 3.3 0.5 5.3 1.5 2.9 2.7 8.1 1.7 19.4 6.5 8.2 3.3 1.0 3.2 3.1 2.8 2.3 7.9 3.5 1.8 2.6 7.1 5.0 3.6 5.3 6.1 9.8 4.8 4.5 2.2 4.6 4.2 7.6 3.8 2.4 0.8 4.7 6.5 3.0 5.0 4.1 6.9 2.9 7.9 4.6 8.1 8.0 3.2 3.0 4.1 6.4 9.5 4.0 5.0 4.2 4.7 2.7 3.1 4.9 6.8 4.1 4.3 3.9 9.4 19.5 1.7 5.3 4.0 1.9 1.1 1.3 2.3 3.3 2.0 2.9 2.7 2.9 1.0 3.8 4.5 5.3 0.2 0.5 1.9 1.6 1.7 1.5 7.3 9.2 6.9 8.5 6.6 4.3 9.1 8.7 6.5 10.8 SMKR1 ENSG00000240204 "Small lysine rich protein 1" H3BMG3 7 129502479-129512932 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 10 "testis: 65.7" "Cell line enhanced" "Detected in many" "MCF7: 12.6;SCLC-21H: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 13 "B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7" "Low region specificity" "Detected in all" HPA078358 Approved Nucleoli Nucleoli "HPA078358: " "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (1.64e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (2.13e-1)" "unprognostic (6.45e-3)" "unprognostic (1.02e-1)" "unprognostic (9.24e-2)" "unprognostic (4.05e-2)" "unprognostic (2.00e-1)" "unprognostic (6.30e-2)" "unprognostic (1.72e-6)" "unprognostic (1.67e-2)" "unprognostic (1.11e-2)" "unprognostic (6.40e-2)" "unprognostic (3.67e-2)" 0.3 1.0 3.1 0.5 6.3 0.3 1.5 0.8 3.3 0.6 0.3 0.1 0.0 0.5 0.4 1.7 0.4 4.6 0.4 0.2 2.7 2.2 0.7 0.2 0.5 0.7 1.1 2.7 0.3 2.6 2.9 2.7 0.9 1.0 0.5 0.4 0.0 0.3 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.5 65.7 0.7 0.0 0.7 0.1 0.7 0.2 0.0 2.9 0.0 0.2 0.0 1.3 3.7 0.4 8.6 8.4 0.2 7.4 0.0 0.0 0.0 0.0 0.2 0.7 0.7 0.0 2.3 0.0 0.8 0.5 1.0 1.5 0.0 1.1 8.0 0.9 0.0 1.7 0.0 1.6 0.1 5.6 0.0 3.7 2.3 1.5 0.3 0.5 0.2 0.4 12.6 1.6 0.8 1.1 7.5 0.8 0.0 1.8 3.1 0.0 22.1 6.0 6.3 0.7 0.5 1.9 1.1 0.1 0.0 0.2 4.9 1.8 2.1 2.7 0.1 3.0 0.3 0.6 0.0 0.0 0.0 3.7 0.0 1.7 2.9 0.7 1.9 0.0 1.5 1.5 1.4 0.2 1.3 0.0 0.0 0.0 0.4 3.1 6.3 0.8 3.3 2.7 2.2 1.1 2.7 1.0 0.7 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123457641-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Approved Nucleoli Nucleoli "HPA059145: , HPA067031: " "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 15.3 15.4 18.7 14.1 20.5 14.1 17.7 25.4 23.1 14.1 15.2 22.8 14.8 14.3 16.0 15.1 17.1 14.8 11.4 22.4 18.5 18.1 16.3 19.3 16.4 16.8 21.2 18.5 13.6 12.9 20.9 19.6 15.6 20.4 16.3 17.1 17.5 21.8 12.9 64.0 24.1 15.0 15.6 20.3 21.0 15.1 14.5 23.6 14.1 20.2 23.7 17.7 12.4 14.2 35.1 24.8 37.5 24.7 23.3 40.4 19.1 12.1 13.1 15.7 8.0 11.4 10.7 13.8 10.7 15.7 11.3 8.2 8.1 8.4 24.2 7.9 15.4 12.6 13.4 19.1 9.7 17.7 10.8 11.3 11.7 18.4 8.0 11.6 18.2 13.0 13.4 10.1 9.7 15.3 14.5 4.9 15.7 25.7 12.4 26.2 10.9 12.4 9.6 6.9 12.8 25.8 24.7 13.4 19.9 9.5 20.1 14.6 24.2 15.7 17.7 7.5 13.7 9.4 9.5 12.3 12.4 14.2 12.3 11.4 10.3 37.0 24.4 37.5 24.3 24.7 24.0 35.1 30.8 27.3 24.6 30.7 24.4 25.9 36.7 23.3 22.7 24.8 40.4 19.1 18.7 20.5 25.4 23.1 18.5 18.1 21.2 18.5 20.4 23.6 TBC1D1 "KIAA1108, TBC, TBC1" ENSG00000065882 "TBC1 domain family member 1" Q86TI0 4 37891087-38139175 "Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 77.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041816, HPA058158" Approved Approved Nucleoli Nucleoli "HPA041816: AB_10796784, HPA058158: " "unprognostic (3.77e-2)" "unprognostic (3.44e-1)" "unprognostic (1.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (1.32e-1)" "unprognostic (1.01e-2)" "prognostic unfavourable (5.22e-4)" "unprognostic (1.37e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" "unprognostic (9.42e-2)" "prognostic favourable (1.47e-8)" "unprognostic (1.49e-2)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.21e-1)" 13.6 3.7 9.3 19.8 8.3 19.0 9.8 9.5 8.4 36.0 48.9 7.1 24.5 10.2 63.4 16.5 14.9 22.9 30.6 24.0 7.5 6.0 29.0 8.8 13.3 16.6 7.0 7.6 16.1 9.4 55.9 8.0 32.4 7.4 18.0 9.8 18.2 8.3 28.1 41.9 5.6 15.1 31.6 7.4 21.2 18.1 15.6 5.4 30.4 26.1 23.1 13.3 27.2 26.8 6.0 4.8 14.0 16.7 6.2 4.3 2.2 5.7 6.5 12.0 12.9 4.3 12.1 10.4 15.6 26.3 14.8 15.1 3.7 18.8 29.4 3.9 10.4 0.3 9.1 11.3 22.8 2.3 5.1 11.3 4.5 7.8 6.9 20.9 13.0 14.6 2.3 9.1 6.3 22.7 13.8 5.1 15.3 4.4 29.0 19.8 6.8 6.0 25.9 19.5 8.5 12.2 10.6 10.5 9.4 5.8 5.4 6.5 5.2 16.2 15.5 19.6 22.3 4.9 22.6 12.5 15.3 77.4 8.5 19.2 17.3 1.9 5.0 14.0 2.6 15.6 4.3 4.8 2.6 2.2 4.8 6.0 2.4 3.0 13.9 6.2 16.7 4.2 2.1 2.2 9.3 8.3 9.5 8.4 7.5 6.0 7.0 7.6 7.4 5.4 TBC1D13 FLJ10743 ENSG00000107021 "TBC1 domain family member 13" Q9NVG8 9 128787204-128810432 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045865 Approved Approved Nucleoli Nucleoli "HPA045865: AB_10965700" "unprognostic (1.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.98e-3)" "unprognostic (1.98e-2)" "unprognostic (2.74e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-3)" "unprognostic (2.16e-2)" "unprognostic (4.23e-2)" "unprognostic (4.29e-2)" "prognostic favourable (3.14e-6)" "unprognostic (1.82e-2)" "prognostic favourable (1.58e-7)" "unprognostic (1.72e-2)" "unprognostic (1.77e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" 12.5 17.4 23.0 8.3 20.8 12.1 10.1 12.0 24.7 9.8 10.7 17.3 8.4 11.7 13.3 14.2 8.4 14.7 10.9 13.4 17.8 18.5 26.0 8.9 10.5 11.0 13.9 12.7 19.3 11.3 30.2 9.7 9.5 14.9 11.6 8.2 12.5 16.9 14.3 16.6 11.6 13.0 12.6 8.7 12.0 11.2 8.1 13.3 8.6 14.1 7.6 11.2 11.2 8.5 5.0 9.0 15.7 2.8 3.4 5.6 3.4 6.2 15.0 15.8 15.7 20.5 9.9 15.3 15.0 12.8 15.6 10.1 16.2 8.4 10.5 10.4 17.7 16.9 9.6 11.9 9.2 8.2 10.9 11.2 17.5 14.8 12.7 16.8 22.9 13.8 14.1 13.4 8.1 20.0 17.1 7.1 18.5 13.4 10.1 10.0 14.9 22.6 11.5 14.6 23.7 11.4 8.1 15.9 11.1 20.8 13.4 8.8 14.2 15.8 15.7 19.5 12.3 15.8 12.1 9.1 11.7 10.3 14.3 10.1 14.0 15.7 2.7 4.6 4.9 2.8 4.9 5.0 3.8 4.7 3.1 4.0 3.3 5.6 2.2 3.4 2.1 9.0 2.8 3.4 23.0 20.8 12.0 24.7 17.8 18.5 13.9 12.7 14.9 13.3 TBL3 "SAZD, UTP13" ENSG00000183751 "Transducin beta like 3" Q12788 16 1972037-1982933 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042562, HPA055695" Enhanced Supported Enhanced Nucleoli Nucleoli "HPA042562: AB_10964911, HPA055695: " "unprognostic (1.96e-1)" "unprognostic (5.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.56e-1)" "unprognostic (4.67e-1)" "unprognostic (2.65e-1)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (3.78e-2)" "unprognostic (8.03e-2)" "unprognostic (2.14e-2)" "unprognostic (8.32e-2)" "prognostic favourable (7.33e-4)" "unprognostic (3.65e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.77e-1)" 8.9 7.9 6.0 9.5 8.3 6.0 5.8 16.3 9.6 6.2 6.8 8.8 6.8 7.7 7.1 6.3 9.4 5.4 6.0 7.5 6.6 6.1 7.2 8.7 6.9 7.2 7.0 7.3 7.7 8.9 10.5 5.5 7.3 5.7 5.7 3.6 5.6 10.5 6.0 18.2 9.5 7.8 5.9 4.8 6.7 9.5 20.5 6.5 9.5 7.2 11.5 9.3 5.1 5.4 8.5 11.2 5.8 12.0 14.8 12.1 8.5 5.5 10.7 3.0 5.8 2.9 2.3 9.7 5.1 3.3 4.4 3.6 13.7 10.7 7.3 12.1 3.9 15.0 4.8 6.0 2.3 5.4 6.8 4.6 5.4 5.2 3.3 8.0 4.4 2.4 4.5 5.5 3.3 5.5 9.3 5.5 2.6 8.9 10.2 4.5 7.0 4.4 17.8 5.5 12.3 2.2 2.1 6.9 5.4 4.6 11.9 4.4 9.0 5.4 8.6 6.1 7.3 5.4 9.9 9.9 4.3 11.6 3.6 5.1 7.0 4.8 10.2 5.8 12.1 12.0 10.7 7.5 8.9 11.8 11.2 8.5 11.4 8.6 2.5 14.8 11.7 5.7 9.6 8.5 6.0 8.3 16.3 9.6 6.6 6.1 7.0 7.3 5.7 6.5 TENM2 "KIAA1127, ODZ2, Ten-M2" ENSG00000145934 "Teneurin transmembrane protein 2" Q9NT68 5 167284799-168264157 "Predicted membrane proteins" "Cell adhesion, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.1;heart muscle: 24.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 26.1;HBEC3-KT: 17.1;HDLM-2: 16.7;U-138 MG: 30.6;U-2 OS: 26.6;U-251 MG: 19.6" "Cancer enriched" "Detected in many" 6 "head and neck cancer: 15.4" "Region enhanced" "Detected in many" "cerebral cortex: 15.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA038018, HPA038420, HPA068691" Uncertain Approved Nucleoli Nucleoli "HPA038018: , HPA038420: AB_10674682, HPA068691: " "unprognostic (6.00e-2)" "unprognostic (1.50e-1)" "unprognostic (2.94e-2)" "unprognostic (9.16e-3)" "unprognostic (3.88e-3)" "unprognostic (3.81e-3)" "unprognostic (5.81e-2)" "unprognostic (2.41e-1)" "unprognostic (4.62e-2)" "unprognostic (2.10e-2)" "unprognostic (3.68e-3)" "unprognostic (4.34e-2)" "unprognostic (4.69e-5)" "unprognostic (3.47e-2)" "unprognostic (1.03e-1)" "unprognostic (5.16e-4)" "prognostic unfavourable (7.52e-4)" 0.2 0.4 2.5 0.0 3.5 0.0 1.8 0.5 15.1 0.6 0.3 0.0 0.0 0.3 0.2 0.4 1.4 0.2 0.3 24.7 6.5 0.9 2.7 1.2 0.3 0.0 0.5 1.7 0.7 0.2 0.0 0.4 0.0 2.3 2.2 0.0 0.2 0.3 1.0 0.2 2.3 0.2 0.0 0.6 0.2 0.3 1.2 0.4 0.0 0.4 0.0 0.9 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 0.0 26.1 0.0 0.0 17.1 0.3 16.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.2 3.0 0.1 2.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 3.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 30.6 26.6 0.0 19.6 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 3.5 0.5 15.1 6.5 0.9 0.5 1.7 2.3 0.4 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212180-37258155 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 20.1" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+ RasG12V: 3.6;HEL: 4.7;hTEC/SVTERT24-B: 3.3;HUVEC TERT2: 4.9;TIME: 12.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045432, HPA071187" Supported Nucleoli Nucleoli "HPA045432: , HPA071187: " "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.3 2.7 0.4 0.4 1.4 1.3 0.3 0.4 1.1 0.3 0.3 1.6 0.0 0.4 0.2 1.1 1.4 0.4 0.7 0.4 0.3 0.4 0.9 0.5 0.5 0.1 0.9 1.0 1.1 3.1 0.6 2.3 0.2 1.0 0.4 0.3 1.1 1.5 0.1 1.0 0.5 0.4 0.5 1.6 0.2 0.2 20.1 0.9 0.0 0.5 0.0 0.3 0.4 0.3 0.1 0.4 0.2 0.0 0.0 0.6 0.1 0.1 0.0 0.3 0.0 0.2 1.2 0.0 0.3 2.7 1.0 3.6 0.7 0.5 0.1 0.2 0.0 0.5 0.3 0.3 1.0 0.1 0.2 4.7 0.0 0.1 0.3 0.0 2.7 0.5 0.7 3.3 0.2 4.9 1.3 0.0 0.5 0.0 0.1 0.4 0.2 0.0 0.2 0.0 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.2 0.0 0.1 12.8 0.2 0.1 0.0 0.2 0.1 0.2 0.5 0.0 0.9 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.4 0.0 0.1 0.4 1.4 0.4 1.1 0.3 0.4 0.9 1.0 1.0 0.9 TNFAIP1 "B12, B61, BTBD34, EDP1, MGC2317" ENSG00000109079 "TNF alpha induced protein 1" Q13829 17 28335602-28347009 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013333, HPA014641" Uncertain Approved Nucleoli Nucleoli "HPA013333: AB_1858160, HPA014641: AB_1858159" "unprognostic (4.42e-1)" "unprognostic (1.54e-2)" "unprognostic (4.32e-2)" "prognostic unfavourable (7.48e-5)" "unprognostic (2.29e-1)" "unprognostic (4.97e-3)" "unprognostic (3.21e-1)" "unprognostic (1.94e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-2)" "unprognostic (8.27e-3)" "unprognostic (1.43e-2)" "unprognostic (4.21e-3)" "unprognostic (2.49e-2)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (7.02e-2)" 23.1 20.4 17.5 13.3 20.9 5.4 20.7 17.5 32.2 17.2 13.5 17.7 12.6 12.9 17.3 12.1 29.2 12.9 21.1 28.6 14.6 11.4 22.9 69.9 27.8 11.7 15.0 16.5 15.2 30.3 19.5 12.7 43.2 14.2 14.3 12.4 19.2 17.5 15.8 14.8 19.5 16.2 22.1 13.9 40.4 16.8 13.3 14.3 12.5 17.7 18.5 14.7 19.8 15.6 7.2 10.9 11.0 9.6 11.2 10.0 5.8 13.0 19.5 12.9 9.2 11.0 9.7 12.5 15.7 19.4 19.2 15.2 51.5 8.1 2.9 10.9 20.6 15.5 6.9 27.0 14.9 7.3 9.4 2.3 19.5 7.8 14.8 4.1 4.0 12.5 31.5 15.2 11.9 22.3 5.9 4.1 8.9 8.3 7.5 2.6 3.1 6.9 3.3 16.6 4.6 28.2 14.2 9.5 10.3 19.7 33.1 8.5 13.9 3.6 23.8 14.3 14.2 11.1 12.0 6.7 5.7 2.9 11.4 3.1 9.2 2.2 8.6 11.0 8.6 8.6 10.0 7.2 6.3 7.6 10.9 5.4 6.2 7.2 2.9 11.2 9.6 5.7 5.4 5.8 17.5 20.9 17.5 32.2 14.6 11.4 15.0 16.5 14.2 14.3 TPCN2 TPC2 ENSG00000162341 "Two pore segment channel 2" Q8NHX9 11 69048897-69162440 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 20.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA016561, HPA027080" Supported Approved Nucleoli Nucleoli "HPA016561: AB_1858207, HPA027080: AB_10600917" "unprognostic (1.29e-1)" "unprognostic (1.53e-2)" "unprognostic (1.39e-1)" "unprognostic (2.95e-1)" "unprognostic (1.63e-1)" "prognostic unfavourable (2.96e-4)" "unprognostic (7.60e-2)" "unprognostic (7.04e-2)" "unprognostic (3.59e-1)" "prognostic unfavourable (1.49e-4)" "unprognostic (4.15e-2)" "unprognostic (1.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-3)" "unprognostic (5.01e-2)" "unprognostic (4.88e-2)" 11.0 6.2 6.3 8.7 11.1 9.2 9.4 14.5 14.0 18.0 18.0 9.2 11.3 15.0 22.4 12.4 11.2 13.8 12.1 7.5 6.2 4.9 11.6 15.7 8.7 10.4 6.0 7.7 12.1 6.8 6.4 7.2 7.1 8.8 13.1 7.4 20.7 8.1 17.8 8.1 16.1 13.7 15.6 6.0 10.9 11.4 8.5 4.9 6.4 7.3 7.4 10.1 11.0 11.2 2.0 7.5 7.1 9.9 6.9 3.2 3.6 3.4 8.8 2.7 4.1 2.6 2.0 11.6 3.8 4.7 4.6 2.8 7.5 10.8 4.4 5.6 4.8 7.9 2.2 4.4 1.4 2.8 2.3 6.0 9.4 2.5 2.4 4.3 8.2 3.3 2.3 2.4 2.5 3.2 2.9 20.9 2.9 8.0 3.6 10.2 3.1 3.1 3.4 2.2 5.5 4.7 5.5 2.4 3.1 4.4 10.1 15.5 6.5 5.7 2.9 3.1 4.7 5.8 3.5 5.5 2.2 2.2 5.1 4.5 6.7 4.3 9.8 2.9 1.0 9.8 0.9 2.0 2.1 2.1 7.5 1.5 1.7 2.0 7.1 6.9 9.9 3.2 3.2 3.6 6.3 11.1 14.5 14.0 6.2 4.9 6.0 7.7 8.8 4.9 UBE2W "FLJ11011, UBC-16" ENSG00000104343 "Ubiquitin conjugating enzyme E2 W" Q96B02 8 73780097-73878910 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045161, HPA073181" Uncertain Approved Nucleoli Nucleoli "HPA045161: AB_10960706, HPA073181: " "unprognostic (5.36e-2)" "unprognostic (1.87e-1)" "unprognostic (7.52e-2)" "unprognostic (1.32e-3)" "unprognostic (3.17e-1)" "unprognostic (9.74e-2)" "unprognostic (3.09e-2)" "unprognostic (6.93e-3)" "unprognostic (1.83e-1)" "unprognostic (3.47e-1)" "unprognostic (1.33e-1)" "unprognostic (2.34e-1)" "unprognostic (5.01e-2)" "unprognostic (4.38e-2)" "unprognostic (9.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.18e-1)" 15.2 14.2 13.5 13.3 21.8 17.5 13.4 18.9 24.4 12.0 9.8 11.3 11.0 7.9 13.4 10.5 16.6 9.4 15.2 14.8 19.0 12.3 21.9 23.4 13.6 11.6 11.6 13.0 11.8 12.7 18.4 20.9 13.6 18.4 12.0 11.5 9.5 12.2 10.6 16.4 10.6 8.5 12.8 12.6 13.6 10.0 16.4 12.3 14.7 17.1 4.8 12.9 16.8 12.8 5.0 8.1 23.0 9.4 4.7 4.3 4.8 8.5 5.6 6.9 7.5 12.1 12.4 6.0 9.4 10.4 9.1 9.5 4.6 9.6 4.0 7.8 9.8 8.7 10.2 9.6 15.2 6.4 6.2 8.1 5.8 7.1 8.2 4.4 11.5 9.7 10.8 10.6 19.0 11.0 4.0 8.6 13.8 6.8 9.6 4.8 5.3 11.1 2.9 7.1 3.4 16.9 9.4 5.1 5.6 7.5 24.5 11.3 11.5 7.9 9.8 11.0 8.4 8.3 6.9 7.3 7.5 2.9 9.6 7.1 9.4 12.9 9.4 11.5 3.5 8.8 4.3 5.0 3.6 2.6 6.3 4.3 3.2 3.8 23.0 4.7 9.4 8.1 4.0 4.8 13.5 21.8 18.9 24.4 19.0 12.3 11.6 13.0 18.4 12.3 URB2 "KIAA0133, NET10, NPA2" ENSG00000135763 "URB2 ribosome biogenesis 2 homolog (S. cerevisiae)" Q14146 1 229626234-229660199 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008902, HPA046788" Uncertain Enhanced Nucleoli Nucleoli "HPA008902: AB_2213805, HPA046788: " "unprognostic (1.26e-1)" "unprognostic (4.03e-3)" "unprognostic (2.16e-2)" "unprognostic (3.63e-2)" "unprognostic (1.79e-1)" "unprognostic (2.48e-1)" "unprognostic (5.53e-3)" "unprognostic (1.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.17e-1)" "unprognostic (1.59e-1)" "unprognostic (2.61e-2)" "unprognostic (1.62e-3)" "unprognostic (7.81e-2)" "unprognostic (2.72e-1)" "unprognostic (1.69e-2)" "unprognostic (1.45e-1)" 9.8 6.2 7.0 7.2 7.8 7.6 6.5 5.8 11.0 4.7 5.0 9.5 2.9 4.3 7.4 3.8 8.0 6.9 5.2 4.9 5.3 3.7 4.3 10.4 4.9 12.0 8.2 7.7 7.2 13.7 6.5 9.9 6.5 8.0 5.0 4.9 6.4 5.8 3.8 14.0 5.8 5.3 6.6 5.8 8.4 5.8 15.6 7.2 10.3 4.6 6.2 9.0 5.5 4.8 2.7 2.7 0.5 3.9 1.9 5.6 2.9 7.3 11.0 7.2 9.6 4.5 3.8 22.0 5.8 3.6 9.1 6.9 10.9 5.8 15.2 6.8 4.1 10.1 17.8 7.1 8.3 7.4 16.9 9.4 9.3 6.4 4.3 13.8 8.2 3.7 5.2 9.0 7.0 4.3 20.0 7.1 5.6 5.8 15.3 6.8 24.1 7.3 17.2 10.2 15.2 4.0 9.3 10.8 13.2 6.9 7.2 5.8 8.1 7.9 4.7 7.5 9.4 9.4 16.6 7.9 7.6 22.8 4.0 10.4 13.5 0.2 1.9 0.5 3.0 3.9 5.6 2.0 2.8 3.6 2.7 2.7 4.3 3.3 0.2 1.9 1.3 1.6 3.1 2.9 7.0 7.8 5.8 11.0 5.3 3.7 8.2 7.7 8.0 7.2 USP46 FLJ12552 ENSG00000109189 "Ubiquitin specific peptidase 46" P62068 4 52590972-52659335 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Behavior, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, CAB076369, CAB076370" Uncertain Approved Nucleoli Nucleoli "CAB076369: , CAB076370: , HPA007288: AB_1080531" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-3)" "unprognostic (1.59e-1)" "unprognostic (2.45e-2)" "unprognostic (1.80e-2)" "unprognostic (2.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (3.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" 4.7 9.5 26.0 3.5 20.9 2.8 7.0 23.7 29.4 8.9 4.2 12.8 5.2 4.8 7.2 6.2 12.4 7.8 5.8 28.9 21.9 19.0 10.8 3.1 4.4 3.7 19.1 13.9 12.3 5.6 12.2 5.3 10.6 12.7 7.7 4.6 5.3 8.0 7.8 13.7 8.0 4.5 5.5 18.9 3.5 6.3 12.2 15.0 1.0 10.0 4.3 5.8 7.3 5.7 1.4 4.4 2.0 1.4 1.2 3.9 1.0 5.3 3.8 12.3 9.1 13.5 16.9 13.6 8.8 7.1 6.5 5.5 7.6 4.2 3.5 10.4 8.7 3.1 21.4 10.2 12.0 3.1 7.5 5.5 3.6 8.5 13.5 7.3 6.5 14.4 9.6 6.7 6.3 9.6 5.4 5.0 13.8 4.9 3.1 3.8 9.1 4.6 7.9 9.0 0.7 14.0 9.9 7.4 8.9 4.3 14.7 8.5 5.4 5.5 8.9 6.4 14.0 7.5 13.2 5.2 2.4 2.8 9.9 4.4 7.9 2.0 1.4 0.3 2.3 1.2 1.7 1.4 3.9 2.0 2.8 1.2 0.9 0.8 0.3 1.2 0.9 4.4 1.2 1.0 26.0 20.9 23.7 24.3 21.9 19.0 19.1 13.9 12.7 15.0 UTP23 "C8orf53, MGC14595" ENSG00000147679 "UTP23, small subunit processome component" Q9BRU9 8 116766503-116849463 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044418 Uncertain Approved Nucleoli Nucleoli "HPA044418: AB_10961139" "prognostic unfavourable (5.18e-5)" "unprognostic (2.30e-2)" "unprognostic (3.34e-1)" "unprognostic (1.18e-2)" "unprognostic (2.64e-1)" "unprognostic (7.23e-2)" "unprognostic (9.45e-3)" "unprognostic (7.73e-2)" "unprognostic (7.78e-2)" "unprognostic (1.77e-1)" "unprognostic (1.34e-2)" "unprognostic (8.62e-2)" "unprognostic (1.75e-2)" "unprognostic (5.78e-2)" "unprognostic (2.03e-1)" "unprognostic (7.15e-3)" "unprognostic (9.27e-2)" 14.5 11.9 16.9 13.1 21.4 39.5 13.6 25.2 20.0 12.3 12.3 9.3 9.3 8.5 15.6 10.1 11.4 12.9 10.5 11.6 14.4 10.0 9.7 11.6 12.4 18.8 15.4 15.5 20.0 12.7 9.7 15.8 12.8 13.3 13.8 8.3 6.8 11.7 13.4 11.7 11.3 11.5 12.7 13.0 13.2 11.0 8.9 16.2 13.1 16.4 8.7 12.0 13.7 13.7 27.4 23.3 24.2 21.7 16.3 33.3 15.9 10.9 11.9 6.5 5.8 9.3 11.4 4.9 10.8 6.3 7.2 7.9 12.4 7.3 16.2 10.6 5.2 7.9 8.9 5.8 9.5 16.0 17.3 20.0 9.1 8.2 9.1 10.0 9.5 9.0 7.1 7.1 9.6 7.7 13.0 12.4 7.5 20.0 24.5 6.0 5.8 22.3 13.8 7.0 14.0 4.4 10.1 11.9 9.5 7.0 28.4 9.9 12.6 7.6 8.6 7.8 10.6 17.8 14.5 15.0 22.8 19.9 9.8 13.1 8.7 24.2 16.3 20.6 26.8 16.8 23.2 27.4 24.4 21.1 14.1 27.3 33.3 23.2 16.2 16.3 21.7 23.3 26.4 15.9 16.9 21.4 25.2 20.0 14.4 10.0 15.4 15.5 13.3 16.2 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6, small subunit processome component" Q9NYH9 17 31860899-31901765 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced Nucleoli Nucleoli "HPA025936: AB_1845588, HPA055806: " "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavourable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavourable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 19.3 17.9 18.7 16.9 19.3 19.0 26.4 28.7 19.3 17.7 19.5 18.0 12.5 10.8 23.4 30.4 15.7 13.3 10.7 13.0 19.5 17.0 16.7 20.7 15.4 23.3 16.2 16.1 19.5 17.0 14.1 26.0 21.4 16.2 19.9 15.9 15.0 15.9 15.0 17.0 25.3 15.2 17.0 18.8 23.1 16.4 18.5 19.1 23.2 17.1 18.5 28.1 16.0 15.5 15.4 19.7 13.1 10.9 5.7 8.0 7.0 8.3 5.5 7.7 4.4 8.0 5.3 9.4 7.2 4.1 11.0 8.5 19.6 4.4 12.6 9.1 6.6 11.0 10.9 9.0 10.2 3.2 16.4 7.8 12.3 17.8 8.8 12.0 8.1 8.1 9.0 10.8 7.9 7.0 13.8 7.2 8.7 6.8 11.2 32.0 10.2 8.6 11.7 11.0 12.3 11.3 7.7 5.1 7.7 7.6 5.4 12.1 13.3 22.5 7.3 16.6 12.5 8.7 14.5 8.1 14.5 18.3 11.4 8.4 8.9 10.6 10.8 6.7 7.6 10.9 7.3 12.7 8.0 8.0 13.6 15.4 7.1 8.0 13.1 5.7 9.7 19.7 7.7 7.0 18.7 19.3 28.7 19.3 19.5 17.0 16.2 16.1 16.2 19.1 WDR36 "GLC1G, TA-WDRP, UTP21" ENSG00000134987 "WD repeat domain 36" Q8NI36 5 111091716-111130502 "Disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Sensory transduction, Vision" "Disease mutation, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037796, HPA037797" Supported Supported Nucleoli Nucleoli "HPA037796: , HPA037797: AB_10672725" "unprognostic (2.14e-1)" "unprognostic (4.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (1.64e-1)" "unprognostic (9.79e-2)" "unprognostic (7.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.93e-1)" "prognostic unfavourable (1.18e-4)" "unprognostic (4.91e-2)" 30.6 12.3 8.2 15.4 12.2 17.5 15.2 14.5 14.6 15.9 12.2 9.3 10.2 9.6 19.0 11.8 18.4 13.9 11.5 11.7 8.2 9.7 14.8 24.6 12.4 18.7 8.8 11.1 20.6 15.0 14.8 19.1 15.3 13.5 15.0 12.8 9.3 13.6 11.0 17.0 15.2 13.7 14.5 8.9 21.7 12.2 11.3 9.4 24.3 16.7 12.9 18.4 13.8 14.7 6.7 9.9 2.5 10.1 6.0 9.4 6.4 10.0 11.3 8.0 20.8 12.6 17.6 13.3 8.4 8.7 12.7 18.8 13.1 12.0 30.2 11.0 6.8 11.1 16.4 19.8 22.3 10.8 9.1 16.6 11.2 10.1 13.2 15.1 30.5 10.0 10.9 22.3 22.3 14.8 19.8 15.4 13.6 8.4 19.8 11.5 10.3 10.0 16.3 18.5 23.4 8.8 13.2 14.2 10.7 11.3 8.2 12.4 9.4 10.2 10.3 16.6 10.9 12.2 17.5 12.5 11.7 32.6 12.8 20.2 13.3 0.2 6.4 2.5 7.8 8.6 9.2 6.7 6.7 8.7 9.9 5.9 9.4 7.8 0.4 6.0 10.1 4.3 9.0 6.4 8.2 12.2 14.5 14.6 8.2 9.7 8.8 11.1 13.5 9.4 WDR82 "MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A" ENSG00000164091 "WD repeat domain 82" Q6UXN9 3 52254421-52288020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040427 Supported Nucleoli Nucleoli "HPA040427: " "unprognostic (7.43e-2)" "unprognostic (3.20e-1)" "unprognostic (1.03e-2)" "unprognostic (2.15e-3)" "unprognostic (1.78e-1)" "unprognostic (1.38e-2)" "unprognostic (1.77e-2)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (2.05e-1)" "unprognostic (2.15e-3)" "unprognostic (2.92e-3)" "unprognostic (9.32e-2)" "unprognostic (2.04e-1)" "unprognostic (8.54e-2)" "unprognostic (1.26e-1)" 27.5 28.4 33.8 31.5 38.4 33.1 27.9 58.7 42.9 36.8 29.0 24.1 23.4 23.3 40.3 23.5 34.1 32.0 30.3 34.5 32.0 36.6 21.3 22.5 24.8 39.3 26.9 35.8 40.6 19.5 29.1 19.9 29.8 27.9 30.2 28.1 28.2 26.0 36.6 49.8 29.2 24.9 37.1 26.4 34.1 22.8 25.4 25.2 63.5 28.7 29.7 40.7 31.7 37.0 7.9 5.6 12.5 9.6 7.4 17.0 7.9 14.3 17.4 32.8 24.5 31.3 26.1 16.5 24.6 20.5 24.3 20.2 20.2 14.4 38.2 9.6 26.2 13.1 44.9 26.3 28.5 27.7 17.2 49.0 22.1 20.7 21.8 46.0 25.9 26.1 26.1 28.5 26.2 25.5 21.8 27.6 23.4 14.5 35.6 18.2 29.7 33.7 18.4 21.9 28.4 25.3 26.5 7.8 33.0 26.3 8.0 15.1 15.0 18.6 26.1 22.9 26.1 23.8 28.2 27.0 39.4 38.8 19.5 35.1 24.9 6.8 6.4 8.2 14.1 6.4 17.0 7.9 12.9 13.7 5.6 6.1 15.1 15.2 12.5 7.4 9.6 5.4 10.8 7.9 33.8 38.4 58.7 42.9 32.0 36.6 26.9 35.8 27.9 25.2 WEE1 WEE1A ENSG00000166483 "WEE1 G2 checkpoint kinase" P30291 11 9573681-9593457 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB004619, HPA068845" Approved Approved Nucleoli Nucleoli "CAB004619: AB_628447, HPA068845: " "unprognostic (6.04e-2)" "unprognostic (1.90e-3)" "unprognostic (1.09e-2)" "unprognostic (9.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-2)" "unprognostic (3.79e-3)" "unprognostic (2.48e-2)" "unprognostic (1.22e-1)" "unprognostic (1.79e-2)" "unprognostic (3.21e-3)" "unprognostic (3.73e-1)" "prognostic unfavourable (5.19e-4)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (2.08e-1)" "unprognostic (3.80e-1)" 6.9 3.5 2.0 26.1 2.1 6.6 27.4 5.3 1.6 12.8 18.0 2.5 15.4 3.7 21.9 14.3 22.1 12.4 20.2 23.0 2.0 2.2 6.8 19.3 10.2 10.9 1.8 1.2 11.1 4.4 4.9 6.1 42.7 4.7 17.0 4.7 5.9 12.8 17.8 12.0 33.3 10.4 22.9 2.4 8.0 12.5 28.3 2.0 35.9 12.0 26.8 26.4 19.8 14.7 8.5 0.1 6.4 0.0 2.1 7.8 0.6 14.2 5.5 21.2 11.7 18.6 9.3 42.0 17.6 13.6 9.9 9.8 10.1 17.5 33.4 6.6 7.7 17.3 14.5 6.8 12.7 11.9 11.9 13.1 8.9 6.7 2.0 19.8 13.1 3.1 7.4 4.6 16.4 6.1 21.3 23.3 17.2 3.4 20.2 10.7 31.9 6.3 19.5 16.6 7.2 7.8 30.1 7.9 10.5 11.9 14.1 8.6 8.9 9.5 7.0 17.8 12.5 7.2 14.1 5.5 16.3 44.2 7.6 10.9 12.5 0.0 0.0 6.4 2.0 0.0 0.2 8.5 2.0 3.3 0.1 3.6 0.1 1.6 0.1 2.1 0.0 0.1 7.8 0.6 2.0 2.1 5.3 1.6 2.0 2.2 1.8 1.2 4.7 2.0 ZNF136 pHZ-20 ENSG00000196646 "Zinc finger protein 136" P52737 19 12163064-12189881 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA054120 Approved Nucleoli Nucleoli "HPA054120: " "unprognostic (1.40e-1)" "unprognostic (5.90e-2)" "unprognostic (3.38e-2)" "unprognostic (1.17e-1)" "unprognostic (6.22e-2)" "unprognostic (4.68e-3)" "unprognostic (2.36e-1)" "unprognostic (9.39e-3)" "unprognostic (5.97e-3)" "unprognostic (1.71e-1)" "unprognostic (4.33e-2)" "unprognostic (5.46e-3)" "prognostic favourable (4.75e-5)" "unprognostic (3.44e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 12.6 10.8 7.2 15.3 11.0 20.5 13.0 19.6 12.4 13.2 9.5 7.1 10.5 4.5 13.3 13.0 5.9 11.6 8.2 8.0 7.3 7.2 9.4 6.0 11.1 12.7 7.5 11.3 19.0 7.5 13.0 16.8 10.6 10.2 13.0 8.6 8.3 10.1 8.9 9.9 10.4 9.4 12.9 12.5 11.7 10.0 10.2 6.8 16.0 14.4 3.6 10.7 12.6 11.3 9.7 5.1 13.5 4.1 8.7 10.0 4.0 2.1 1.2 7.3 7.6 4.1 4.6 4.4 4.0 4.3 3.9 4.1 1.4 0.7 9.9 5.2 2.9 2.2 3.4 2.4 4.9 4.9 4.6 5.6 3.6 2.4 3.1 11.9 10.1 5.0 4.4 3.6 4.6 2.7 4.2 16.1 4.9 2.9 8.2 4.8 8.6 4.5 6.5 9.3 3.8 4.1 7.6 7.6 7.2 5.0 1.2 4.2 3.2 6.3 5.7 9.5 3.3 4.0 3.5 10.9 19.0 11.3 3.6 4.6 4.9 13.5 3.9 9.0 7.9 3.7 9.4 9.0 8.9 8.5 4.2 9.7 10.0 8.4 11.6 8.7 4.1 5.1 5.9 4.0 7.2 11.0 19.6 12.4 7.3 7.2 7.5 11.3 10.2 6.8 ZNF146 OZF ENSG00000167635 "Zinc finger protein 146" Q15072 19 36214602-36238774 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003358 Supported Supported Nucleoli Nucleoli "HPA003358: AB_1080674" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (5.35e-3)" "unprognostic (2.11e-3)" "unprognostic (1.82e-2)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" "unprognostic (3.95e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-2)" "unprognostic (1.92e-1)" 20.6 17.2 24.5 23.5 40.4 8.6 33.0 25.7 27.9 28.9 20.7 28.4 23.5 17.9 30.0 18.2 22.3 23.0 18.0 21.5 25.6 20.0 21.1 25.0 18.1 25.0 46.4 23.7 33.7 20.3 32.5 45.2 25.1 32.0 25.2 25.5 13.4 19.6 23.9 38.3 21.1 17.7 26.2 30.9 19.9 19.2 9.9 36.3 33.6 27.1 24.0 28.3 25.8 20.5 13.7 9.8 5.9 14.6 10.2 18.3 10.3 21.6 30.3 25.9 24.9 19.2 21.6 13.8 19.2 17.8 18.6 18.5 13.7 15.9 21.1 31.0 17.7 10.1 32.9 22.4 33.7 32.7 18.3 35.3 11.7 16.4 22.4 55.4 24.5 17.6 34.8 17.9 51.1 23.0 37.4 23.3 22.3 14.2 25.7 13.1 35.0 18.5 29.8 26.1 18.1 22.6 21.4 32.9 20.8 23.7 30.1 20.3 13.4 28.4 17.5 21.0 25.2 16.4 33.5 16.3 19.2 30.2 14.8 27.5 26.7 4.9 8.2 5.9 12.2 9.9 17.4 13.7 14.1 12.2 9.8 12.1 18.3 16.6 2.0 10.2 14.6 4.9 12.1 10.3 24.5 40.4 25.7 27.9 25.6 20.0 46.4 23.7 32.0 36.3 ZNF275 ENSG00000063587 "Zinc finger protein 275" Q9NSD4 X 153334155-153360110 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 38.6" "Cell line enhanced" "Detected in many" "U-266/70: 35.4;U-698: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000566 Approved Approved Nucleoli Nucleoli "HPA000566: AB_1080700" "unprognostic (6.96e-2)" "unprognostic (8.97e-2)" "unprognostic (3.10e-2)" "unprognostic (1.11e-3)" "unprognostic (5.25e-2)" "unprognostic (1.45e-1)" "unprognostic (9.59e-2)" "unprognostic (9.37e-2)" "unprognostic (2.80e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (4.33e-2)" "unprognostic (2.69e-1)" "unprognostic (1.95e-1)" "unprognostic (3.74e-2)" "unprognostic (1.14e-2)" 6.5 38.6 5.9 3.4 5.9 2.2 11.5 5.9 6.9 5.8 3.5 7.0 20.4 2.8 5.9 12.6 2.5 5.4 4.9 3.0 6.8 6.9 3.8 8.5 3.3 7.0 8.8 5.3 30.3 8.5 5.8 6.9 2.1 6.2 5.1 3.2 3.8 6.3 27.9 3.1 2.5 4.5 5.6 10.7 6.8 4.1 10.5 6.5 3.9 4.7 1.7 5.3 4.0 2.6 4.5 2.7 0.7 1.7 2.8 5.0 2.0 5.8 2.6 5.2 3.6 5.9 5.9 2.6 4.1 6.8 2.7 4.0 2.7 1.3 10.1 8.5 7.7 1.0 5.9 3.7 3.9 2.3 4.7 3.3 2.5 3.8 8.0 4.1 3.0 6.9 2.7 2.3 4.2 3.2 5.0 0.0 4.7 4.3 4.8 3.4 2.3 4.2 5.9 5.5 3.5 2.0 3.9 2.6 3.6 2.1 0.2 5.0 0.9 7.3 3.5 4.0 4.8 6.6 5.3 35.4 9.4 20.2 3.6 8.3 2.8 0.7 1.7 0.2 3.7 1.5 4.4 4.5 3.4 3.3 1.6 4.4 5.0 4.2 0.1 2.8 1.4 2.7 4.6 2.0 5.9 5.9 5.9 6.5 6.8 6.9 8.8 5.3 6.2 6.5 ZNF286A "KIAA1874, ZNF286" ENSG00000187607 "Zinc finger protein 286A" Q9HBT8 17 15699577-15720787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA021594 Approved Nucleoli Nucleoli "HPA021594: " "unprognostic (2.09e-2)" "unprognostic (1.51e-2)" "unprognostic (2.05e-1)" "unprognostic (1.91e-2)" "unprognostic (1.24e-1)" "unprognostic (8.83e-2)" "unprognostic (2.47e-4)" "unprognostic (4.66e-2)" "unprognostic (9.68e-2)" "unprognostic (1.67e-2)" "unprognostic (2.29e-4)" "unprognostic (5.60e-2)" "unprognostic (1.66e-3)" "unprognostic (4.95e-2)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (4.94e-2)" 3.7 5.9 6.6 5.5 9.5 2.0 6.0 8.2 7.8 9.7 5.3 6.5 10.0 2.5 11.3 10.0 7.6 6.6 6.6 11.5 7.6 6.5 6.1 3.2 3.5 7.0 8.7 4.7 14.3 2.9 9.8 15.9 4.0 9.4 7.1 3.5 7.1 4.7 8.3 3.8 4.0 3.5 8.4 10.7 4.5 3.4 14.2 9.0 5.2 8.0 3.8 6.0 6.9 6.0 6.4 2.7 1.0 3.6 6.0 9.8 2.5 15.4 17.5 25.6 12.3 7.5 10.8 8.1 7.2 6.4 12.0 9.7 10.5 5.5 13.9 6.0 6.1 13.7 18.0 8.5 15.1 10.2 14.0 9.5 17.9 9.0 7.4 4.6 4.6 10.1 5.5 11.4 11.5 15.8 8.2 2.7 16.9 4.2 20.3 4.3 23.6 4.1 15.1 37.1 6.8 8.7 6.0 8.1 18.3 15.7 6.8 5.5 6.3 2.7 7.0 7.5 8.1 6.6 11.0 6.1 9.5 0.0 9.2 0.1 8.4 0.8 1.6 1.0 6.9 1.9 7.1 4.0 7.9 7.0 2.5 6.4 9.2 9.8 1.0 6.0 3.6 2.7 9.5 2.5 6.6 9.5 8.2 7.8 7.6 6.5 8.7 4.7 9.4 9.0 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 80.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoli Nucleoli "HPA015705: AB_1859199, HPA056325: " "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavourable (3.66e-6)" "prognostic favourable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 21.7 15.9 8.9 12.2 13.7 16.2 13.8 17.5 11.2 14.9 17.4 9.8 14.2 9.5 19.0 15.6 13.6 14.0 10.5 80.7 9.0 9.5 14.9 26.7 15.2 13.4 13.7 8.6 14.9 16.5 13.2 15.1 10.4 12.7 12.2 12.3 22.3 44.9 11.4 34.7 10.9 12.6 18.9 14.1 16.0 14.2 14.2 13.3 14.3 23.5 15.4 13.5 18.7 16.0 16.3 21.9 12.2 20.8 14.6 19.3 11.8 7.6 9.5 11.5 9.1 20.6 18.6 16.2 20.7 12.0 13.4 12.7 12.8 14.8 33.0 12.7 13.0 6.2 20.3 13.4 20.5 15.2 13.3 15.3 14.6 17.9 22.1 38.5 12.4 18.6 15.8 12.5 18.4 13.9 31.0 22.5 17.0 17.4 29.7 18.1 10.2 18.1 24.3 16.5 20.9 14.3 8.6 20.1 9.3 7.2 16.7 20.3 8.3 10.5 14.8 17.1 11.6 10.2 14.7 37.7 27.1 31.3 14.3 24.1 12.1 9.7 20.8 12.2 12.9 17.5 17.8 16.3 16.4 16.6 21.9 13.4 18.0 16.2 3.2 14.6 13.5 15.0 19.3 11.8 8.9 13.7 17.5 11.2 9.0 9.5 13.7 8.6 12.7 13.3 ZNF483 "KIAA1962, ZKSCAN16, ZSCAN48" ENSG00000173258 "Zinc finger protein 483" Q8TF39 9 111525159-111577844 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.3;pituitary gland: 40.4" "Cell line enhanced" "Detected in many" "NTERA-2: 11.5;SCLC-21H: 6.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055041 Approved Nucleoli Nucleoli "HPA055041: " "unprognostic (4.33e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (2.34e-1)" "unprognostic (4.11e-2)" "unprognostic (5.95e-3)" "unprognostic (9.18e-5)" "unprognostic (2.02e-1)" "unprognostic (9.50e-2)" "unprognostic (4.44e-3)" "unprognostic (5.49e-2)" "unprognostic (5.19e-4)" "unprognostic (7.19e-3)" "unprognostic (1.74e-1)" "unprognostic (4.30e-2)" "unprognostic (6.17e-2)" 3.2 10.1 13.9 2.1 30.5 7.7 5.6 35.9 36.3 6.1 4.0 8.6 2.9 2.0 10.0 11.9 2.4 7.0 4.9 4.7 18.1 7.3 5.1 2.5 3.9 3.4 9.5 23.0 12.6 4.3 13.6 40.4 1.8 24.4 7.2 2.4 5.9 3.2 7.7 2.3 3.5 2.9 5.5 9.8 4.8 3.9 11.8 10.3 0.0 12.5 0.0 3.1 4.7 4.8 2.5 1.0 4.6 1.0 2.1 6.5 1.5 0.3 3.2 3.1 4.7 0.4 0.6 1.0 0.4 1.5 3.1 2.9 0.3 1.5 0.5 0.5 1.3 0.9 1.5 1.6 1.9 0.2 1.8 1.6 4.4 2.5 0.9 0.6 0.4 1.2 0.6 1.7 0.9 2.9 1.3 0.8 0.7 3.0 0.2 0.8 11.5 1.1 0.3 4.8 0.4 1.2 1.3 6.7 3.2 1.2 0.6 0.8 1.9 0.4 0.5 0.9 1.6 1.4 2.2 0.7 1.9 0.4 1.0 0.5 0.7 4.6 1.0 0.6 4.8 0.5 2.7 1.5 3.3 2.3 0.3 2.5 5.9 6.5 3.4 2.1 0.7 1.0 1.6 1.5 13.9 30.5 35.9 36.3 18.1 7.3 9.5 23.0 24.4 10.3 ZNF519 "FLJ36809, HsT2362" ENSG00000175322 "Zinc finger protein 519" Q8TB69 18 14057457-14132490 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" HPA028982 Uncertain Approved Nucleoli Nucleoli "HPA028982: AB_10610705" "unprognostic (1.85e-2)" "unprognostic (4.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.15e-3)" "unprognostic (1.90e-1)" "unprognostic (2.53e-2)" "unprognostic (6.70e-2)" "unprognostic (3.43e-1)" "unprognostic (2.31e-2)" "unprognostic (1.18e-1)" "unprognostic (6.47e-2)" "unprognostic (1.50e-2)" "unprognostic (1.16e-5)" "unprognostic (1.40e-2)" "unprognostic (1.58e-1)" "unprognostic (2.38e-1)" "unprognostic (3.65e-4)" 1.8 1.4 2.8 1.9 7.6 1.4 2.8 13.7 14.4 5.7 4.6 0.7 0.8 1.2 7.0 2.6 3.4 4.5 1.8 1.9 3.4 1.6 0.8 1.0 2.7 6.6 1.7 4.0 8.7 1.2 1.1 1.5 1.2 3.0 2.6 2.6 2.0 1.6 2.7 1.0 2.0 2.1 6.0 2.1 2.2 1.4 3.0 2.5 1.1 2.0 0.9 1.9 4.3 3.8 1.7 0.1 0.0 0.6 0.5 3.5 0.7 1.3 0.3 5.9 6.2 0.8 1.2 1.6 1.6 0.9 3.5 3.1 2.6 1.2 3.1 1.6 1.2 0.9 4.8 1.2 4.0 1.8 3.3 5.4 1.7 1.1 0.2 11.1 2.4 0.6 1.5 2.8 1.2 0.6 2.7 4.6 2.0 1.8 6.7 4.4 2.6 1.4 7.2 5.7 3.8 0.9 1.8 9.1 2.4 2.3 0.7 1.8 0.7 3.0 0.4 5.6 7.5 2.5 1.8 1.8 1.2 4.5 1.8 4.3 4.7 0.0 0.3 0.0 1.1 0.6 1.8 1.7 1.4 1.5 0.1 0.8 3.5 2.2 0.0 0.5 0.5 0.1 2.0 0.7 2.8 7.6 13.7 14.4 3.4 1.6 1.7 4.0 3.0 2.5 ZNF57 ZNF424 ENSG00000171970 "Zinc finger protein 57" Q68EA5 19 2900898-2918476 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA061915 Approved Nucleoli Nucleoli "HPA061915: " "unprognostic (3.59e-2)" "unprognostic (1.53e-3)" "unprognostic (1.91e-2)" "unprognostic (8.86e-3)" "unprognostic (3.32e-2)" "unprognostic (3.07e-2)" "unprognostic (7.66e-2)" "prognostic favourable (6.26e-4)" "unprognostic (1.35e-1)" "unprognostic (4.04e-2)" "prognostic favourable (7.72e-4)" "unprognostic (2.34e-3)" "prognostic favourable (4.11e-9)" "unprognostic (6.26e-3)" "unprognostic (2.82e-2)" "unprognostic (7.35e-2)" "unprognostic (6.49e-3)" 3.6 2.9 3.6 3.2 4.7 4.0 7.3 17.2 5.7 6.2 15.7 2.3 5.1 7.8 5.6 4.2 11.0 4.7 4.0 4.2 3.3 2.7 9.2 3.9 4.9 2.9 2.6 3.2 5.4 7.4 3.9 4.1 5.8 4.2 6.1 10.1 3.6 5.5 8.7 7.4 18.6 18.5 2.1 2.4 3.6 11.7 26.4 3.9 2.9 5.4 7.0 6.6 5.0 7.9 4.9 3.6 1.4 5.8 6.3 8.4 4.1 6.8 3.2 4.5 6.6 4.3 3.8 7.6 2.9 2.3 4.7 4.9 6.7 2.7 5.8 3.8 2.4 8.1 7.1 10.1 5.9 0.0 3.7 3.4 3.8 8.8 3.3 0.0 6.4 3.0 11.3 4.1 9.0 3.5 6.0 0.1 3.7 6.9 8.8 3.8 2.9 5.7 8.2 13.8 1.3 6.4 11.3 2.3 3.4 4.3 8.1 2.8 5.0 5.6 2.8 3.3 3.2 7.4 4.1 1.2 6.6 2.9 2.7 0.9 2.5 0.0 3.3 1.4 6.5 5.8 5.4 4.9 7.1 6.7 3.6 4.9 8.4 7.4 1.2 6.3 3.1 3.4 7.1 4.1 3.6 4.7 17.2 5.7 3.3 2.7 2.6 3.2 4.2 3.9 ZNF713 FLJ39963 ENSG00000178665 "Zinc finger protein 713" Q8N859 7 55887475-55942225 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SH-SY5Y: 10.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059425, HPA062887" Uncertain Approved Nucleoli Nucleoli "HPA059425: , HPA062887: " "unprognostic (5.27e-2)" "unprognostic (2.50e-1)" "unprognostic (1.66e-1)" "unprognostic (4.97e-2)" "unprognostic (1.36e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-3)" "unprognostic (1.46e-1)" "unprognostic (7.07e-2)" "unprognostic (4.63e-2)" "unprognostic (2.77e-3)" "unprognostic (7.78e-2)" "unprognostic (4.80e-2)" "unprognostic (8.00e-2)" "unprognostic (8.16e-3)" "unprognostic (1.34e-1)" "unprognostic (1.63e-3)" 2.0 2.7 7.0 2.6 9.7 4.1 4.0 5.6 9.3 3.8 2.2 10.6 2.7 2.7 5.5 3.5 1.7 7.1 2.9 2.4 7.8 6.1 3.9 1.7 2.6 1.7 13.4 4.8 5.6 3.2 4.2 8.1 2.2 7.3 4.1 1.9 2.6 2.4 2.9 4.7 3.1 1.9 3.7 9.8 2.5 4.0 9.4 10.6 6.9 4.9 0.4 1.8 2.1 2.0 2.2 1.7 6.9 1.3 1.4 1.0 0.4 1.7 1.2 7.3 6.6 0.9 1.0 2.6 0.8 0.5 1.0 1.4 0.6 2.3 3.0 2.6 0.6 0.7 1.8 0.6 1.4 1.7 2.9 0.7 2.5 1.9 1.2 3.7 2.0 1.7 1.5 0.5 1.3 1.7 1.9 1.4 1.2 1.6 3.6 2.2 4.9 1.4 3.1 1.8 0.4 3.5 3.2 8.4 10.0 4.2 1.1 1.2 2.7 3.2 1.9 0.9 3.5 0.7 1.2 1.6 2.2 1.3 0.6 2.0 6.2 3.7 1.3 3.3 0.9 1.0 0.6 1.3 0.7 0.6 0.4 2.2 0.9 1.0 6.9 1.4 1.0 1.7 0.4 0.4 7.0 9.7 5.6 9.3 7.8 6.1 13.4 4.8 7.3 10.6 ZNF790 "FLJ20350, MGC62100" ENSG00000197863 "Zinc finger protein 790" Q6PG37 19 36817428-36850787 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056134, HPA060288" Uncertain Approved Nucleoli Nucleoli "HPA056134: , HPA060288: " "unprognostic (1.14e-1)" "unprognostic (3.79e-2)" "unprognostic (3.87e-1)" "prognostic unfavourable (7.66e-4)" "unprognostic (1.55e-1)" "unprognostic (5.10e-2)" "unprognostic (1.05e-1)" "unprognostic (1.03e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-2)" "unprognostic (4.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.48e-2)" "unprognostic (5.54e-2)" "unprognostic (1.34e-1)" "unprognostic (1.44e-1)" "unprognostic (2.85e-2)" 6.6 8.9 9.3 9.9 15.9 3.2 7.2 21.5 14.8 7.6 6.4 12.5 7.1 6.4 7.7 7.7 7.5 6.1 8.1 8.8 10.8 7.9 10.3 13.8 6.1 7.9 14.2 7.2 7.8 7.3 11.6 14.5 6.0 13.1 6.8 4.5 7.4 5.7 7.3 7.3 15.6 6.1 6.1 11.4 7.4 7.9 20.4 15.9 8.5 13.2 4.9 6.8 7.7 7.9 9.7 6.8 6.8 6.2 6.7 9.0 3.0 0.0 0.7 6.3 11.5 4.4 4.7 4.1 4.5 6.1 3.6 6.5 0.0 1.4 1.4 9.0 3.2 1.7 5.0 4.0 3.2 10.3 4.5 7.4 0.7 1.7 3.8 3.2 5.5 6.0 3.4 3.1 0.0 6.1 0.2 0.1 7.9 3.5 8.3 2.6 4.3 0.8 1.5 5.3 5.6 3.8 8.3 7.9 7.2 4.2 0.1 2.5 5.2 6.2 6.6 4.9 3.8 4.5 5.8 9.0 12.6 5.2 0.0 0.2 3.9 6.0 3.7 6.8 5.9 6.2 6.1 9.0 8.4 8.3 6.8 9.7 9.0 7.4 1.3 6.7 2.2 5.6 6.8 3.0 9.3 15.9 21.5 14.8 10.8 7.9 14.2 7.2 13.1 15.9 ZNF816 ZNF816A ENSG00000180257 "Zinc finger protein 816" Q0VGE8 19 52949379-52962911 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA042466 Uncertain Approved Nucleoli Nucleoli "HPA042466: AB_10797497" "unprognostic (1.83e-2)" "unprognostic (1.90e-1)" "unprognostic (1.64e-1)" "unprognostic (4.81e-2)" "unprognostic (3.12e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-4)" "unprognostic (1.69e-1)" "unprognostic (1.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.01e-1)" "unprognostic (3.72e-2)" "unprognostic (5.36e-3)" "unprognostic (6.21e-2)" "unprognostic (5.45e-1)" "unprognostic (8.59e-2)" "unprognostic (1.39e-2)" 6.2 6.4 4.9 8.0 8.3 2.8 8.0 14.7 6.6 10.2 8.9 4.5 12.5 4.7 6.7 10.1 8.4 12.1 9.8 5.8 5.0 3.3 9.6 3.2 7.0 7.1 10.4 3.4 9.5 8.7 6.7 11.8 9.2 6.1 15.5 10.4 4.5 8.6 9.8 2.4 5.3 7.3 8.0 9.1 11.0 9.4 5.4 8.9 18.9 10.2 5.8 8.5 14.3 9.4 11.6 8.4 14.4 7.7 17.6 17.5 7.4 4.0 0.1 3.7 9.5 6.9 7.6 10.9 3.4 3.5 4.4 6.5 3.2 2.7 10.9 7.2 3.0 2.4 5.3 3.9 4.3 5.4 11.2 5.1 4.2 4.9 2.3 0.0 7.9 3.6 5.0 2.6 5.1 3.7 8.0 0.4 5.5 3.2 8.7 5.8 4.4 5.0 4.9 8.0 5.4 6.9 32.9 2.8 5.2 0.4 5.7 2.2 3.8 5.9 3.5 3.2 3.2 2.1 3.8 3.8 10.9 10.2 0.4 5.4 3.8 10.0 7.3 14.4 13.6 6.2 17.5 9.9 12.7 13.1 8.4 11.6 17.2 13.8 4.1 17.6 7.7 8.3 11.5 7.4 4.9 8.3 14.7 6.6 5.0 3.3 10.4 3.4 6.1 8.9 ZNF837 ENSG00000152475 "Zinc finger protein 837" Q96EG3 19 58367618-58381060 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 13.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" HPA042833 Uncertain Uncertain Nucleoli Nucleoli "HPA042833: AB_10806373" "unprognostic (2.61e-1)" "unprognostic (7.62e-2)" "unprognostic (1.33e-1)" "prognostic favourable (1.27e-4)" "unprognostic (1.07e-1)" "unprognostic (7.33e-3)" "unprognostic (1.02e-2)" "unprognostic (2.75e-1)" "unprognostic (9.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.37e-3)" "unprognostic (6.02e-2)" "prognostic favourable (1.76e-5)" "unprognostic (2.35e-3)" "unprognostic (9.74e-2)" "unprognostic (1.90e-2)" "unprognostic (1.07e-2)" 3.7 3.3 4.2 2.2 5.4 1.1 2.3 1.0 6.1 3.1 2.5 2.9 1.2 4.6 3.6 4.4 3.1 5.2 3.0 1.4 2.0 1.7 5.3 10.8 3.7 2.1 1.6 0.9 4.3 5.1 2.7 4.1 3.7 2.1 3.8 1.0 2.9 4.6 2.5 1.3 5.7 6.1 1.1 1.4 4.7 4.9 2.6 1.2 9.4 7.1 1.3 5.1 2.3 2.2 0.9 0.5 0.1 0.3 0.0 1.7 0.4 2.0 1.0 1.2 1.4 0.2 0.5 2.3 2.0 0.4 0.1 0.2 0.5 2.1 2.5 1.7 0.0 0.6 0.1 0.1 0.1 1.2 13.2 1.1 0.3 0.1 0.5 0.8 0.7 0.8 0.4 0.2 0.1 0.2 1.5 0.7 0.2 2.7 5.7 2.3 3.4 3.3 4.9 0.6 2.4 0.3 1.5 4.0 5.1 1.5 1.3 2.3 1.6 1.1 0.5 3.0 0.1 0.8 0.7 3.1 2.3 2.2 1.9 0.4 0.8 0.0 0.3 0.0 1.3 0.0 1.4 0.5 1.6 0.0 0.4 0.9 1.7 0.2 0.1 0.0 0.0 0.5 0.7 0.4 4.2 5.4 1.0 6.1 2.0 1.7 1.6 0.9 2.1 1.2 ZNF853 DKFZp434J1015 ENSG00000236609 "Zinc finger protein 853" P0CG23 7 6615617-6624290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 28.9" "Cell line enhanced" "Detected in many" "AN3-CA: 14.5;SH-SY5Y: 21.6;U-2 OS: 14.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 3.1" "Group enriched" "Detected in many" 5 "granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA067690 Approved Approved Nucleoli Nucleoli "HPA067690: " "unprognostic (1.35e-3)" "unprognostic (2.63e-1)" "unprognostic (7.17e-2)" "unprognostic (8.77e-2)" "unprognostic (2.76e-1)" "unprognostic (1.96e-1)" "unprognostic (1.17e-1)" "unprognostic (3.54e-1)" "unprognostic (2.26e-2)" "unprognostic (5.06e-2)" "unprognostic (1.87e-3)" "unprognostic (9.28e-2)" "prognostic favourable (2.30e-6)" "unprognostic (4.41e-3)" "unprognostic (4.95e-2)" "unprognostic (2.30e-3)" "unprognostic (4.01e-2)" 3.7 3.9 16.6 2.9 14.4 1.0 4.6 4.5 13.5 7.8 7.7 10.4 2.8 1.8 9.4 5.9 5.6 11.8 5.8 12.3 16.1 15.5 3.3 0.9 4.5 4.3 14.8 9.1 15.6 10.6 7.3 4.5 3.7 11.9 7.6 2.5 6.0 6.7 11.5 28.9 2.4 2.7 8.5 10.1 4.3 3.6 3.0 9.9 2.6 9.9 2.7 2.7 6.5 11.7 0.3 0.4 3.1 0.0 1.1 1.5 0.3 0.0 1.1 3.4 14.5 0.1 0.0 0.1 0.3 0.0 1.5 0.3 2.5 0.5 0.0 5.7 0.0 0.0 5.2 0.1 1.5 0.0 1.9 0.4 0.0 2.6 2.1 0.0 0.1 0.5 0.5 0.2 0.0 0.0 2.2 0.0 0.9 0.1 0.3 1.8 5.4 0.0 1.6 5.7 0.1 1.1 5.4 4.6 21.6 0.0 0.2 0.9 0.8 3.0 0.0 1.1 14.5 0.0 1.3 0.3 0.1 0.0 0.0 0.0 5.6 0.0 0.0 3.1 1.2 0.0 1.5 0.3 0.8 1.4 0.0 0.3 0.2 1.4 0.0 1.1 0.0 0.4 0.0 0.3 16.6 14.4 4.5 12.4 16.1 15.5 14.8 9.1 11.9 9.9 ZSCAN1 "FLJ33779, ZNF915" ENSG00000152467 "Zinc finger and SCAN domain containing 1" Q8NBB4 19 58034032-58054631 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.7;epididymis: 16.4;pituitary gland: 15.8" "Cell line enhanced" "Detected in some" "EFO-21: 6.2;HMC-1: 4.3;NTERA-2: 4.4;T-47d: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA007938 Uncertain Approved Nucleoli Nucleoli "HPA007938: AB_1080768" "unprognostic (1.60e-3)" "unprognostic (2.44e-1)" "unprognostic (2.21e-1)" "unprognostic (3.58e-1)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (1.97e-2)" "unprognostic (1.29e-1)" "unprognostic (3.34e-1)" "prognostic favourable (7.36e-4)" "unprognostic (1.41e-2)" "unprognostic (3.81e-2)" "unprognostic (1.26e-2)" "unprognostic (1.09e-2)" "unprognostic (1.32e-1)" "unprognostic (2.47e-2)" "unprognostic (3.60e-1)" 0.9 2.2 7.0 0.7 9.5 0.9 3.2 4.0 13.7 2.2 0.8 6.5 1.0 0.8 1.7 16.4 0.8 4.3 1.3 1.6 6.3 9.7 2.8 0.7 1.4 0.8 6.0 6.7 0.9 2.1 7.3 15.8 1.3 8.2 3.7 0.7 3.4 1.6 3.0 0.8 0.8 1.0 1.1 3.7 0.9 1.0 13.3 2.4 0.9 8.1 0.0 0.7 1.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 0.0 1.5 0.1 0.0 0.0 0.0 6.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 4.4 0.0 0.0 0.0 0.0 0.0 1.3 0.4 1.3 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 9.5 4.0 13.7 6.3 9.7 6.0 6.7 8.2 2.4 ZXDC "FLJ13861, MGC11349" ENSG00000070476 "ZXD family zinc finger C" Q2QGD7 3 126437601-126475919 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049593 Approved Nucleoli Nucleoli "HPA049593: " "unprognostic (3.06e-1)" "unprognostic (2.00e-2)" "unprognostic (2.65e-1)" "unprognostic (2.81e-3)" "unprognostic (1.59e-1)" "unprognostic (6.53e-2)" "prognostic unfavourable (2.27e-4)" "unprognostic (3.06e-2)" "unprognostic (5.97e-2)" "unprognostic (4.34e-2)" "unprognostic (3.37e-2)" "unprognostic (2.67e-2)" "unprognostic (1.06e-1)" "unprognostic (8.13e-2)" "unprognostic (2.98e-1)" "unprognostic (4.66e-2)" "unprognostic (1.12e-3)" 13.4 9.7 11.5 8.5 13.1 44.5 12.6 15.9 11.7 12.1 10.6 16.0 12.3 6.9 14.4 12.0 11.9 12.3 10.3 8.5 10.5 5.7 10.2 14.9 10.6 9.9 17.4 7.9 15.7 19.3 19.2 11.9 9.9 10.9 12.4 7.6 13.4 13.2 9.7 28.9 18.0 10.2 10.0 10.5 11.0 9.8 9.0 13.2 14.1 11.6 8.5 9.1 14.5 12.3 1.0 2.2 2.5 7.6 0.8 1.1 0.4 13.9 7.2 9.1 8.5 9.9 7.8 16.1 6.4 7.1 9.4 8.4 10.8 6.1 10.4 10.9 5.7 11.6 12.0 7.4 7.4 5.6 10.2 8.1 8.3 7.0 10.6 12.4 13.3 6.1 14.5 5.7 10.4 9.5 8.7 14.0 7.8 8.1 11.9 6.9 12.8 7.3 13.0 6.1 13.1 6.6 10.1 16.5 9.2 12.3 9.0 16.9 12.2 11.1 9.6 8.6 11.2 12.9 7.7 11.7 5.5 13.8 9.4 9.8 9.5 2.4 0.8 1.6 1.1 0.4 0.4 0.3 0.8 0.8 1.4 1.0 1.1 1.0 2.5 0.8 7.6 2.2 0.5 0.4 11.5 13.1 15.9 11.7 10.5 5.7 17.4 7.9 10.9 13.2